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Abstract

The general aim of this work was to develop novel synthetic approaches to the 1hydroxytropane and 1-hydroxynortropane class of compounds from the structurally
advanced alkaloids, scopolamine 9 9 and castanospermine 7, which are isolated from
Australian plants.
This project consists of two parts. The first part (Chapter 2) deals with the
preparation of 3a-hydroxyphysoperuvine 1 0 3 from scopolamine. This was achieved in
nine steps with an overall yield of 1 6 % . The main steps in this synthesis included the
deoxygenation of scopolamine and the Meisenheimer rearrangement of a tropane Noxide. The deoxygenation of scopolamine was achieved using zinc-copper couple in a
near quantitative conversion to give 6,7-dehydrohyoscyamine 111. The thermolysis of
3a-f-butyldimethylsiloxy-8-methyl-8-azabicyclo[3.2.1]oct-6-ene axial /V-oxide

161

proceeded quite readily, giving a 5 3 % isolated yield of the Meisenheimer rearrangement
product (1R*, 3 S * , 5S*) -3a-tazabicyclo[3.2.2]non-6-ene

butyldimethylsiloxy - 9 - methyl - 8 - oxa - 9 -

164. The thermolysis of 3a-f-butyldimethylsiloxy-8-

methyl-8-azabicyclo[3.2.1]oct-6-ene equatorial /V-oxide 1 6 2 did not proceed as readily,
but it still gave the Meisenheimer rearrangement compound 1 6 4 in a 1 4 % isolated yield.
The 3a-hydroxyphysoperuvine 1 0 3 did not show any glycosidase inhibition activity.
Chapter 3 deals with the mechanistic aspects of the Meisenheimer rearrangement
of the tropane TV-oxides 1 6 1 and 162. Rate studies showed that the /V-oxide 1 6 1
rearranged approximately seven times faster than 1 6 2 at 100°C in D M S O - d g . Computer
modelling studies failed to give a definitive answer as to w h y one /V-oxide rearranged
faster than the other.
The steps towards the total synthesis of the naturally occurring compound, 1hydroxytropacocaine 1 5 were also investigated (Chapter 4). A Mitsunobu reaction
carried out on the model compound 8-methyl-8-azabicyclo[3.2.1]oct-6-en-3a-ol 1 3 8
was successful in inverting the stereochemistry at C 3 to give 6,7-dehydrotropacocaine
183. However, using this procedure to invert the stereochemistry at C 3 of [3S-

vi

(la,5a,3p)]-heptafluorobutyric acid 3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-l-yl
ester 1 8 2 was not successful. Hence 1-hydroxytropacocaine was not synthesised.
The second part of this project involved the attempted conversion of
castanospermine 7 via ring cleavage modification to give 2,3,4,6-epicalystegine C I 106.
The ring cleavage of a mixture of TBDMS-protected castanospermine with excess methyl
chloroformate gave a mixture of piperidine carbamates 202-205. The removal of the
TBDMS

groups

with

tetrabutylammonium

fluoride

gave

in

good

yield

(lS,6S,7R,8R,8aR)-l-(2'-chloroethyl)-l,5,6,7,8,8a-hexahydro-6,7,8-trihydroxy-3i/oxazolo[3,4-<z]pyridin-3-one 2 1 6 . The dechlorination of 2 1 6 gave in good yield the
corresponding olefin 2 0 9 . Hydrolysis of 2 0 9 yielded a new derivative 2 1 7 related to 1deoxynojirimycin 5 which was tested for glycosidase inhibition. However, it showed no
activity against a range of enzymes. This was the extent of the approach to 106. The next
main step in this synthesis required the oxidation of a carbamate to insert what would
eventually be the bridgehead hydroxyl. The oxidation of a model compound methyl 1piperidinecarboxylate with ruthenium tetroxide gave the corresponding methyl 2-oxo-lpiperidinecarboxylate in good yield. However all attempts to oxidise a range of
carbamates derived from castanospermine failed to yield any of the required oxidised
products.
Although the olefin 2 1 7 did not show any glycosidase enzyme inhibition activity,
it does provide the basis for the elaboration of a range of n e w polyhydroxylated amine
derivatives in the future.
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Chapter 1:
General Introduction
1.1 Antiviral Drug Discovery
There are m a n y viruses that are responsible for a high morbidity and or mortality
in humans. These viruses include human immunodeficiency vims (HIV), herpes viruses,
hepatitis B virus, influenza virus plus many other exotic viruses. There is a great need
for a diverse range of anti-viral compounds that can combat this viral onslaught.
For a compound to show anti-viral activity it must target a unique biochemical
event which is specific for viral replication, not cellular growth. The search for n e w
anti-viral lead compounds has resulted in the screening of thousands of natural and
synthetic compounds. F r o m these anti-viral screens, only one or two compounds are
considered for further evaluation each year.
The virus that has seen the most research in the last few years is unquestionably
HIV. The life cycle of H T V is complex 1 ' 2 but it presents a large number of possible
targets for chemical intervention (Figure 1).
HIV T4 Cell

Figure I. H I V Life Cycle2
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The most prominent of these targets is the virus-coded reverse transcriptase (RT),
step three in the life cycle of HIV. This particular function is unique to viruses, therefore
a drug that specifically targets this process will not harm any cellular activity.
C o m p o u n d s that have been developed to target R T include a variety of nucleosides2 of
which 3'-azido-3'-deoxythymidine 1 ( A Z T ) is one.
Since the discovery of the therapeutic importance of this n e w class of
compounds, organic chemists and natural product chemists have synthesised or isolated
m a n y structural analogues in the hope of developing a more potent and selective drug.
There are n o w over 800 nucleosides in the United States National Institute of Allergy and
Infectious Diseases H I V data base, a large proportion of these are synthetic2.
Recently there has been discovered a novel class of anti-viral compounds that
target step twelve in the H T V life cycle, protein glycosylation. O n e compound,
6-O-butyryl-castanospermine 2 has been shown to be as effective as A Z T in inhibiting
splenomegaly in Friend leukemia virus infected mice 3 .

HO
HO

H OH

C H 3 C H 2 C H 2 C 0 2 **'

3'-Azido-3'-deoxythymidine (AZT)

6-O-Butyryl-castanospermine

The exact understanding of how this new class of compounds are exerting their
anti-HIV effect is still under investigation4. It is known, however, that they are all potent
inhibitors of the first stage of the protein glycosylation step involving the enzyme
a-glucosidase I.

3

1.2 Glycoproteins and Protein Glycosylation
Glycoproteins are a large and varied group of proteins that are involved in a wide
range of important biological processes including enzymatic reactions, molecular
recognition events and cell-cell interactions.
All glycoproteins, whether from the cell or virus, mediate the same
post-translational pathway (Scheme l)5. This process begins inside the endoplasmic
reticulum (ER) of the cell with two glucosidase glycoprotein processes involving
oc-glucosidase I and a-glucosidase n. The a-glucosidase I enzyme is specific for the

terminal glucose residue, after which the a-glucosidase II enzyme cleaves the remain
two glucose units as monomers. There is one ER mannosidase process which selectively
cleaves one mannose unit. Further processing occurs in the Golgi by another two
glycoprotein processes involving a-mannosidase I and a-mannosidase U.
Glc
i
Glc

High-mannose
glycans

Glc
Glc

I
Glc
Man Man Man
Man Man Man
Man jMan
ER
Man
a-Glucosidase I
GlcNAc

i31 Man
Man
M: Man

•

M

I

Man

Y Man Man
Man
Man
^M
Ian
"" GlcNAc
I
GlcNAc
I
—Asn-

ER

^Man q-Glucosidasen
GlcNAc
GlcNAc

GlcNAc

I

I

—Asn-

—AsnComplex
type

Hybrid
type

GlcNAc

GlcNAc

Man Man
Man Man
Man ^Aan
^Man GlcNAc
Man
Golgi
Transferase I
GlcNAc Mannosidase II GlcNAc

|
GlcNAc
—Asn- —Asn-

""

I
GlcNAc

Man

B fan

n

Man Mi

an

M™

• *" Man Man

Man J, A,

cr)

j Man,Man
Man Man
Man

Mannosidase • GlcNAc

I
GlcNAc
Golgi
Mannosidase I
Man Man
Man Man
Man
GlcNAc
I
GlcNAc

Oligosaccharide processing of N-Linked glycans by E R and Golgi glycosadases
Glc = D-glucose, M a n = D-mannose, GlcNAc = Af-acetylglucosamine, Asn = asparagine

Scheme 1
The addition of GlcNAc and other sugars by the Golgi-bound transferases
produce mature high-mannose, hybrid and complex type glycans (Figure 2)5. These

glycans, which are attached to proteins, are often vital for their correct performa
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molecular recognition events and cell-cell interactions. A s mentioned earlier, a n e w class
of compounds has been discovered that inhibit glycoprotein processing and a few of
these compounds have been reported to inhibit HIV replication in vitro6'11 The

compounds that have been reported to inhibit HTV replication in vitro have all been po
a-glucosidase inhibitors. These compounds are effective because HTV and other
enveloped viruses contain glycoproteins in the envelope which are obligatory for
successful replication.

SA

SA

I

Man Man Man

Gal Gal

I Man Man
Man
Man
Man

GlcNAc GlcNAc
Man Man
Man
I
GlcNAc
I
GlcNAc
I
—Asn-

GlcNAc
I
GlcNAc
I
—Asn-

High Mannose Glycan

I

SA

I

Gal
Gld Ac
f Man Man
Man
Man
Man
I
GlcNAc
GlcNAc
I
—Asn-

Hybrid Glycan

Complex Glycan
General structures of high mannose, complex and hybrid glycans, S A = sialic acid, Gal =galactose
Glc = D-glucose, M a n = D-mannose, GlcNAc = N-acetylglucosamine, Asn = asparagine

Figure 2

A s well as inhibiting the post-translational processing of glycoproteins, these
compounds have also been reported12 to inhibit a large range of other glycosidase
processes including ones involved in intestinal digestion and lysosomal catabolism.

1.3 Polyhydroxylated Alkaloid Glycosidase Inhibitors
This new class of compounds are known as polyhydroxylated alkaloid
glycosidase inhibitors. Within the last two decades a large number of these alkaloids
been isolated from plants and microorganisms. These natural compounds can be grouped
into five different sub-classes. They are the pyrrolidine, nortropane, piperidine,
pyrrolizidine and indolizidine alkaloids. Examples of each of these include
2R,5R-dihydroxymethyl-3R,4R-dihydroxypyrrolidine (DMDP) 3, calystegine Bi 4,
1-deoxynojirimycin 5, australine 6 and castanospermine 7 respectively.

5

OH

W

OH

HO

OH

OH

A n i, in l y — — ,

HN V-

-N
H

OH

I \-J
HO 't)H
CalystegineBl

3
DMDP
HO

HON
1 -Deoxynojirimycin

OH

HO
6
Australine

Castanospermine

These compounds can be viewed as analogues of sugars in which the oxygen of

the pyranose or furanose ring is replaced by nitrogen; they are commonly referred t
amino-sugars or aza-sugars. It is this mimicry of sugars that give these compounds

ability to inhibit glycosidase processes. All of these amino-sugars are of biologic

interest because of their biological activity which includes anti-viral, anti-bacte
anti-tumour and anti-diabetic activity13'14.

1.4 Therapeutic Potential of A m i n o Sugars
An analogue of 7, 6-O-butyryl-castanospermine 2, a strong a- and P-glucosidase

inhibitor, reached phase II clinical trials as an anti-HIV drug. The increase in th

lipophilicity of 6-<9-butyryl castanospermine improves the cell's ability to absor
drug. However, it appears that the 6-0-butyryl-castanospermine is converted to

castanospermine inside the cell and it is the free castanospermine that is the acti
An analogue of 5, N-butyl-l-deoxynojirimycin 8, another strong a- and

P-glucosidase inhibitor, is also in clinical trials for the control of HIV infectio
However, one complication that has been noted from the oral administration of

A/-butyl-l-deoxynojirimycin is the acute onset of osmotic diarrhoea which is attrib
the inhibition of intestinal disaccharidases. Since initial Phase I testing, a pro

of 8, an O-butanolated ester of 8, has been developed which does not cause diarrhoe

6

Analogues of 1-deoxynojirimycin are also being considered as potential anti-diabetic
agents5. This anti-diabetic activity is a result of inhibition of intestinal dissacharridases by
1 -deoxynojirimycin.
T h e indolizidine alkaloid, swainsonine 9, is a potent inhibitor of lysosomal
a-mannosidase as well as Golgi a-mannosidase n 1 7 ' 1 8 and has also been shown to have
anti-metastatic activity19. The anti-metastatic activity is attributed to its potent Golgi
a-mannosidase inhibition. A s a result of this anti-metastatic activity, it is in Phase I trials
as an anti-cancer drug 20 . Results so far appear to show minimal toxicity when 9 is
administered intravenously to patients at levels high enough to inhibit both Golgi
a-mannosidase II and lysosomal a-mannosidase20.

HO
HO

HO

OH

H O >

YMU
N

CH3CH 2 CH 2 C02 * " ' ^ ' ^

HO-<

N^X^s/

?H

?H

8

0>

N-Butyl-1-deoxynojirimycin

Swainsonine

\—/

/

HO*

2
6-0-Butyryl-castandspermine

H

OH
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1.5 A m i n o - S u g a r s as Synthetic Targets
T h e potential that amino-sugar glycosidase inhibitors have as tools in the fight
against m a n y diseases has lead to strong interest in and demand for, these compounds.
T h e isolation of these compounds from natural sources are usually difficult and costly.
This has lead to m a n y synthetic approaches to these natural compounds as well as to
m a n y of their stereoisomers and analogues.
The compound which has seen the most synthetic approaches is castanospermine.
A review carried out in 1992 titled " Synthetic Approaches to Stereoisomers and
Analogues of Castanospermine" describes nine synthetic approaches to castanospermine,
plus the synthesis of twelve of the possible thirty-two stereoisomers of
castanospermine21. Since this 1992 review there have been at least another four synthetic
routes to castanospermine as well as numerous synthetic approaches to more

7

stereoisomers and structural analogues of castanospermine22"40. Castanospermine,
however, has been commercially extracted by Phytex Australia Pty Ltd., for the past few
years, from the seeds of Castanospermun australe. This has abated the need somewhat
for a commercial synthetic approach to castanospermine.
1-Deoxynojirimycin has also been the focus of many synthetic approaches. Most
of these are based on a chiral starting material, in particular, glucose. A major review,
published in 1994, dealt with the literature up to December 1992, outlining many
synthetic approaches to 1-deoxynojirimycin and its analogues5. O n e of these approaches,
which was undertaken by Berger et al, sought to introduce an ethyl extension at the C 6
position of 1-deoxynojirimycin41. Their research program was designed to evaluate the
influence of increasing the kpophilicity of 1-deoxynojirimycin by the extension of the
side chain at the C 6 position. This was achieved by the synthesis and biological
evaluation of (6S)-6-C-ethyl-1-deoxynojirimycin 10.
H

? H 0H

10

The most recent class of polyhydroxylated alkaloids to be discovered are the
1-hydroxy-nortropane alkaloids (calystegines). Calystegine Bi is a potent inhibitor of
P-glucosidase14. It is comparable in potency to castanospermine. Calystegine Bi is,
however, not classed as an inhibitor of a-glucosidase although it does show weak
activity42 towards the a-glucosidase enzyme derived from rice (IC5o=7.5xlO" 5 M). A
mixture containing calystegines A 3 12 and Bi 4 and B 2 11 showed no H I V inhibition43.

8

A s yet there has been very little synthetic work carried out on the
1-hydroxy-nortropane family of alkaloids and their analogues. While strong aglucosidase activity has yet to be found in any of the plant derived 1-hydroxy-nortropane
alkaloids, basically no synthetic work has been carried out to investigate structure-activity
relationships which might help to develop potent a-glucosidase activity. There is a need
for the synthesis of more analogues of the 1-hydroxynortropane series for structureproperty studies, which would hopefully lead to the synthesis of new, more powerful
and selective a-glucosidase inhibitors, which could in turn help in the fight against the
H T V epidemic.
Our main interest was to develop a convenient synthetic approach to the 1hydroxy nortropane and tropane skeleton using structurally advanced, commercially
available alkaloids from Australian plant sources as starting materials. Our other interest
was to carry out a biological activity evaluation of all intermediates involved in this
project, including C 6 derivatives of 1-deoxynojirimycin. This approach has the added
possibility of value adding to an Australian export product.

1.6 Past Synthetic Approaches to the 1-Hydroxytropane and
1-Hydroxynortropane Alkaloids.
T h e novel structural feature c o m m o n

to the 1-hydroxytropane and

1-hydroxynortropane alkaloids is the hemi-aminal functionality at the bridgehead
position. This structural feature induces these compounds to exist as an equilibrium of
tautomeric forms 13a ^=? 13b and 14a *=? 14b.

R
N

O

i>

13a ^7 13b, R = Me, 1-Hydroxytropane (physoperuvine)
14a ^ 14b, R = H, 1-Hydroxynortropane

9

The first 1-hydroxytropane alkaloid to be discovered was physoperuvine 13a *=?

13b which was isolated from the roots of Physalis peruviana (Solanaceae)44. On
other 1-hydroxytropane has been discovered, that being 1-hydroxytropacocaine

the leaves of a green house cultivated plant, Erythroxylum novogranatense var
novogranatense (Erythroxylaceae)45.
Me
N

HO

^A^-OCOPh

15
1 -Hydr oxytropacocaine
Five synthetic approaches (three racemic and two enantioselective) to

physoperuvine have been developed. The first racemic synthetic approach empl
the key step, a ring enlargement of 4-aminocyclohexanone 18 with
A/-nitrosomethylurethane to provide physoperuvine46 (Scheme 2).

MeNH

MeNH

MeNH

n

Physoperuvine
i) H2 cat. ii) Chromic acid, iii) Na2C03, AT-nitrosomethylurethane 0°C, 71% from 17
Scheme 2
The second synthesis of racemic physoperuvine47 was similar to the first, in that

the same type of ring expansion of cyclohexanone was employed. The mechanism of th

ring enlargement is illustrated in Scheme 3. The formation of 21b occurred as a si

product of the reaction conditions, in 3% yield. The major product was 21a which w
obtained in 31% yield.
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,+ CI-

NHBn

NHBn

Physoperuvine

21a R=H, 21b R=Me
i) 1. CeHsCHO, toluene reflux, then EtOH, Na, reflux, 6 4 % 2Jones
oxidation, 50%. ii) MeOH, Diazald, 29%. iii) H2 Pd/C

Scheme 3
The third racemic synthesis had as its key step a Diels-Alder addition of a nitroso

compound to cyclohepta-l,3-diene 22 (Scheme 4). This step inserts what will finally b
the bridgehead nitrogen and the important bridgehead hydroxyl group. The next four
steps are straight-forward chemistry which includes reduction of a double bond, N-0

bond cleavage, removal of the carbamate protecting group and finally oxidation of the

alcohol to give racemic physoperuvine in an overall yield of 79% from cycloheptadiene

N^R

O

R=PhCH2OCO

N^R

o o

22

O'

HO

Physoperuvine 26
i) PhCH2OCO-N=0 97%. ii) HN=NH 94%. iii) Na-Hg 98%. iv) LiAHLj 94%. v) Jones

Scheme 4
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T w o entioselective syntheses of physoperuvine have also been published. The

first synthesis used a chiral rhodium-complex catalysed enantiospecific isomeriza
meso-ene-l,4-diol bis-TBDMS ether 28 to give 29. Deprotection of 29 with

tetrabutylammonium fluoride (TBAF) then HF gave (S)-4-hydroxycycloheptenone 30 in

96% yield. Protection of the alcohol as the mesylate followed by displacement wit
aqueous methanolic methylamine then gave (S)-(-)-physoperuvine49 (Scheme 5).
TBDMSO

TBDMSO

TBDMSO

27

28
MeNH

MesO
IV

(SM-)-Physoperuvine

31

30
+

i) TBDMSC1, imadazole, D M F , 86%. ii) 2 mol % chiral [Rh{(R)-binap}(cod)] C104 ,
C1CH 2 CH 2 C1 reflux 24h. iii) BU4NF, T H F 0°C 9 6 % then HF-MeCN (1:19) iv) methanesulfonyl
chloride, pyridine, 0°C -> RT. (82%). v) 4 0 % aq MeNH 2 -MeOH, RT. (57%)

Scheme 5
The second stereoselective synthesis of physoperuvine (Scheme 6) used
deprotonation of tropinone 32 with a chiral lithium amide derivative 33 to give

lithium enolate in over 95% ee. Treatment of this enolate 34 with benzyl chlorof

(CBz-Cl) gave the ring opened cycloheptenone 35 in 85% yield. Epoxidation follow
by Wharton rearrangement gave a mixture of alcohols 37 in 50% yield. Oxidation

followed "by reduction of the double bond and removal of the Cbz protection grou
(+)-physoperuvine in 95% ee50.
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IV

MeNH
VI

/

/

ROOC
(+)-Physoperuvine

ROOC
37

38
Me Me

i) LiCl, Li-amide, ii) CbzCl. iii) H ^ , K O H
iv) N H 2 N H 2 v) PDC vi) H2/Pd

Ph-^N^Ph

A
33
Li-Amide

Scheme 6

The 1-hydroxynortropane alkaloids, calystegines A 3 12, Bi 4 and B 3 41 were
first discovered in the root secretions of Calystegia sepium a m e m b e r of the
Convolvulaceae family51. M o r e recently calystegine A 3 12 A 5 39 A 6 40 Bi 4 B 2 11 B3
41 Ci 42 C 2 43 and N l 44 have been isolated from plants representing the Solanaceae
and Moraceae families52"54.
It was shown that the calystegines A 3 , Bi and B 2 stimulate the growth of the
nitrogen fixing bacterium, Rhizobium meliloti 41 by serving as a source of carbon and
nitrogen55. There is also evidence that calystegines m a y play a role in plant defence
mechanisms and plant-insect interactions56. M o r e importantly, though, the calystegines
have been shown to be potent glycosidase inhibitors42,14,53.
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Synthetic studies on calystegines have lead to the total synthesis of racemic
calystegine A 3 from ring enlargement of an aminocyclohexanone 47 , the total
enantioselective synthesis of (+) and (-)-calystegine B 2 as well as a 7-hydroxymethyl
substituted calystegine B 2 from D-glucose57"59 and both enantiomers of calystegine A3
from cycloheptatriene60.
The synthesis of racemic calystegine A 3 was the result of an extension of the
chemistry employed by Lallemand et al. to the synthesis of physoperuvine by ring
enlargement of aminocyclohexanone47.
The synthesis of calystegine A 3 required the introduction of hydroxy groups at
the two and three positions on the tropanering.This was achieved viaringenlargement
of the aminocyclohexanone 45 by cyclopropanation of the derived silyl enol ether 46.
Cleavage of the three membered ring upon treatment with iron (IE) chloride followed by
dehydrochlorination with sodium acetate, yielded the a, p- unsaturated ketone 48
(Scheme 7).
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NHCbz

NHCbz

NHCbz

NHCbz

OSiMe 3
46
i) Me3SiCl, Et3N, D M F , 50°C, 18h, 94%. ii) CH2I2, Zn/Ag, Et20,18h, 35°C.
iii) 1) FeCl3, D M F , 0°C, 2h. 2) NaOAc, MeOH, 60°C, 2h, overall yieldfrom44: 63%

Scheme 7

Epoxidation of the double bond with alkaline hydrogen peroxide then gave a

mixture of trans epoxides which were separated by HPLC. The epoxide 50 was trea

with perchloric acid to give the diol 51. Hydrogenolysis of 51 then gave calyst
(Scheme 8).

NHCbz

NHCbz

NHCbz

m
OH

O
Calystegine A 3

i) H2O2, NaOH, CH3OH, -5°C, 3h. (75%, 1:1). ii) aq. HC104
14%, THF, rt, 18h. (40%). iii) H2 Pd/C 10%, M e O H

Scheme 8
Lallemand then extended the ring enlargement via cyclopropane technology to the

synthesis of (-)-calystegine B2 from D-glucose. The first part of the synthesi

convert D-glucose to the cyclohexanone 56 from which the cyclopropane ring expa
via 58 yielded the cycloheptanone 60 (Scheme 9).
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Me3SiO
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BnO- T""c
OBn
OBn
57 R = OTBDMS 56
O
BnO,

U

<J

BnO

BnC

61

i) l)PhCHO, ZnCl2 2) NaH, BnBr, D M F 3) HC1, MeOH, 50% ii) I2, PPh3, imadazole, PhCH3 85%, iii) NaH,
BnBr, DMF, 0°C, 60%. iv) Hg(OAc)2, Acetone, H 2 0,1% CH 3 COOH, 64% v) t-BuMe2SiOTf, 2,6-lutidine,
CH2C12,, 90%. vi) LDA, TMSCl THF, -70°C, 70%. vii)Et2Zn, CH2I2, PhCH3,0°C. viii) FeCl3, D M F 70°C, 2h
ix) AcO"Na+, MeOH,reflux(61: 49% from 57)

Scheme 9

Compound 60 was converted to calystegine B2 by dehydrochlorination to 61

(Scheme 9) then reduction of the double bond (Scheme 10). The ketone 62 was

to give a 1:1 mixture of alcohols which were separated. Mesylation of the a
followed by displacement of the mesylate group by an azide group permitted

incorporation of the nitrogen. Removal of the TBDMS group then oxidation an

deprotection followed by treatment with base yielded (-)-calystegine B2 (S
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\__/

Bnd"

OTBDMS

66

i)H2, Pd/C 10%, EtOH, 90%. ii) 1) NaBH* dioxane, 20°C iii) MsCl, DMAP, Pyridine, iv) NaN3
DMF, 80°C, v) 1) B114NF, THF 2) PCC, CH 2 C1 2 12h, 85%. vi) H 2 , Pd/C 10%, AcOHaq 2) NaOH
H 2 0,60%
Scheme 10

Lallemend later published a full paper that also included the synthesis of

(+)-calystegine B261. This was achieved by silyl deprotection of 61, then re

the mesylate which was then displaced by azide after reduction of the ketone

oxidation of 72 followed by deprotection and basification yielded (+)-calys
(Scheme 11). Testing results showed that (+)-calystegine B2 is the natural
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BnO,

BnQ,
BnO

BnO-^

BnO" OTBDMS BnO* OH
61

OH
BnO*^ fl

HO

BnOC

(+)-Calystegine B2

71

i) n-Bu4NF T H F (73%) ii) MsCl, pyridine (72%) iii) DB3ALH, Et 2 0, -60°C
iv) NaN 3 , r.t (71: 55%, 70 : 10%) v)Dess-Martin reagent, pyridine, CH 2 C1 2 , r.t
vi) H 2 Pd/C 10%, AcOH/H 2 0 vii) Permutite 50, aq. N H 3
Scheme 11

This, however, was not the first published enantioselective synthesis of
i

calystegine B2. A few months earlier than Lallemend's publication of (-)-calystegine B2,
Dureault et al published a synthesis57 of 7-(S)-hydroxymethyl-calystegine B2 82. In
this synthesis the protected a-D-methylglucoside 74, derived from glucose, was
converted to the ethylenic ester 75 in a one pot, two step reaction. The complete
reduction of 75 gave the alcohol 76 in 95% yield. The iodination of 76 followed by

elimination gave the olefin 77. Acetolysis of 77 then gave the pyranose 78 which wa

refluxed in methanol with hydroxylamine, hydrochloric acid and sodium acetate to gi
the oxime 79. Intramolecular cycloaddition of an olefinic nitrile oxide 79 to give
isoxazoline 80 was achieved with aqueous sodium hypochlorite in dichloromethane. A

Mitsunobu reaction on 80 gave, with inversion of configuration, the azide 81. The t
hydrogenolysis of 81 yielded 7-(S)-hydroxymethyl calystegine B2 (Scheme 12).
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OMe

81

82

i) DMSO/(COCl)2, -78°C, Et3N, -78°C to 40°C, then Ph3P=CHC02Et, -40°C to rt, 8 1 % ii) 1)
H 2 , Ra/Ni, M e O H ,rt2) AIL1H4 Et20,0°C tort,9 5 % iii) 1) I2, PPh3, CH 2 C1, py, 0°C 2)
t-BuOK, THF, rt, 7 7 % iv) 1) Ac 2 0, H 2 S 0 4 (cat), CHC1 3 ,rt2) MeONa, M e O H , rt 8 1 % v)
N H 2 O H , HC1, CH 3 ONa, M e O H , reflux, 3h, 9 4 % vi) 1.75M aq. NaOCl, CH 2 C1 2 , 20°C, 20h, 5 0 %
vii) Zn(N3)2, Mitsunobu viii) Pd/C 8 0 % aqueous acetic acid, 3 days, 4 5 %

Scheme 12

Dureault then converted 80 to (+)- and (-)-calystegine B2 5 7 . This was achieived

by the protection of the alcohol of 80 as either the methoxymethyl ether or the tosylate.
Hydrogenolysis and cleavage of the hydroxymethyl group gave 84a/84b. Reduction of
84a/84b with diisobutylaluminium hydride gave quantitatively, with greater than 9 5 %
selectivity, 85a/85b. A zinc azide mediated substitution of 85a, followed by
deprotection and oxidation, gave (+)-calystegine B2. A n azide nucleophilic substitution
performed on the tosylate 85b followed by oxidation and deprotection gave
(-)-calystegine B2 82 (Scheme 13).
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83bR = Ts

OBn
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OBn
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^ PBn
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ROC bBn
85a/85b

(+>Calystegine B 2

OH
(-)-Calystegine B 2

i) 1) M O M C 1 , iPr2NEt, CH 2 C1 2 ,20°C or TsCl, pyridine, 20°C 2) H 2 Ra/Ni, M e O H : H 2 0 , B(OH) 3
ii) excess DMSO/(COCl) 2 Et3N, -60°C iii) Zn, T M E D , AcOH, EtOH, 2h iv) DIB AIH, Et 2 0, -50°C
v) 1) Zn(N3)2, PPlb, D I A D 2) M e O H , H + , 8 1 % 3) Swern oxidation, 9 5 % 4) H 2 , 6 0 % vi)l) NaN 3 ,
D M F , 80°C, 7 8 % 2) Swern oxidation, 9 5 % 3) H 2 , 6 0 %
Scheme 13

Both enantiomers of calystegine A3 have been synthesised59. They were derived

from cycloheptatriene using enzyme-catalyzed transesterification as t

14). The diol 87, obtained from cycloheptatriene 86, was treated with

Amano P-30 lipase (from Pseudomonas cepacia) to give the optically ac

88 in 91% yield. This was then converted into both enantiomers of cal
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Calystegine A 3
Scheme 14

1.7 C 6 Modified Derivatives of 1-Deoxynojirimycin
There has only been one study carried out that has looked at the C6

of 1-deoxynojirimycin. This research41 compared the glucosidase inhi

1-deoxynojirimycin 5 and castanospermine 7 with 1,6-dideoxynojirimy

(6S)-6-C-ethyl-1-deoxynojirimycin 10 and a 6-deoxyfluoro derivative
1-deoxynojirimycin, 89.

HO

H

OF

OH

HO

1H O H

H

OH

10
HO

HO,
HOv

HO**
89

H
NH

90

The results of the glycosidase inhibition studies, showed that the enzyme

inhibitory activity of 10 against a-glucosidases from yeast (Ki = 3p

0.023pM) was superior to those of castanospermine (Ki > 1500 = 0.01

* In this test there was a slow approach to the inhibition equilibrium; Ki refers to thefinalstate.
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1-deoxynojirimycin (Ki = 460 and 0.16pM) and it was also superior to those of 89 (Ki =
340 and 15pM) 90 (Ki = 1560pM and inactive)41.
The synthesis of 10 started from the known lactol 91. Treatment of 91 with

ethylmagnesium bromide in ether gave an inseparable mixture of diastereomeric diol

The full protection of this mixture as the MOM ethers gave a separable mixture of

diastereomers. The removal of the f-butyldimethylsilyl protecting group from the l

polar diasteroisomer 93 gave the alcohol 94 which after O-sulfonylation with trif
anhydride, followed by treatment with sodium azide gave the azidodeoxyoctose

derivative 95. The removal of the protecting groups followed by reductive cyclisat
gave (6S)-6-C-ethyl-1-deoxynojirimycin4110 (Scheme 15).
TDn.,cn

TBDMSO TBDMSO
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T O
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2~5-J""°yJ— HO-V"V V'9 ii MOMO-^^%.,,0
^

H d ^ V X
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iii

HO
0
OH MOMO—f>^ N..,,o MOMO-y^Y^V.q
MOMO'
94

HO

-oK

OH

HO.

i) ethylmagnesium bromide, ether. ii)chloromethyl methyl ether, N-ethydiisopropylamine.
iii) BIMN+F-, THF. iv) triflic anhydride, NaN3, DMF. v) Amberlite IR 120 [H+]>
acetonitrile/water (1:1). vi) Pd/C 5%
Scheme 15
The compound 89 was synthesised earlier by the same group. This synthesis was

glucose based and by differential protection, the C6 hydroxy compound was convert
the fluoride by displacement of the triflate62 (Scheme 16).
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HO*'—NH
97 89

Scheme 16

The glucosidase testing results of compound 90 for this study were obtaine

from Kajimoto63 et al.. The synthesis of 90 was achieved by the catalytic h
of 98 (Scheme 17).
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'

H2, Pd/C f
90

Scheme 17
1.8 Aims of this Project
The synthetic approaches to the 1-hydroxytropane and 1-hydroxynortropane
alkaloids so far developed, involve a wide range of novel chemistry. The

developed for the synthesis of the highly hydroxylated compound, calysteg

glucose based and consist of more than ten synthetic steps with an overal
than five percent.
The aim of this project was to develop a new synthetic route to the

1-hydroxytropane and 1-hydroxynortropane alkaloid skeletons as well as th

and evaluation of a number of C6-modified 1-deoxynojirimycin analogues us

commercially available Australian alkaloids, that are structurally-advance

materials. The expectation was to develop potent a-glucosidase inhibitors
used in the fight against HIV. The use of structurally-advanced starting

reduce the number of synthetic steps needed and open up the possible synt
interesting analogues for structure-activity studies.

The Australian plant derived alkaloids that were used were scopolamine 99

castanospermine 7. Both are produced on a commercial scale by Phytex Aust
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Ltd. and this company provided bulk quantities of the two compounds for the project.
Scopolamine is used mainly in pharmaceutical preparations as an anti-motion sickness
agent.

OHH

OH

O C H 2 O H

0

r\

99
Scopolamine

7
Castanospermine

The first part of the project was to take the tropane alkaloid 99 and attempt to
convert it to l,3a-dihydroxytropane (3a-hydroxyphysoperuvine) via a Meisenheimer
rearrangement of a tropane /V-oxide (Scheme 18). Scopolamine was used as the starting
material because of its epoxide functionality. The epoxide could serve as a precursor of
the olefin 100, which would in turn be used to facilitate the Meisenheimer rearrangement
of a tropane /V-oxide. This is the key step which would allow the later development of the
bridgehead hydroxyl functionality. There are no reports in the literature of either the
conversion of the epoxide of scopolamine to give the olefin, 6,7-dehydrohyoscyamine,
or the Meisenheimer rearrangement of a tropane /V-oxide. This approach also allows for
the synthesis of the 1-hydroxynortropane series, by potential incorporation of an
/V-demethylation step in the later stages.
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The second part of the project was to take castanospermine and via ring cleavage
modification, followed by later recyclisation, synthesise compounds in the 1hydroxynortropane series. The key steps involved would be the initial cleavage step (it
was envisaged that the cleavage would favour the opening of the five membered ring),
the introduction of the oxygen on the methylene carbon a to the nitrogen via oxidation of
a carbamate, then ring formation via an alkyl lithium attack on the carbonyl group in the
piperidine ring (Scheme 19). This approach would lead to 2,3,4,6-tetraepicalystegine C\
106a *=> 106b.
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1.9 Outline of Thesis
The Meisenheimer approach to the total synthesis of 3oc-hydroxyphysoperuvine
from scopolamine, will be discussed in Chapter 2. Rate studies carried out on the
Meisenheimer rearrangement of the /V-oxide stereoisomers will be discussed in
Chapter 3. Chapter 4 is concerned with approaches to the total synthesis of
1-hydroxytropacocaine. The approaches to the nortropane skeleton from castanospermine
as well as the biological evaluations of most of the compounds synthesised from
castanospermine will be discussed in Chapter 5, with Chapter 6 covering all the
experimental details.
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CHAPTER 2
THE TOTAL SYNTHESIS OF RACEMIC 3a-HYDROXY
PHYSOPERUVINE
2.1 Retrosynthetic analysis.

This research project was aimed at establishing on a model system, the feasibility
of a novel Meisenheimer rearrangement approach to introduce a bridgehead hydroxyl
group to the tropane skeleton, with a view to extending this n e w chemistry to more
highly oxygenated synthetic derivatives which could then be converted to calystegines.
T h e approach focused on the synthesis of 3oc-hydroxyphysoperuvine
103a ^=7 103b using the structurally advanced alkaloid, scopolamine, as the starting
materiaL The purpose of this research was twofold. Firstly to develop novel chemistry in
the process of taking scopolamine through to 103a *=? 103b. The second goal was to
investigate the possiblity of value-adding to an existing export product via chemical
modification of scopolamine.
Examining the retrosynthetic analysis (Scheme 20), two steps in the total
synthetic route could be viewed as key stages, neither of which had been previously
reported in the literature. They are the deoxygenation of the epoxide in scopolamine and
the Meisenheimer rearrangement of a tropane /V-oxide. T h e deoxygenation of
scopolamine is crucial to enable insertion of a double bond to give allylic radical
stabilisation for the promotion of the Meisenheimer rearrangement.
The structure of scopolamine has been k n o w n for over one hundred years and in
that time the chemistry that has been carried out on scopolamine has been limited to base
hydrolysis64 and dehydration64 of the tropic acid residue, as well as the formation of the
/V-oxide 65 and a variety of quaternary a m m o n i u m salts66"68. Deoxygenation of the
epoxide of scopolamine, which appears to be a simple transformation, seems to have
been neglected.
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The remaining chemistry that is involved in the proposed synthetic scheme is

based on straight forward functional group manipulation, with much of the chemi

already established on similar compounds69'70 (for example, see Scheme 4 on page
HNR
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Scheme 20

2.2 Meisenheimer Rearrangement

2.2.1 History of the Meisenheimer Rearrangement
The Meisenheimer rearrangement dates back to 1895, when Pinner reported

investigations on the reactions of a new substance, nicotine-1-oxide 112 and d

a further new compound, nicotone71113, formed on.heating the /V-oxide (Scheme 2
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However the structure that Pinner assigned to nicotone was incorrect and was not given

the correct structure 114 until 1950 by Rayburn72. But it was some twen

Pinner's discovery that Meisenheimer first correctly recognised such a

rearrangement73. He showed that heating /V-methyl-/V-allylaniline oxide

basic conditions afforded the isomeric 0-allyl-/V-methyl-/V-phenylhydr

(Scheme 21) and this rearrangement type was subsequently named after h

Heat
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NHMe
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114

O
i
Me-N-CH
2 CH=CH 2

Me-N-OCH 2 CH=CH 2
Heat

115

116

Scheme 21
Two types of rearrangement ([1,2] and [2,3]) are differentiated74 but

[1,2] type which is the focus of the work described in this project (

R
1+

R^\°"

[1,2]

—

[2,3]

1—OR
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Jll

M

FT%
R
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Scheme 22

Meisenheimer was unable to effect a similar transformation of dialkyl

oxides. However, Cope and Towle showed that under anhydrous conditions

dialkylallylamine oxides (alkyl = Me, Et, n-Pr, iso-Pr, n-Hexyl) do i
(Scheme 23).

CH2=CHCH2N(alkyl)2
117

Heat
CH2=CHCH2ON(alkyl)2
118
Scheme 23
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M o r e recently Meisenheimer technology has been applied to intramolecular ring
expansions to form a number of fused heterocycles. These include, for example, the
formation of 120 from the thermolysis of 1 1 9 7 6 and the formation of 122 from the
thermolysis of 1 2 1 7 7 (Scheme 24).

Heat

120

119

Heat

121

N-Me

122

Scheme 24

The reaction conditions to bring about the Meisenheimer rearrangement vary
widely from one system to another. In the above examples, the Meisenheimer
rearrangement of 119 to give 120 was achieved in refluxing acetonitrile after fifty
minutes. However, to bring about the Meisenheimer rearrangement of 121 to give 122
the conditions were much harsher, requiring heating at 140°C for fourteen hours.

2.2.2 Competing reactions
The Cope elimination of /V-oxides74 can compete with the Meisenheimer
rearrangement. The Cope elimination, however, requires a planar five membered
transition state (Scheme 25), which is not possible in most rigid systems.
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Therefore the Cope elimination would be highly unlikely in the Meisenheimer
rearrangement of tropane /V-oxides (Scheme 26) due to structural constraints on
transition state.

Cope elimination
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MeNOH
127

126
Scheme 26

2.3

Synthesis

2.3.1 Deoxygenation of scopolamine

The conversion of epoxides to olefins has been achieved with a large variety of

reagents78. The deoxygenation of epoxides can proceed with retention or inversio
configuration (Scheme 27).
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Deoxygenation of the cw-epoxide of scopolamine must proceed with retention
because of structural constraints induced by the bicyclic form of the molecule. Reagents
that were k n o w n to deoxygenate epoxides to olefins with retention of configuration,
include magnesium-iodine-diethyl ether79 and trimethylsilyl iodide80. Both reagents,
however, failed to give any 6,7-dehydrohyoscyamine when tried with scopolamine.
The reaction of magnesium-iodine-diethyl ether with scopolamine yielded only
starting material. The reaction of trimethylsilyl iodide with scopolamine was only
successful in converting a small amount to aposcopolamine 131 (Scheme 28) which is
formed via elimination in the tropic acid residue.
MeN

MeN

ori"\

0.

P^CH2OH

°\xPH2

TMSI ,

Sb

Jb
S c h e m e 28

One other reagent tried was zinc-copper couple. Kupchan et al. have shown its
stereocontrol is limited, although retention of configuration81 predominated amongst the
products from a range of cw-octene oxides and frans-octene oxides.
The reaction of scopolamine with freshly prepared zinc-copper couple 82 in
refluxing ethanol was successful with a near quantitative conversion of scopolamine to
the 6,7-dehydrohyoscyamine 111 (Scheme 29). This yield is greater than any observed
by Kupchan.
MeN,

MeNv

0

CH2OH

Jb

Zn/Cu couple
ethanol, reflux
ca 1 0 0 %

O^CH2OH
111

Scheme 29
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T h e structure of 1 1 1 w a s confirmed by its EI M S , IR and * H N M R
spectroscopic data which are identical to the reported values 83,84 obtained from an
alternative synthesis of 111. This alternative synthesis constituted part of the total
synthesis of scopolamine. The 1 3 C N M R data (so far unreported) is tabulated with the
rest of the spectroscopic data in Chapter 7.
Since the publication85 of this work in January 1996, Malpass et al. has used this
method of deoxygenation of 6,7-epoxytropanes in the synthesis86 of homoepibatidine
134 (Scheme 30). The parent compound, epibatidine, is reported to have 200 to 500
times the analgesic potency of morphine in hot-plate and Straub-tail reaction assays87.
Homoepibatidine has also been shown recently to be as active as epibatidine using hotplate assays88.
C02CH2Ph

N
• "^s
•^>A
>\
132

CX)2CH2Ph
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Zn/Cu coupleB f
ethanol, reflux* p^
77%
133

^r

134

Scheme 30

Malpass has also shown that this technology is extendable to exo-epoxides, with
the deoxygenation of a 7,8-epoxyhomotropane (Scheme 31).
C02CH2Ph
N

sk>

C02CH2Ph
N
Zn/Cu, ButOH, 52%
< ^ >

135

136

Scheme 31

The zinc-copper reductive elimination is presumed 81 to proceed via C - 0 bond
cleavage to a radical like 137. Radical cleavage of the remaining C - 0 bond followed by
recombination then gives the olefin 111 (Scheme 32); complexation of the nitrogen in
6,7-epoxytropanes with the metal ion could be enhancing the reaction. This is supported
by the increase in yield found for the deoxygenation of scopolamine compared with that
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found by Malpass in the deoxygenation of other 6,7-epoxytropanes and homotropanes.
C o m p o u n d 1 3 2 has the nitrogen protected as the carbamate, hence reducing the
avaliability of the nitrogen lone pair of electrons for complexation. In the case of the exoepoxide of 135 such complexation is not possible.
NMe

V^

°\VCH2°H

-

O

CH2OH
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137
Scheme 32

2.3.2 Hydrolysis of 6,7-Dehydrohyoscyamine 111.

Base hydrolysis was employed to cleave the tropic ester residue of 111 (Scheme
33). Refluxing 111 under basic conditions gave 138 in 7 4 % yield. The structure of 138
was confirmed by its EI M S , IR and * H N M R which were identical the reported
values84,83. Previously unreported 1 3 C N M R data is given in the experimental section.
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OH

»° b

138
Scheme 33

Simplification of the *H and 1 3 C N M R spectra in 138 compared with 111 was
consistent with loss of chirality. Figure 3 shows part of the *H N M R spectra of 138 and
111 which illustrates this simplification due to the loss of chirality.
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Figure 3 400MHz X H N M R spectra of a) 6,7-dehydrohyoscyamine (aromatic protons are not shown)
b) 6,7-dehydrotropine
T h e cleavage of the ester and reprotection of the secondary hydroxyl group as the
silyl ether in the following step was essential for two reasons. The first was that the Noxide of scopolamine 139 could displace the tropic acid residue89 w h e n heated to form
140 (Scheme 34). This type of reaction would be in competition with the Meisenheimer
rearrangement. T h e second reason was that selective oxidation of another secondary
alcohol group was required in a later step.
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It should be noted that 138 is a very important compound in tropane chemis

and is, or can be, used as the intermediate in the synthesis of many tropa

There have been only three reports of the selective synthesis of 138. Thes

four step conversion from the alkaloid valerine 145 via a seven step trans

hydroxytropan-3-one produced by the Robinson method90'91 (Scheme 35) and a f

step synthesis via an iron carbonyl promoted reaction of 1,1,3,3-tetrabrom
and a pyrrole derivative 149 (Scheme 36)^ .
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There is n o w an alternative, two step, high yielding route to 138 from
scopolamine.

2.3.3 Synthesis of the Trimethylsilyl Derivative of 138.
Protection of the alcohol of 138 as the trimethylsilyl ether was readily achieved
with excess trimethylsilyl chloride in tetrahydrofuran with triethylamine as the base
(Scheme 37).

TMSC1. Triethvlamine,
THF
138 O H

154 O T M S
Scheme 37

The structure of 154 was confirmed by its mass spectrum and N M R spectrum.
A n EI mass spectrum indicated a molecular ion of m/z 211 which equates to the molecular
weight of the starting material, which is 139, plus 72, ie. ( M + + T M S - H). The lH
N M R spectrum confirmed 21 protons with the methyl signals of the silyl group at 80.06.
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The 1 3 C N M R spectrum of 154 showed six resonances, two methines 8131.7 and 64.3,
two methylenes 866.0 and 41.4 and two methyls 837.2, 25.7 and -4.9. A

1

JQH

correlated 2 D N M R spectrum allowed assignment of all non quaternary carbons to their
attached protons.

2.3.4 Synthesis of the /V-Oxides of 154.
The reaction of 1 5 4 with excess hydrogen peroxide in ethanol at room
temperature afforded, in high yield, a mixture of iV-oxide isomers 155 and 156 in a ratio
of approximately 1:1 (Scheme 38). Separation of these isomers was not attempted and
they were utilised as a crude oil.

30% H2Q2

+

ethanol

154 OTMS

155

OTMS

156 O T M S
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The confirmation of the structures of 155 and 156 was based solely on !H N M R
analysis of the mixture. The /V-methyl signals of 155 and 156 resonated at 83.42 and
3.40 respectively, which is a shift downfield with respect to the starting material by
approximately lppm. This is consistent with the formation of an /V-oxide. The
assignment of the /V-methyl signals in 155 and 156 was done by analogy with the
equivalent signals for 161 and 162 (Section 2.3.7).

2.3.5 Thermolysis of 155 and 156.
The thermolysis of the crude mixture of 155 and 156 in refluxing butyronitrile
for two hours yielded, after work up, a dark brown oil. Thin layer chromatography of
this crude mixture revealed one dark spot under ultraviolet light with an Rf value of 0.8.
Development of this same plate in an iodine atmosphere revealed another major spot at
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Rf 0.2. Separation of this mixture by flash column chromatography was successful in
isolating the two major components of the mixture.
The first compound isolated was a clear volatile oil. It displayed a very strong
absorption in the ultraviolet spectrum attanax241nm. A n EI mass spectrum indicated the
compound had a molecular ion of m/z 110. The infrared, ultraviolet and *H N M R spectra
were identical to those reported92'93 for 3,5-cycloheptadienol 157 (Scheme 39). The
formation of 157 would require the loss of nitrosomethane 158. The origin of the
cycloheptadienol is explained in Section 2.3.10

HOH
U^

A

+ Me-N=0 +[TMSX

157

158
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The second compound was isolated as a brown oil. A H R E I mass spectrum
indicated that the compound had a molecular ion at m/z 155.0942 consistent with the
molecular formula C g H 1 3 N 0 2 (starting material - T M S + H ) , which is suggestive of a
bicyclic species. It also exhibited mass fragments at m/z 133,110, 82 and 44.
The X H N M R spectrum of the compound revealed two allylic protons at 86.56
and 86.36 as well as eight aliphatic resonances at 81.77, 1.90, 2.38, 2.46, 2.59, 3.53,
4.34 and 4.48 corresponding to 1,1,1,1,3,1,1,1 protons respectively. This is consistent
with an unsymmetric bicyclic species.
The 1 3 C N M R confirmed that there were only two allylic carbons and six aliphatic
carbons. A ^ C H correlated 2 D N M R spectrum confirmed that there were two sets of
axial equatorial protons at (81.77, 2.38) and at (81.90, 2.46).
The C O S Y H - H correlated experiment confirmed these observations and
established the linkage of nine coupled protons. Since four of these nine protons made up
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two sets of axial equatorial protons, the C O S Y confirmed the presence of a seven
membered carbon ring.
The structure was therefore assigned on the above evidence as being the expected
Meisenheimer rearrangement product 159 with the loss of the protective trimethylsilyl
group (Scheme 40). Since the trimethylsilyl group was cleaved under the Meisenheimer
rearrangement reaction conditions or work up, a more robust protecting group was
needed.

+ TMSX
155 OTMS

156 OTMS

159

Scheme 40

2.3.6 Synthesis of f-Butyldimethylsilyl Protected 138.
In order to have a more stable protecting group, the *-butyldimethylsiloxy
derivative of 138 was made. This was readily achieved using excess f-butyldimethylsilyl
chloride in /V,/V-dimethylformamide with imidazole as base to afford the silylated
analogue 160 in 8 8 % yield (Scheme 41).

TBPMSC1. Imidazole .
DMF
138 OH

160 OTBDMS
Scheme 41

The structure.of 160 was confirmed by its mass spectrum and N M R spectrum.
A n H R E I mass spectrum indicated that there was a molecular ion at m/z 253.1856 which
equates to the molecular weight of the starting material ( M W = 139) plus 114, ie.
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(starting material + T B D M S - H). The *H N M R spectrum confirmed 26 protons with the
methyl signals of the silyl group at 80.83 (9H, C(CH 3 ) 3 ) and 0.06 (6H, Si(CH3)2). The
13

C spectrum of 160 showed eight resonances, two methines 8131.7 and 64.3, two

methylenes 866.0 and 41.4, three methyls 837.2, 25.7 and -4.9 and one quaternary
carbon at 817.1. A 1JQU

correlated 2 D N M R spectrum allowed assignment of all non

quaternaries to their attached protons.

2.3.7 Synthesis of N- Oxides 161 and 162.
The reaction of 160 with excess hydrogen peroxide in ethanol at room
temperature afforded, in high yield, a mixture of the axial and equatorial /V-oxide isomers
161 and 162 in a ratio of approximately 1.5:1 (Scheme 42). The only purification
needed was the removal of the solvent and then trituration of the semi solid residue with
diethyl ether; the /V-oxide 162 crystallised under these conditions and 161 was
recovered from the mother liquor.
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Confirmation of the relative stereochemistry of the /V-oxides was obtained from
N O E S Y experiments where correlations between the protons of the /V-methyl group and
protons 6 and 7 confirmed the structure of 161. This correlation was absent in 162.
The structures of 161 and 162 were confirmed by their mass spectrum and
N M R spectrum. The E S mass spectrum of both isomers gave an M H

+

ion of m/z 270

which equates to the molecular weight of the starting material plus 16, ie. (the addition of
an oxygen atom). The *H N M R spectrum of 161 confirmed the presence of 26 protons
at 86.18, 4.03. 3.67, 3.37, 3.02, 1.53, 0.83 and -0.02. The /V-methyl signal (83.37)
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w a s shifted d o w n field with respect to the starting material by 1.22ppm. This is
consistent with the formation of an /V-oxide.
The 1 3 C spectrum of 161 showed eight resonances, consisting of three methines
8132.0, 74.6 and 61.7,

one methylene 832.1, three methyls 854.5, 25.6 and -5.0 and

one quaternary carbon at 821.9. Again the /V-methyl group was shifted d o w n field with
respect to the starting material from 37.2ppm to 54.5ppm, consistent with the presence of
the /V-oxide.
A ^ C H correlated 2 D N M R spectrum allowed assignment of all non-quaternary
carbons to their attached protons.
The * H and 1 3 C N M R spectra of 162 were very similar to those of 161,
for the lH N M R resonances of the axial and equatorial protons, H 2 and H4.

except

Here there is

a major difference (Figure 4). The axial protons of 162 had very similar chemical shifts
to those of the starting material, whereas the axial protons of 1 6 1 were shifted
considerably downfield by the deshielding effect of the negatively charged oxygen.
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b) equatorial N-oxide 162,

in CDCI3
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2.3.8 Thermolysis of the /V-Oxides 161 and 162
The thermolysis of 161 in refluxing butyronitrile was monitored by *H NMR at

approximately 15 minute intervals. Figure 5 shows a typical spectrum of the reactio
mixture in the allylic region after refluxing for two hours. The * H N M R spectrum
showed resonances in the allylic region that looked very similar to the two major

components that were isolated from the thermolysis of 155 and 156. The reaction was
stopped at this time and subjected to column chromotography.
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Figure 5 400MHz *H NMR spectrum (CDCI3) of the olefinic region after two hours of refluxing the
axial /V-oxide, 161 in butyronitrile.

Thefirstcompound isolated was a colourless, volatile oil. It also displayed a very

strong absorption of ultraviolet light at 243nm. An EI mass spectrum gave a molecu
ion at m/z 224 which is consistent with the formula C13H24OSL The *H and 1 3 C N M R
spectra were all but identical to the !H and 13C NMR spectrum of 157, the only
difference being the additional resonances for the f-butyldimethylsilyl group. Thus the
structure was assigned as 6-f-butyldimethylsiloxy-l,3-cycloheptadiene 163 (Scheme
43).
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T h e second c o m p o u n d isolated was also a major component of the reaction
mixture. T h e H R E I mass spectrum gave a molecular ion at m/z 269.1807 consistent with
the molecular formula C14H27O2S1N. This is the same molecular weight as the starting
material. However, the * H and 1 3 C N M R spectra were very similar to the corresponding
spectra of 159. T h e proton N M R spectrum of compound is displayed in Figure 6. It is
characterised by two olefinic resonances at 86.45 and 6.25 and 8 aliphatic resonances at
4.54, 4.42, 3.44, 2.60 ( N C H 3 ) , 2.38, 2.32, 1.60, 1.53, 0.86 ( C ( C H 3 ) 3 ) and 0.06
(Si(CH,) 2 ). T h e 1 3 C N M R spectrum showed eleven resonances, three of which
belonged to the T B D M S group, 84.775 (Si(CH 3 ) 2 ), 17.9 ( £ ( C H 3 ) 3 ) and 25.7
(C(CH 3 ) 3 ). The other eight include five methines 8132.5, 129.6, 68.80, 68.77 and 57.6,
two methylenes 841.0 and 39.8 and one methyl at 846.7. A 11CH

correlated 2 D N M R

spectrum allowed assignment of all non quaternaries to their attached protons and also
confirmed the presence of two sets of axial and equatorial protons.
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Figure 6. 400MHz J H N M R spectrum of the Meisenheimer rearrangement product from 161 in
CDCI3. Note: the f-butyldimethylsilyl protons are not shown.
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T h e C O S Y H - H correlated experiment showed the linkage of nine coupled
protons (Figure 7), which confirmed the presence of a seven membered carbon ring.
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T h e structure was therefore assigned on the above evidence as being the expected
Meisenheimer rearranged product 164 (Scheme 44).
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164 OTBDMS

161 OTBDMS
Scheme 44
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The reaction with the equatorial /V-oxide gave the same mixture of compounds but
the rate of reaction was considerably slower (Scheme 45). Figure 8 shows the reaction

mixture after three hours of refluxing in butyronitrile. The rates of the Meisenheimer
rearrangement will be discussed further in Chapter 3.
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Figure 8. 400MHz *H NMR spectrum (CDCI3) of the olefinic region after three hours of ref
the equatorial ^V-oxide, 162 in butyronitrile.

N o C o p e elimination products were observed in either Meisenheimer
rearrangement.
The isolation of only one stereoisomer from the thermolysis of 161,162 and
155, 156 is evidence that products 164 and 159 are derived directly from a
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Meisenheimer rearrangement reaction. However, the coupling constants measured for the
3-endo proton were inconsistent with the assigned structures 164 and 159. It was
decided therefore to investigate the stereochemical aspects further.
In the next section, the structure and conformation in solution of 164 and 159
are ratified, based on extensive N M R studies, centred around the complete analysis of the
* H N M R spectra andfirstorder analysis of the 3-exo proton, as well as extensive
N O E D I F F experiments. This, coupled with computer modelling studies ( A M I
semi-emperical calculations) carried out by Prof. Robert Glaser (Ben Gurion University
of the Negev, Israel), have unambiguously determined the structure and solution
conformation of 164 and 159.

2.3.9 Structural and Mechanistic Aspects of the Meisenheimer
Rearrangement Product

2.3.9.1 Past Syntheses of Oxaza Bridged Seven Membered Rings
The oxazabicyclic system incorporated in compounds of type 159 and 164 has
been synthesised on at leastfiveother occasions94'69'70-48'95, all from the Diels-Alder
addition of a nitroso compound to cycloheptadiene.
Me. Me
1SI

N

164 OTBDMS 159 OH

For example the synthesis of 167 and 168 was achieved69 via the Diels-Alder
addition of 1-chloro-l-nitrosocyclohexane to the cycloheptadiene derivative 165 (Scheme
46).
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166
Scheme 46

The compounds 167 and 168 are the only two of their type that have been
synthesised with a substituent at the 3 position. The conformation in solution

should be very similar to the conformation in solution of 164. Iida et al assig

structures of 167 and 168 based on their XH NMR spectra, arguing that the 3-endo

proton of 167 occurs significantly higher (84.95) than expected, indicating tha
lie within the shielding cone of the C6-C7 double bond, while the 3-exo proton

of 168 suffers much less of a shielding effect by the double bond. This argumen

proved correct upon the synthesis of the natural product, tropacocaine69 169 fro
(Scheme 47).
There were no H-H coupling constants given in the reported *H NMR spectra for

the above compounds. If measurable, the H-H coupling constants for the 3-endo p

of 167 would be expected to be quite different to the coupling constants for th

proton of 168, if they both adopt the same conformation in solution as depicted i
Schemes 46 and 47.
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2.3.9.2 Stereochemistry of O x a z a Bicyclic Systems
The structures of 159 and 164 can be viewed as consisting of two seven

membered rings sharing common atoms, one being a cycloheptene ring the other being a
1,2-oxazacycloheptane ring (Figure 9).

1,2-Oxaza-cycloheptane ring in bold

Cycloheptene ring in bold
Figure 9

The oxaza-bridged seven membered ring compounds have always been shown in
the literature, as they have here, with the oxazacycloheptane ring in the chair
conformation. However analysis of the splitting pattern of the 3-exo proton of 164
(Figure 10) has revealed two coupling constants, 9.4 and 6.0 Hz.
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Figure 10. 400MHz *H NMR spectrum of 164, expanded to show only the multiplicity g
by the proton H3.
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This finding is inconsistent with the above conformational preference, based on

the expected coupling constants predicted by the Karplus equation (ca 4.8 and 1.8Hz

a four synclinal type (60°) H-C-C-H dihedral angle. This finding threw into doubt th
structure of 164 and all possible structures were then reconsidered.
There are four possible structures (SI, S2, S3 and S4) for 152 that my be

considered. These differ in the oxazepane ring conformation and the C3 configuration

The structures below are numbered so that an extra digit is given to differentiate e
nucleus within a diastereotopic pair.
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Me
/
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\\

H22

,N H1

H22
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H21
H417

H417

OTBDMS

H3
H3

SI
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The observed coupling constant values of 9.4 and 6.0Hz for H 3 only represent
reasonable values for S2 and S4 where the angle H22-C-C-H3, H44-C-C-H3 in S4 and
H21-C-C-H3, H41-C-C-H3 in S2 is approximately 60 degrees and the angle H21-C-CH3, H41-C-C-H3 in S4 and H22-C-C-H3, H42-C-C-H3 in S2 is approximately 180
degrees. The angles H21-C-C-H3, H41-C-C-H3, H22-C-C-H3 and H44-C-C-H3 in SI
and S3 are all approximately 60 degrees.
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2.3.9.3 N O E D I F F

Experiments

Analysis of the coupling constants associated with the H 2 and H 4 resonances at
82.32 and 82.38 revealed, for both, an apparent 5 spin system as they both afforded a
multiplet having 16 transitions in 12 lines in a ratio of 1:1:1:2:1:2:2:1:2:1:1:1. As the
protons responsible for the resonances at 82.32 and 82.38 have only one geminal and
two vicinal neighbours the extra set of eight transitions must be due to long range
"W"-type four bond coupling. This type of coupling is usually associated with a
"W"-type diequatorial arrangement. It was therefore reasoned that a series of nuclear
Overhauser effect difference experiments (NOEDIFF) will distinguish between the
stereoisomers S 2 and S 4 since the vinylic and equatorial methylene protons are on
opposite sides of the cycloheptenyl ring in S4, while they are on the same side in S2.
Table 1 lists the results of a series of N O E D I F F experiments on 164. From these
experiments there was no N O E enhancements detected for the designated equatorial
protons at 82.32 and 82.38 from the irradiation of either the vinylic protons or the Nmethyl group. Therefore the structure of 164 must be that of S4.

Table 1. N O E D I F F Experiment Results on 164
Peak Irradiated

N O E s Developed. Percentage Developed in Brackets ()

6.46

1.54 (1.0)

6.25

2.62(0.3)

1.60 (0.3)

2.62 (NCH3)

3.48 (7.1)

6.25 (1.4)

1.60

6.25 (0.7)

6.46 (0.7)

The removal of the bulky /-butyldimethylsilyl protecting group of 164 with dilute
hydrochloric acid, gave a compound that was in all respects identical to 159.
The only conformational models that need to be considered for 159 are SI and
S4. The coupling constants of proton H 3 were found to be 6.8 and 5.7Hz. These
coupling constants, however, do not fit either model based on the Karplus equation,
(boat 159 ca 10.4 and 6Hz), (Chair 159 ca 1.8 and 4.8Hz).
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Computer modelling by Glaser96 suggested that there is a 60:40 weighted average

for the boat-chair conformations of 159 and a more biased 90:10 weighted b
average for 164.
The assignment of NMR *H and

13

C resonances of 164 and 159 are given in

Table 2.
Me Me
/

H3

j

H3

H6 H6
164 159

Table 2. *H and 1 3 C Spectral Parameters for 164 and 159

(ppm)

164

159

H-l

4.44

4.48

H-21

1.53

H-22

| 8c (ppm)

164

159

C-l

68.77

69.46

1.77

C-2

40.98

41.49

2.32

2.38

C-3

68.80

67.61

H-3

4.51

4.34

C-4

39.78

39.86

H-41

1.60

1.90

C-5

57.56

58.12

H-42

2.38

2.46

C-6

129.55

130.06

H-5

3.48

3.53

C-7

132.50

132.83

H-6

6.25

6.36

NCH3

46.65

46.22

H-7

6.46

6.56

C(CH 3 ) 3

17.87

NCH 3

2.62

2.59

C(CH 3 ) 3

25.73

C(CH3)3

0.86

Si£H 3

-4.78

SiCH3

0.05

Si£H 3

-4.78

SiCH3

0.06

8H
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2.3.9.4

Conclusion

T h e evidence supplied by N M R experiments, have shown that (1R*, 3S*, 5S*)3-( f-butyldimethylsiloxy)-9-methyl-8-oxa-9-azabicyclo[3,2,2]non-6-ene 164 is the
Meisenheimer

rearranged

product formed

from

the thermolysis of 3 a -

f-butyldimethylsiloxy-8-methyl-8-aza-bicyclo[3,2,l]oct-6-ene /V-oxides (axial and
equatorial) in refluxing butyronitrile and that this product adopts in solution (CDC1 3 ) a
conformation that places the bulky 3- t-butyldimethylsiloxy substituent in the exodisposed equatorial position on a boat 1,2-oxazacycloheptane ring. Also, (1R*, 3S*,
5S*)-3-hydroxy-9-methyl-8-oxa-9-azabicyclo[3,2,2]non-6-ene 159 is the Meisenheimer
rearrangement product formed from the thermolysis of 3a-trimethylsiloxy-8-methyl-8aza-bicyclo[3,2,l]oct-6-ene /V-oxides (axial and equatorial) in refluxing butyronitrile and
that it adopts in solution, a conformation where the 1,2-oxazacycloheptane ring is in
equilibrium between boat and chair conformations, with a slight bias to the boat
conformation.

2.3.10 Origin of the Cycloheptadienols.
The origin of the 6-r-butyldimethylsiloxy-l,3-cycloheptadiene 163 and also the
3,5-cycloheptadienol 157 from the thermolysis of 155 and 156 could involve two
pathways. They could possibly be produced from a thermal decomposition of the
/V-oxides (161,162) and (155,156) or the thermal decomposition of 164 and 159.
T o solve this problem pure 164 was refluxed in butyronitrile for one hour. The *H N M R
spectrum of the crude reaction mixture clearly showed the presence of 163. Therefore
163 and 157 are the products, at least in part of the thermal decomposition of 164 and
159, presumably via a retro Diels-Alder reaction (Scheme 48). This would give
nitrosomethane 158 as a side product, although this product (or its dimer or oxime
rearrangement product) was not detected.
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Heat
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+ [Me-N=0]
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"
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^
l^

OH

^

159
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157

OH
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Scheme 48

2.3.11 Synthesis of 6-f-Butyldimethylsiloxy-4-[(methyl)amino]cyclohept2-enol 165.
The reductive cleavage of 3a-f-butyldimethylsiloxy-9-methyl-8-oxa-9azabicyclo[3.2.2]nona-6-ene

1 6 4 with zinc in acetic acid gave the 6-t-

butyldimethylsiloxy-4- [(methyl)amino]cyclohept-2-enol 165.

MeHN
Zn/acetic acid

164 OTBDMS

"OTBDMS

165

Scheme 49

The structure of 165 was confirmed by spectroscopic means. The HREI mass
spectrum gave a molecular ion of m/z 271.1969 consistent with the molecular formula
C 14 H 29 N0 2 Si. The compound also displayed a moderate N-H stretch at 3296cm-1 and a
broad O-H stretch at 3000-3750cnr1 in the infrared absorption spectrum. The ! H N M R
spectrum confirmed the presence of two olefinic protons at 86.00 and 5.75 and twenty
seven aliphatic protons at 84.55, 4.26, 3.61, 2.43, 1.70-1.95, 0.88 (C(CH3)3) and
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-0.06 Si(CH 3 )2. The 1 3 C N M R spectrum confirmed the presence of five methines
8139.58, 130.96, 66.57, 64.59 and 53.24, two methylenes at 843.1 and 38.9 three
methyls at 832.3, 25.74 ((C(£H 3 ) 3 ) and -4.9 (Si(£H3)2) and one quaternary carbon at
817.96 (C(CH 3 ) 3 ). A X J C H correlated 2 D N M R spectrum allowed assignment of all non
quaternaries to their attached protons.

2.3.12 Synthesis of 6-f-Butyldimethylsiloxy-4[(methyl)amino]cycloheptanol.
Catalytic hydrogenation of the double bond in 165 gave 6-f-butyldimethylsiloxy4-[(methyl)amino]cycloheptanol 166 in very high yield.
MeHN MeHN
)-...OTBDMS

-g^

-

f

y.-OTBDMS

Scheme 50

The structure of 166 was confirmed by spectroscopic methods. The HREI mass
spectrum gave a molecular ion at m/z 273.2122 which is consistent with the molecular
formula C 1 4 H 3 1 N 0 2 S i , required for 166. The *H N M R spectrum confirms the absence
of any olefinic carbons and confirmed the presence of fourteen aliphatic protons at 8:
4.21 (m, IH), 4.00 (b, IH), 2.85 (b, IH), 2.38 (s, N C H 3 ) , 2.20-1.65 (m, 8H), 0.84
(s, C(CH 3 ) 3 ) and 0.06 (s, Si(CH3)2). The 1 3 C N M R spectrum confirms the presence of
eleven carbons including three methines 8: 67.5, 65.3 and 56.8, four methylenes, 843.8,
37.2, 32.4 and 26.0, four methyls 30.8, 25.7, -5.0 and -5.1 and one quaternary at
817.8. A ^ C H correlated 2 D N M R spectrum allowed assignment of all non quaternaries
to their attached protons.
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2.3.11 Synthesis of 3a-;-Butyldimethylsiloxy-8-methyl-8azabicyclo[3.2.1]octane-l-ol (3a-f-butyldimethylsiloxy-physoperuvine)
The reaction of 1 6 6

with pyridine chlorochromate ( P C C ) gave

3a-f-butyldimethylsiloxy-8-methyl-8-azabicyclo[3.2.1]octane-l-ol 167a «-? 167b in
high yield.

MeHN

OR
R = TBDMS

Mfr*,W7b
Scheme 51

The structure of the 3a-f-butyldimethylsiloxyphysoperuvine 167a *=? 1 6 7 b
was confirmed by spectroscopic means. The H R E I mass spectrum gave a molecular ion
at m/z 271.1962 consistent with the molecular formula C14H29NO2SL The lH N M R
spectrum in CDCI3 showed considerably broadened lines, making analysis difficult This
would indicate the possibility of tautomers. The 1 3 C N M R spectrum in CDCI3 was also
broad, although it was sharp enough for analysis. The peak at 8201.8 and the absence of
any peak around 890 confirmed the presence of only one isomer in solution, that being
the monocyclic 4-methylamino-cycloheptanone tautomer 167a. In contrast to this, the
13

C N M R spectrum in pyridine-ds confirmed the presence of only the bicyclic tautomer.

This was evident by the quaternary signal at 889.2 and the absence of any peaks around
the 8200 region. The tautomeric equilibrium of 167a *=? 167b is thus solvent
dependent. Such solvent dependence has also been noted for similar 1-hydroxytropane
compounds 4 8 .
This tautomerism was also evident from the infrared spectrum of
157a s=, 167b. The solution IR spectrum of 167a «=? 167b in chloroform showed a
strong ketone carbonyl stretch at 1703cm"

(Figure 11). The IR spectrum of
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1 6 7 a «=* 167b in a potassium bromide disc, however, showed an absence of a ketone
carbonyl stretch but displayed a broad O H stretch between 3050cm- 1 and 3400cm" 1
(Figure 12).
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Figure 11 Infrared Spectrum of 167a «-» 167b in CHC1 3
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Figure 12 Infrared Spectrum of 167a «-» 167b, KBr disc.

The solid state structure was unequivocally determined by single crystal X-ray
analysis and shown to be the 3a-f-butyldimethylsiloxyphysoperuvine (Figure 13), in
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agreement with the IR data. T h e X-ray crystal structure was determined by Associate
Professor Allan White and Dr Brian Skelton University of Western Australia.

F i g u r e 13. Structure of 167b as determined by single crystal X-ray analysis.

An interesting aspect with regard to the crystal structure of racemic
167a ^=5 167b is that the crystal matrix is made up of paired molecules of 167 b which
are positioned in such a way that the 1-hydroxyl group is hydrogen bonded with the
nitrogen of the racemic partner (Figure 14).

F i g u r e 14. Orientation of the molecules of 167b within the unit cell.
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2.3.12 T h e Synthesis of 3a-Hydroxy

Physoperuvine.

The removal of the f-butyldimethylsiloxy group was achieved by stirring the
compound 167a«=5 167b with aqueous 3% hydrochloric acid overnight. This gave
3a-hydroxphysoperuvine in good yield.

Me

MeHN
R = TBDMS

MeHN

iOR ^

"OH ^

167a ^167b

103a^l03b

Scheme 52

The structure of 3a-hydroxyphysoperuvine 103a *=? 103b was confirmed by
spectroscopic means. The HREI mass spectrum gave a molecular ion of m/z 157.1105
consistent with the formula C8H14NO2. The *H NMR spectrum in CD3OD at room
temperature was not fully analysable, being broad and complex. The CD3OD

13

C NMR

spectrum was sharp and it revealed that there was more than one conformation in

solution. The major component in solution was, however, the bicyclic tautomer. Thi

was evident by the presence of one quaternary carbon at 898.3; the rest of the spe

consisted of two methine carbons at 865.2 and 64.1, four methylene carbons at 845.
38.1, 30.3 and 24.2 and one methyl carbon at 833.1.

2.4 Biological Activity
As this part of the project was to develop a new synthetic approach to the
1-hydroxytropane series, biological activity of the final compound as well as the
intermediates with respect to glycosidase inhibition was not expected, due to the

hydroxy groups. However, biological activity testing of the final compound as well
most of the TBDMS deprotected intermediates was still undertaken.
All compounds shown below were tested against commercial
a,P-amyloglucosidase, a,[3-glucosidase, a,(3-mannosidase and a,(3-galactosidase
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enzymes as well as anti-HTV and anti-tumour screening. However, all compounds were
classed as inactive against every screen. The H I V and anti-tumour screening was
undertaken by the National Cancer Institute, Washington, U S A and the gycosidase
inhibition assays by Professor A. Elbein, University of Arkansas, U S A .

OCOCHPh
98

129

CH 2 OH

MeHN

MeHN

MeHN

OH

•«OH

168

159

169

••••OH =5

103a ^ 103b

2.5 Conclusion
The compound 3a-hydroxyphysoperuvine was synthesised from scopolamine in
nine steps with an overall yield of 16%. The Meisenheimer rearrangement of tropane N-.
oxides was shown to be a viable alternative method for the synthesis of analogues of the
1-hydroxy tropane alkaloids. Further development to include nortropanes derivatives,
however, was not investigated due to time constraints.
The zinc/copper couple method discovered for deoxygenating a 6,7-tropane
epoxide has n o w given access to the synthesis of large quantities of
6,7-dehydrotropanes, thus, allowing the expansion of research in tropane chemistry.
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Chapter 3
Mechanistic Analysis of the Tropane N-Oxide
Meisenheimer Rearrangement
3.1 Introduction: iV-Oxide Formation
W h e n an Af-oxide is formed from an N-alkyl cyclic amine which has another
stereogenic center, for example 170, it usually forms as a mixture of diastereoisomers
171 and 172 (Scheme 53). Depending on whether the reaction is kinetically or
thermodynamically controlled, the ratio of these diastereoisomers will vary greatly from
compound to compound.

'R £> ~0 Jt'

'*.+•

R'

"^

/R^

™^ ^

170

\+S

171

172

Scheme 53

In the case of the N-methyl base 160 the N-oxide diastereoisomers 161 and 162
were formed in a 1.5 : 1 ratio (axial Af-oxide : equatorial iV-oxide). As the iv*-oxides are
incorporated in a rigid portion of the bicyclic system, the oxygens of the Af-oxides
experience two very distinct chemical environments. In one diastereoisomer the oxygen
of one Af-oxide is directed over the axial ring protons, while in the other, the oxygen is
directed over the double bond.

"O Me

"Kk "Kk "Kk
TBDMSO
160

TBDMSO
161
Axial N-oxide

TBDMSO
162
Equatorial N-oxide
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As this was the first Meisenheimer rearrangement of a tropane Af-oxide observed,
it was decided to study in more detail the rates of rearrangement of these two distinct
N- oxides.

3.2 Rate Studies.
Kinetic measurements on the Meisenheimer rearrangement have been investigated
on a number of occasions97,98, however, the comparison of rates for different
diasteroisomers has not been undertaken.
A s mentioned in Chapter 2, there is a marked difference in the rates of
rearrangement of the tropane Af-oxide diasteroisomers 161 and 162 (Scheme 54).

161

OTBDMS

164

OTBDMS

ki>k2
162

OTBDMS
Scheme 54

Unpublished work by Malpass et al. has shown that the relative rates of
rearrangement in similar diastereoisomeric Af-oxides are also noticeably different99
(Scheme 55). Quantitative values for this rearrangement, however, were unavailable.

62

Me^+ 6

174

Scheme 55
This Chapter reports the results of the rates of the Meisenheimer rearrangement of
tropane N-oxides and attempts to address some of the questions raised by the different Noxide rearrangement rates.

3.3 Rates of Reaction
Rate studies of the rearrangement of both tropane AT-oxides 161 and 162 were
carried out in D M S O - d 6 and monitored by *H nmr at temperatures varying from 80°C to
120°C at five, ten or fifteen minute intervals. The rates displayed in Tables 3 and 4 were
evaluated from a plot of time versus the disappearance of the starting material (monitoring
the disappearance of the olefinic singlet). To standardise the rates at the various
temperatures each recording was calculated as a ratio between the area of the olefinic
singlet at time zero and the area of the olefinic singlet at time t
The thermolysis of 161 in D M S O - d 6 gave the same mixture of compounds as
was found with the thermolysis of 161 in butyronitrile. However, an additional set of
olefinic protons were present that appeared as doublets at 86.71 and 86.39. They made
up approximately 1 0 % of the product, assuming they integrated for one proton. At the
end of the kinetics run (120 minutes at 100 °C) there was a 2 9 % peak area reduction in
the olefinic proton for the starting material. Figure" 15 shows the composition at the
olefinic region, of this reaction mixture at the completion of the rate study.
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Figure 15 400MHz lH NMR spectrum (DMSO-d6) of 161 showing the olefinic region after
minutes at 100 °C.
To establish the origin of this new compound produced, two experiments were
undertaken. Firstly the thermal stability of a small amount of the TBDMS protected
cycloheptadienol 163 in DMSO-d6 was monitored by *H NMR at 120°C. This
confirmed that 163 was not the origin of this new compound. A small amount of the
Meisenheimer product 164 in DMSO-d6 was also monitored by *H NMR at 100°C.
From this experiment, the new compound was detected. Figure 16 shows the
composition of the olefinic region after thermolysis of 164 in DMSO-d6 for 125

minutes. This confirmed that this new compound arises from the decomposition of 164.

Since this compound does not originate directly from the A^-oxide, it therefore doe
contribute to the observed rates of rearrangement

Vt*tfMlirt*>f*/^j*Hi>*m,l\rfrfft

rn rL

I I I | I I I T | I I I I | I I I I | I I I I | I I I I [ I I I I | I I I I [ I I 1 I [ I I I I [ I I I I I I I I I I II

I ' 'I I 'I I 'I I ' ' ' ' I ' ' ' ' |

6.9

6.7

6.5

6.3

6.1

5.9

5.7

ppm

Figure 16 400MHz *H N M R spectrum (DMSO-d6) of 164 showing the olefinic region after 125
minutes at 100 °C.
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The thermolysis of 162 in D M S O - d g also gave the same mixture of compounds,
along with the n e w decomposition product derived from 164. After thermolysis for 55
minutes at 100 ° C there was a 7 % peak area reduction of the olefinic protons in the
starting material. Figure 17 shows the composition of the reaction mixture after the rate
study conducted at 120°C was completed (75 minutes).
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Figure 17 400MHz 1H NMR spectrum (DMSO-d6) of 162 showing the olefinic region after
minutes at 120 °C.

Tables 3 and 4 show the rates obtained for the disappearance of the Af-oxides at
various temperatures.

Table 3. Rate Constant for the Meisenheimer Rearrangement of the Axial
W-Oxide 161

Temperature °C

Rate of reaction (minutes"1)

80

7.79 xlO'4

90

1.73 x 10-3

100

3:91 x 10"3
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Table 4 Rate Constant for the Meisenheimer Rearrangement of the
Equatorial AT-Oxide 162
Temperature °C

|| Rate of reaction (minutes-1)

95

4.03 x 10-4

100

5.27 x 10-4

110

4.21 x 10-3

120

7.72 x 10-3

A comparison of the rates in Table 3 and Table 4 shows that the axial Af-oxide
161 rearranges about seven times faster than the equatorial Af-oxide 162 at 100°C.
The rate constants which were obtained at three different temperatures for the
Meisenheimer rearrangement of each AT-oxide, were used to obtain AS*, A H * , E A and
A G * for this process. The Arrhenius expression for the rate constant (kc) may be written
as equation [1], or as it is more commonly used, equation [2].
kc = A.exp.(-EA/RT)

ln(kc) = In A - ( E A / R T )

Equation [ 1]

Equation [2]

In these equations the pre-exponential term (A) = (kT/h)e'.exp(AS*/R); k = Boltzmann
constant and h = Planck constant
Thus from a plot of ln(kc) against T"1, the activation energy ( E A ) and the entropy
of activation (AS*) can be determined from the slope and intercept respectively.
For the plot ln(kc) vs T _ 1
slope = - E A / R
.-. E A = (-slope).R
The y-intercept = ln(A)
, ln(A) = ln(kT/he') + (AS*/R)
= 30.46 + (AS*/R) for T = 298
.-. A S * = R(ln(A) - 30.46)
From E A w e can evaluate A H * from equation [3]
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E A = AH* + RT

Equation [3]

A n d A G * can be evaluated from equation [4]
AG* = A H * - TAS*

Equation [4]

The Arrhenius plot for 161 gave an acceptable linear plot. The plot for 162,
however, is somewhat questionable, this being due to the higher temperature required for
the Meisenheimer rearrangement to proceed, which made monitoring by lH

NMR

difficult and limited the total extent of the reaction observed. The values obtained,
however, can be regarded as being a reasonable reflection of the true values. Table 5 lists
the values of the slope and intercept as well as calculated values for AG*, AS*, E A and
A H * determined from the Arrhenius plots for the N-oxides 161 and 162 in Figure 18
and Figure 19. The entropy term is strongly negative, in keeping with a sterically
demanding transition state and this is a major contributor to AG*. The entropy change for
162 is 56IK" 1 mol- 1 greater than for 161. This suggests a considerable increase in
randomness in the activated complex for 162. The energy of activation for the equatorial
Af-oxide 162 was found to be 6.9KJmoH greater than for the axial Af-oxide 161 and is
consistent with the greater ease of rearrangement of the latter.
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Figure 18. Arrhenius Plot, ln(kc) vs T 1 for the Axial N-oxide 161
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Figure 19. Arrhenius Plot, ln(kc) vs T1 for the Equatorial Ar-oxide 162.

Table* 5. Results of the Arrhenius plots for 161 and 162; AS*, EA, AH*
and AG* are calculated at 298K
compound

slope

y-

AS*

intercept

JK-imol"1 Imol"1

EA

AH*

AG*

Imol"1

kJmol-1

161

-648.71

0.92021

-245.6

5394

2916

76.10

162

-1483.5

7.6504

-189.6

12334

9856

64.36

3.4 Molecular Modelling
Computer-based molecular modelling was next undertaken in order to try and
obtain some reason for the difference in the observed rates.
The accepted reaction pathway of the Meisenheimer rearrangement is via a
homolytic dissociation-recombination pathway100. In the proposed pathway for the
Meisenheimer rearrangement of 161 (Scheme 56), the first step involving radical

cleavage of the N-C bond is reversible. The diradical formed 176 is delocalised wit

the double bond and between the nitrogen and oxygen, the latter involving a nitroxy

radical. Rotation of the N-C bond is then needed to align both radicals for recombi
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The reaction pathway would be the same for the diasteroisomer 162, the only difference
being the reversed positions of the methyl and oxygen prior to N - C bond rotation.
It was envisaged that by molecular modelling this reaction pathway as a potential
energy surface and looking at the transition state structures, an explanation for the
observed difference in the Meisenheimer rearrangement rates m a y be found.

OTBDMS

161

OTBDMS

OTBDMS

176

OTBDMS

OTBDMS

164
S c h e m e 56

From the independent observation that Malpass" has made that 173 and 174
also show a considerable rearrangement rate difference, the bulky f-butyldimethylsiloxy
group of 161 and 162 was assumed to have little effect on the observed difference in
rates. These groups were therefore removed to limit computing time in the modelling
studies.
The two Af-oxides 177 and 178 were first geometrically optimized using the
available S P A R T A N A B INITIO program, model U H F / S T O - 3 G , although it is
acknowledged this program has limitations. The ground state energies obtained for 177
and 178 were -272525kcalmoH and -272519kcalmol'1 respectively. The more stable
compound is 177 by 6kcalmol'1. The difference in the energies is too small to have a
bearing on the rates of reaction and if it did the more stable one would

be expected to

rearrange the slowest. W e observed the higher energy one, 178, rearranging the slowest.
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177

178

A transition state structure search was then undertaken to observe the difference,
if any, in the generated transition structures. Initially one N-C bond on both compounds
177 and 178 was stretched and constrained to 2.7 A. These new structures were again
optimized using the same program and parameters, except for the multiplicity which was
now set to 3 (ie. triplet state) to allow for the C-N bond cleavage. This then gave two
new structures 177a and 178a.

A n AB-INITIO transition state optimization using the same parameters as above,
was carried out on 177a and 178a. This gave two possible transition structures, 177b
and 178b with ground state energies of -272562kcalmoH and -272559kcalmoH
respectively.
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177b

178b

The energy difference between these two structures is only 3kcalmoH and the

least stable structure was derived from the compound that rearranges the slowest. T

structures can be represented by the following energy diagram (Figure 20). This dia
includes the AB-INITIO, geometrically optimized product 179, that is expected from
rearrangement.
Transition State

178b
-272559kcalmol-l

177b
-272562kcalmol-l

-272556kcalmol

178a
-272555kcalmor1

178
-272519kcal mol-1

177
-272525kcalmol-l
Reactant

179
-272578kcalmol-l

179
-272578kcalmol

Figure 20. The Reaction Pathway of the Meisenheimer Rearrangement of the N-Oxides
177 and 178.
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If 1 7 7 b and 1 7 8 b were valid transition states then E A for 1 7 7 -> 1 7 7 b would
be 37kcalmoF and for 178 -> 178b, 40kcalmoH; the experimental values of EA (at
298K) were l.SkcalmoF for 161 and 2.9kcalmoH for 162. The difference of
-3kcalmoH for the calculated EAofl77—>177b supports the observation that the axial
N-oxide rearranges faster than the equatorial N-oxide.
To verify that 177b and 178b were in fact valid transition structures, they were
both optimized again, but this time the multiplicity was now set back to 1 (ie. singlet

state). It was envisaged that if indeed they were transition states to the final product 1
the results from this optimization would resemble either the starting material or the
product.
The results from this experiment gave structures 177c and 178c. Both

structures, however, do not resemble either the starting material or the product. What was
therefore calculated were transition states on a triplet surface that lead to products

different from 179. Therefore, the calculation of transition structures on a triplet surf
does not fit into the singlet scheme. More work using higher order calculations is thus
required to fully understand the reason for the observed rate difference in the
Meisenheimer rearrangement of the A^-oxide diastereoisomers.

177c
3.5 Discussion
The results from the modelling studies do predict a variation in the activation
energies (EA), which supports the finding that the axial A^-oxide rearranges faster then

equatorial A^-oxide. However, the calculated transition structures do not lead to the fina
product 179. Therefore, the reason that one isomer rearranges faster than the other
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cannot at this stage be answered by computer assisted molecular modelling studies.
Higher order calculations involving a multiconfigurational treatment are required.
O n e other possible reason that might explain the rearrangement rate difference is
that upon C - N bond cleavage of 150 the oxygen of the equatorial Af-oxide m a y be
forming a partial bond with the olefinic carbon closest to the nitrogen (Scheme 57). This
would stabilise the intermediate and hamper N - C bond rotation thereby favouring the
equilibrium to the left
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.Me

.Me
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M o r e research is required to explain the observed Meisenheimer rearrangement
rate difference of nitrogen-bridged, bicyclic, N-oxide diastereoisomers.
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Chapter 4
Approaches to 1-Hydroxytropacocaine
4.1 Introduction
Apart from physoperuvine, only one other 1-hydroxytropane has been
discovered, that being 1-hydroxytropacocaine 15 from the leaves of a greenhouse
cultivated plant Erythroxylum

novogranatense

variety

novogranatense45

(Erythroxylaceae)

OCOPh
1 -Hydroxy tropacocaine

Quantitative levels of 15 in dry leaf were found to be 0.3-0.5%. This was similar
to its cocaine content. Isolation of this alkaloid was accomplished by toluene extraction of
basified ( N a H C 0 3 ) leaf tissue, followed by trap, ion-pairing and alumina column
chromatography. However, this only gave sufficent amounts of 15 for mass spectral
analysis. C o m p o u n d 15 was subsequently found to be unstable in w a r m methanol and
other solvents. T o isolate enough material for N M R studies, the crude extract was treated
with heptafluorobutyric anhydride. This yielded sufficient amounts of the stable 1-0heptafluorobutyryl derivative of 15 (1-OHFB-tropacocaine 180) for N M R studies.

CF3CF2CF2OCO

^OCOPh
180
1 -OHFB -Tropacocaine

There have been no synthetic approaches to 1-hydroxytropacocaine 15 reported
in the literature. It was envisaged that 1-OHFB-tropacocaine, the stable analogue of 15,
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could be prepared based on the synthetic technology developed for 3ahydroxyphysoperuvine.

4.2 Retrosynthetic Approach to 1-OHFB-tropacocaine 180.
It w a s envisaged that the protection of 167a

«=?

167b

1-O-heptafluorobutyryl derivative, followed by selective deprotection of 181,

as the
would

yield the l-OHFB-3a-hydroxy-physoperuvine 182. A Mitsunobu reaction101 applied to
182 using benzoic acid as the nucleophile should then yield 1-OHFB-tropacocaine 180
(Scheme 58). The Mitsunobu reaction is known to occur primarily with inversion of
configuration.

R

NUOCOPh
180

^>

=>

Mitsunobu
reaction

desilylation
OTBDMS

182 O H

1 -OHFB -Tropacocaine
esterification
R=OCOCF2CF2CF3

167b

OTBDMS

Scheme 58
However, to verify the feasibility of this approach, the first part of the synthesis
looked at employing the Mitsunobu reaction on a model system. The model compound
chosen was 6,7-dehydrotropine 138. The Mitsunobu reaction on 138 if successful
would yield 6,7-dehydrotropacocaine 183.

OCOPh
183
6,7-Dehydrotropacocaine
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This chapter describes the synthesis of of 6,7-dehydrotropacocaine as well as
approaches to the synthesis of 1-OHFB-tropacocaine

4.3 Synthesis of 6,7-Dehydrotropacocaine
Treatment of a mixture containing 138, benzoic acid and triphenyl phosphine
(TPP) in tetrahydrofuran (THF) at 0 ° C with diethyl azodicarboxylate ( D E A D ) gave, after
workup and separation by centrifugal chromatography, an 8 5 % yield of 6,7dehydrotropacocaine 183 (Scheme 59).

C02H

DEAD, TPP
THF,0 0 ( J
138

OH

OCOPh

183

184
S c h e m e 59

The structure of 183 was confirmed by its mass spectrum and N M R spectrum.
A n EI mass spectrum indicated a molecular ion of m/z 243 which equated to the
molecular weight of tropacocaine 169 ( M W = 245) less two units, which was consistent
with the proposed structure.

OCOPh
169 H
Tropacocaine

The fragmentation pattern of 183 had many similarities to the EI mass spectrum
of 169. In addition to the molecular ion, a base peak at m/z 138 was observed, again two
units less than the corresponding base peak for tropacocaine of m/z 140. There were also
two major peaks at m/z 121 and m/z 122 arising from the loss of PI1CO2H and PI1CO2,
with the latter being two mass units less than the 1 0 0 % base peak of m/z 124 of
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tropacocaine69'45. The ^U N M R spectrum confirmed 17 protons, five aromatic, two
allylic and 10 aliphatic. The H 3 proton at 85.09 is part of an apparent five spin system
and appears as a mutilplet having 16 transistions in 9 lines in the ratio of
1:2:2:1:4:1:2:2:1, with Jj-2 =Ji-3 and Jj.5 =Ji-9. The finding of unequal coupling
constants of 9.6 and 7.0Hz is consistent with H 3 n o w being in an axial position. This
pattern is almost identical to that found for the H 3 proton of compound 164, which is
also in an axial position, hence the Mitsunobu reaction proceeded as expected with
inversion of configuration. The

13

C spectrum of 183 showed eleven resonances, two

quaternaries (8165.9 and 130.5), three aromatic (8132.8, 129.5, 128.3), one allylic
(8129.4), two methines (868.5, 66.2), one methylene (831.9) and one methyl (840.5). A
^ C H correlated 2 D N M R spectrum allowed assignment of all non quaternaries to their
attached protons.

4.4 Reaction of the TBDMS Protected 3a-Hydroxyphysoperuvine 167a *=*
167b with Heptafluorobutyric anhydride.
The compound 3a-?-butyldimethylsiloxy-8-methyl-8-azabicyclo[3.2.l]octane-lol (167a *=> 167b) in acetonitrile was treated with excess heptafluorobutyric anhydride
for thirty minutes at room temperature. After workup, the crude reaction mixture was
subjected to column chromatography, from which two compounds were isolated.
The first compound isolated was a major component of the reaction mixture. A
H R C I mass spectrum gave an M H

+

ion at m/z 468.1813 which supports the molecular

formula C18H29F7NO3SL This equates to the molecular weight of the starting material
(271.1962) plus 196, ie. (starting material + C O C F 2 C F 2 C F 3 - H ) . The lU

NMR

spectrum of this compound was broad at room temperature and difficult to analyse.
However, it was clear that there were two conformations in solution.
The 1 3 C N M R spectrum confirmed the existence of two conformations in solution
as all peaks were doubled up. This was not due to the carbons coupling to the fluorines,
as the doubling up was observed throughout the spectrum, including the carbons
belonging to the ?-butyldimethylsilyl protecting group, so it is most likely due to amide
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rotamers. The two quaternary carbon resonances at 8210.1 and 8209.4 confirmed the
presence of a ketone. The quaternary carbon associated with the heptafluorobutyric ester
appeared at 8157.2 as a triplet, which is due to long range coupling to the fluorines.
Based on this evidence and the absence of any quaternary peaks around 90ppm, this
compound was assigned the structure of the cycloheptanone structure 185.
O

0

••••OTBDMS

,NOCOCF2CF2CF3
Me

185

The second compound isolated was also a major component of the reaction
mixture. A H R C I mass spectrum gave an M H

+

ion at m/z 468.1813 which is also

consistent with the molecular formula CisH29F7N03Si. The *H N M R spectrum of this
compound wa:s also broad at room temperature and difficult to analyse. However, the
13

C N M R spectrum was sharp at room temperature and revealed the presence of three

quaternary carbons at 8163.3 (triplet, long range coupling to the fluorines), 97.1 and
17.2, two methines at 865.4 and 62.8, four methylenes at 845.2, 37.9, 29.4 and 23.2,
three methyls at 832.6, 25.6 and -5.2. All other carbons associated with the
heptafluorobutyrl chain were present as a complex series of peaks between lOOppm and
130ppm. Based on the presence of the quaternary carbon at 897.1 it was assigned the
structure of l-0-heptafluorobutyryl-3a-r-butyldimethylsiloxy-8-methyl-8azabicyclo[3.2.1]octane 181. This compound was the one required to take on further in
the synthesis.

CF3CF2CF2OCO N|
OTBDMS
181
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4.5 Synthesis of l-0-heptafluorobutyryl-8-methyl-8azabicyclo[3.2.1]octan-3cc-oI 187.
The removal of the r-butyldimethylsiloxy group was achieved by stirring 178
with aqueous 3 % hydrochloric acid overnight. This gave 1-O-heptafluorobutyryl ester
182 in good yield.

CF3CF2CF2OCO

N|
OH

182

The structure of 182 was confirmed by its mass spectrum and NMR spectrum.
A n H R C I mass spectrum gave an M H + ion of m/z 354.0938 which is consistent with the
formula C12H16F7NO3. The * H and 1 3 C nmr spectra showed the absence of the silyl
group.

4.6 Attempted Mitsunobu Reaction of l-0-heptafluorobutyryl-8-methyI-8azabicyclo[3.2.1]octan-3a-ol 182 with Benzoic Acid.
Treatment of a mixture of 182, benzoic acid and T P P in tetrahydrofuran at 0 ° C
with D E A D failed to give the desired product 180. The ^H N M R spectrum of the crude
reaction mixture revealed the absence of any peaks at 5.32ppm (the chemical shift for H 3
of 180), which would have confirmed the formation of a benzoate ester. The crude
reaction mixture was dissolved in water and extracted with dichloromethane. The
aqueous phase was found to contain mostly starting material.
Theoretically this Mitsunobu reaction should proceed. However, due to lack of
starting material and as a result of time constraints, only one reaction was attempted.
Further modification of the reaction conditions was not attempted.
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The conversion of 3a~hydroxyphysoperuvine 1 0 3 a *=s 1 0 3 b directly to 1hydroxytropacocaine, using the same conditions as above was also attempted. A GCMS
analysis of the reaction mixture, however, failed to show the presence of any 1hydroxytropacocaine, although the presence of a large amount of starting material was
confirmed.

4.7 Discussion
An explanation for the failed approach to 1-OHFB-tropacocaine may be the result
of steric factors. The lH NMR of 1-OHFB-tropacocaine is reported to be sharp at room
temperature, however the lH NMR of 181 and 182 is broad at room temperature.
Molecular modelling carried out on 181 (AMI semi-emperical calculations) has shown

the optimized structure (Figure 21) to exist in a boat form with respect to the piperid

ring. A conformational search carried out on this structure failed to find any more sta
conformations. The broad iH NMR spectrum, however, suggested an equilibrium
between two conformations.

Figure 21. Semi-emperical (AMI) conformation search result on 181.

Molecular modelling carried out on 182 using the same program as above,
showed the optimized structure to be in a chair conformation with respect to the
piperidine ring. However, a conformational search carried out on this structure has

shown the existence of another stable conformation, that being with the piperidine rin

a boat form (Figure 22). The small difference in energy between these two confirmations
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suggest that in solution they would exist in equilibrium. This finding is supported by the
broad !H NMR spectrum.

Heat of Formation -456.234 kcal/mol

Heat of Formation -454.485 kcal/mol

Figure 22. Semi-empirical (AMI) conformational search results on the hydroxy ester 182.

The Mitsunobu reaction requires the formation of a bulky oxyphosphonium salt
intermediate 186. Computer modelling (AMI semi-emperical) predicts an equilibrium
between chair and boat conformations and hence steric hinderance between the lone pair
of electons of the nitrogen and H3 in the boat conformation would not allow an SN2
displacement by the nucleophilic benzoate ion (Scheme 60).

Me,

H
CF3CF2CF2OCO

PhC02'
186

^

H-^y
CF3CF2CF2OCO

^

PhC02-

pph3

186

Scheme 60
The same argument would apply to the failed conversion of 3ahydroxyphysoperuvine 167b to 1-hydroxytropacocaine. This is, however, complicated
by the presence of the the ring-opened tautomer 167a. The lH NMR of 167a ^=5 167b
in methanol-d4, does show the equilibrium favouring the bicyclic structure 167 b.
Computer modelling carried out on the oxyphosphonium salt of 167b, predicts an
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equilibrium between boat and chair conformations. This equilibrium would again hinder
the Mitsunobu reaction.

4.8 Conclusion
The synthesis of 1-OHFB-tropacocaine and 1-hydroxytropacocaine failed at the
last step. However, the conversion of 138 to 6,7-dehydrotropacocaine 183, in high
yield, opens up an alternative approach to 1-hydroxytropacocaine. The compound 183
could be used to prepare 1-hydroxytropacocaine using the technology developed for the
synthesis of 3a-hydroxyphysoperuvine. The deprotection of 183, followed by
protection of the hydroxyl as the T B D M S ether, would be required. This compound
could then be taken through to the Meisenheimer product, which could then be converted
to 180 (Scheme 61).

OCOPh-

OTBDMS

183

OCOPh
OCOPh

180

191
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Chapter 5
Synthesis of Deoxynojirimycin Analogues
Approaches to the 1-Hydroxynortropane Skeleton
5.1 Retrosynthetic analysis.
A n alternative approach to the 1-hydroxynortropane skeleton 106b was also
investigated, using castanospermine as a structurally advanced starting material. This
approach also allows for the synthesis and biological examination of C6-modified
analogues of 1-deoxynojirimycin, which would be intermediates 104, 193-196 in the
synthetic analysis proposed (Scheme 62). Again the goals of this research were two-fold.
One goal was to develop novel chemistry. The second goal was the possiblity of value
adding to an existing Australian export product via the chemical modification of
castanospermine 7 to produce useful new bioactive products.
The main steps involved in the proposed transformation of castanospermine to the
1-hydroxynortropane 106b (Scheme 62), included ring cleavage, dehydrohalogenation,
oxidative cleavage of an olefin, oxidation of a carbamate and finally halogen exchange to
form a carbanion that could cyclise to give the 1-hydroxynortropane derivative, 106b
(2,3,4,6-tetraep* analogue of calystegin CI).

HO„

H

J3H

HO-

-Ch
HO

^
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[H] R O
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5.2. Structure-Activity Relationships of Glycosidase Inhibitors.
Somewhat limited structure-activity relationship studies have been carried out on
glycosidase

inhibitors 6 3 , 1 0 2 ' 1 0 3 ' 4 3 . Conformational comparisons

between

1-deoxynojirimycin and castanospermine suggest that the greater activity of
castanospermine towards HTV-1 m a y be due to the fixed axial position of the 0 6 atom 103 .
Structure-function relationships between nortropane alkaloids have shown that while an
equatorial hydroxyl group on C-2 is essential for the inhibition of P-glucosidase and aand P-galactosidase, an axial configuration decreases inhibitory activity43.
The biological activity of 106a *=» 106b towards a- and P-glucosidase should
add further valuable knowledge to the structure-activity relationships of glycosidase
inhibitors. All the stereocenters of 106a «=» 106b are the same as in castanospermine,
the only change being that the C 3 of castanospermine is n o w connected to C 5 rather than
N 4 , together with the introduction of one extra hydroxyl group. It does, however,
change the preferred conformation somewhat.
T h e calculated semi-empirical molecular model ( A M I ) of compound
1 0 6 a *=» 106b, showed the most stable structure to be the one with the piperidine ring
in a boat conformation. This places each of the hydroxyl groups of the piperidineringin
an equatorial orientation. Comparing this structure with that of castanospermine and
calystegin Ci, there appears very little difference in all three structures, with respect to the
orientation of the nitrogen and the oxygens of the piperidine ring. Figure 23 shows a C S
C h e m 3 D Pro depiction of the calculated semi-empirical molecular models ( A M I ) of 106a
*=? 106b, castanospermine and calystegine Ci illustrating the structural differences. The
main difference in the three structures is the orientation of O H 2 and 0 H 4 of 106a *=?
106b which is slightly different to the others. Also the orientation of O H 6 of epicalystegin Ci is opposite to that of calystegin Ci. Athough these are subtle changes to the
structure, the glycosidase activity of 106a «=? 106b could still be quite different from
that of castanospermine and calystegine CI.
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Castanospermine

Calystegine Ci

Figure 23 Semi-emperical molecular model (AMI) optimized structures of castanospermine,
calystegin CI and 2,3,4,6-tetrae/?z'calystegine Cj

5.3 Synthesis

5.3.1 Protection of the H y d r o x y l G r o u p s in C a s t a n o s p e r m i n e
The first part of the proposed synthesis required protection of the four hydroxyl

groups of castanspermine. It was decided therefore to investigate silyl-based protecting
groups.
Treatment of castanospermine with excess ?-butyldimethylsilyl chloride in N,Ndimethylformamide, with imidazole as the base, resulted in a mixture of compounds.
Thin layer chromatography revealed the presence of four compounds with Rf values of
0.93 (198), 0.85 (199), 0.55 (200) and 0.38 (201). The overall isolated yield of this
reaction was 88%, based on there being an average of 2.85 TBDMS groups present. This
average was obtained from the integrals of the !H NMR spectrum of the reaction mixture.
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Flash column chromatography enabled easy separation of the compounds 200
and 201; however, separation of compounds 198 and 199 was much more difficult.
Only a small amount of 199 was successfully separated by flash column
chromatography for structural analysis.
T o be able to structurally assign 199, 200 and 201, J H and H-H cosy N M R
spectra of castanospermine in DMSO-cbj were required. This allowed the assignment of
the hydroxyl groups of castanospermine, which, by comparison of these spectra with
those of the lU and H - H cosy N M R spectra in D M S O - d 6 of 181, 182 and 183, the
structures of these three compounds were solved. Figure 24 shows the H-H cosy N M R
spectrum of castanospermine in D M S O - d g and Figure 25 shows the chemical shift
assignments based on this spectral information.

H2

AJJLA!

3.5
Fl

3.0
(ppm)

Figure 24. 400MHz H-H COSY N M R spectrum of castanospermine in DMSO-d 6
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2.05, 1.50
4.63

H

H

2.99, 1.70

2.98, 1.86

Castanospermine
Figure 25. Complete *H N M R assignment of Castanospermine in DMSO-dg.

The structures of 199, 200 and 201 were confirmed by their mass spectra and
N M R spectra.
The T B D M S protected castanospermine analogue 200 was isolated as a
colourless solid. A n H R E 1 mass spectrum of 200 gave a molecular ion of m/z 417.2735
which is consistent with the molecular formula C2nH43N04Si2. T h e *H N M R spectrum
of 200 in D M S O - d s confirmed the presence of two hydroxyl groups at 84.65 and 4.30.
The H - H cosy N M R spectrum of 200 in D M S O - d 6 (Figure 26) showed that the
hydroxyl at 84.65 was coupled to H 7 and the hydroxyl at 84.30 was coupled to H 8 ,
thus, confirming the structure of 200 as 1,6-0,0-bis-f-butyldimethylsilylcastanospermine.
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Figure 26. 400MHz H-H COSY N M R spectrum of 200 in DMS0-d6
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200

The second T B D M S protected analogue of castanospermine isolated was
compound 201. A n H R E I mass spectrum of 201 gave a molecular ion of m/z 417.2735
which is also consistent with the molecular formular C2oH43N04Si2. The lH N M R
spectrum of 201 in D M S O - d 6 confirmed the presence of only two hydroxyl groups at
84.50 and 4.21. The H-H cosy N M R spectrum of 201 in DMSO-d6 showed that the
hydroxyl at 84.50 was coupled to H 7 and the hydroxyl at 84.21 was coupled to HI,
thus, confirming the structure of 201 as 6,8-0,0-bis-/-butyldimethylsilylcastanospermine.
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(H3C)3C(H3C)2SiO_

0 H

H

HO.
(H3C)3C(H3C)2SiO^

201

The third compound that was isolated from the reaction mixture was assigned the
structure 199 on the following grounds. A n E S + mass spectrum of 199 indicated that
the compound had a molecular ion of m/z 532 (C26Hs8N04Si3) which is consistent with
the addition of three T B D M S groups. The ! H N M R spectrum of 199 in D M S O - d 6
confirmed the presence of only one hydroxyl groups at 83.90. The H-H cosy N M R
spectrum of 199 in D M S O - d 6 showed that the hydroxyl at 83.90 was coupled to H8,
thus confirming the structure of 199 as 1,6,7-0,0,0-tris-t-butyldimethylsilylcastanospermine.
°5 H pSi(CH3)2C(CH3)3
(H3C)3C(H3C)2SiO ^ I ^ ? /

:in,,-Lw
199

(H3C)3C(H3C)2SiO'

The fourth component of the reaction 198 could not be isolated by flash column
chromotagraphy or centrifugal chromotagraphy. A n ES mass spectrum of a mixture of
198 and 199 gave a single M H + ion at m/z 532. This suggests that the compound 198
has the same molecular formula as 199. Based on this evidence and the structures of
199, 200 and 201 the compound 198 was tentatively assigned to be 1,6,8-0,0,0-trisf-butyldimemylsnyl-castanosperniine.
(H3C)3C(H3C)2SiO=
HO,

0 Si(CH 3)2 C(CH3)3

(H3C)3C(H3C)2SiO^'
198
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5.3.2 Ring Cleavage of Silyl Protected Castanospermine
The ring cleavage reaction was first trialled on the partially protected compound
200. Refluxing the 1,6-protected castanospermine 200 in chloroform with excess
methyl chloroformate gave, in high yield, the ring cleaved compound 202 (Scheme 63)
as colourless crystals.

OH
OTBDMS
O
LJ OTBDMS
V>sJ 7
II
HO. Xj
t
.
excess CHsOCCl / CHCb
T
T ^^^^G!
x,
N /
TBDMSO "^^ ^
K^Os
TBDMSO^'^^^^CHa
200
202 O

9HJ

HC

Scheme 63

The structure of 202 was confirmed by its mass spectrum and N M R spectra. An
HREI mass spectrum of 202 indicated that the compound had a M-C(CH3)3+ molecular
ion of m/z 454.1841 (Ci8H46N0635ClSi2). This is consistent with ring cleavage of
castanospermine by the methyl chlorformate. The *H N M R spectrum of 202 confirmed
the presence of 43 protons at 84.35 (IH), 4.23 (IH), 4.04 (IH), 3.82-3.62 (7H), 3.28
(IH), 2.04 (2H), 0.87 (18H) and 0.11 (12H). An H-H cosy spectrum of 202 revealed
the conectivity of 83.64, 2.04, 4.35 and 4.21, which confirmed the fragment shown in
Figure 27. The resonance at 83.64 is typical for a chloromethyl group104, which is in
accord with the proposed structure of 202.

4.35ppm 3.64ppm
TBDMSO
H
H
H
4.23ppm H
R

H
H
2.04ppm
Figure 27
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The

13

C N M R spectrum of 2 0 2 indicated the presence of three quaternary

carbons at 8157.6, 18.3 and 18.0, five methine carbons at 871.9, 71.6, 69.7, 69.5 and
60.7, two methylenes at 843.3 and 40.8 and seven methyls at 852.7, 26.0, 25.8, -4.4,
-4.6, -4.7 and -4.9. The chemical shift for a carbonyl of the carbamate H 2 N C O 2 C H 2 C H 3
from 1 3 C tables*"4 is 8157.8, therefore the observed carbonyl at 8157.6 is consistent
with the formation of a carbamate. A ^ C H correlated 2 D N M R spectrum allowed
assignment of all non quaternaries to their attached protons. The protons of C-CH2-CI
group correlated to the carbon at 840.8; the predicted

13

C chemical shift of this

c a r b o n 1 0 4 is 839.9. This experiment also confirmed the presence of one set of axial
equatorial protons, 84.04 and 3.28, connected to 843.3. All this evidence supported the
assigned structure of 202.
The ring cleavage reaction was then carried out on the mixture of T B D M S
protected castanospermine obtained from the T B D M S protective step. This reaction
yielded the expected mixture of ring cleaved products 202, 203, 204 and 205. The
main evidence for the formation of these products came from the broad, lone, triplet at
2.02ppm for the H 2 ' protons in the J H N M R spectrum of this mixture. The parent
compounds have five resonances between 81.2 and 82.3 corresponding to H 2 (axial and
equatorial), H 3 (axial), H 5 (axial) and H8a. Upon ring cleavage H 3 , which is now H3',
is shifted downfield by the electron withdrawing effect of the chlorine atom; H 5 (axial),
which becomes H 6 (axial) and H 8 a became H 2 are shifted downfield by the electron
withdrawing effects (ie. deshielding effect) of the carbamate.
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The isolation of pure compounds from this mixture was difficult, so conversion
to the common compound 206 by the removal of the TBDMS groups with
tetrabutylammonium fluoride (TBAF), was attempted. This is discussed in the
section.

H?H OH

.L N O

HO^^^Y

CHa

O
206

5.3.3 Desilylation of 202-205 with Excess Tetrabutylammonium Fluoride
(TBAF)
A mixture of 202,203,204 and 205 in tetrahydrofuran was treated with excess

TBAF and stirred overnight at room temperature. This gave a mixture of three
compounds, which were separated by reverse phase preparative HPLC.
The first compound isolated was a solid consisting of sugar-like colourless

crystals. A CI mass spectrum gave a parent ion of m/z MNa+ 256.1, with M+ eq

233. The mass spectrum also indicated that the chlorine had been lost based
absence of the expected isotope pattern.
The XH NMR spectrum of this first product, confirmed the presence of eleven

aliphatic protons at 84.65 (IH), 3.86 (IH), 3.74 (2H), 3.60-3.30 (4H), 2.8
1.99 (2H). This showed that the methoxy group had been cleaved. An XH NMR

spectrum in DMSO-d6 (Figure 28) showed that this compound had four hydroxyl

at 85.4 (d), 5.2 (d), 5.1 (d) and 4.6 (t). The triplet at 84.6 indicated th
chlorine had been displaced by a hydroxyl group.
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Figure 28. A *H N M R spectrum of 207 in DMSO-d 6 showing the coupling pattern of OH6, O H 7
O H 8 and OH2'. Assignment of OH6, O H 7 and OH8 was not possible due to overlap of H6, H7 and H8

The 13C NMR spectrum confirmed the presence of nine carbon atoms, consisting
of one quaternary at 8159.1, five methines at 878.0, 77.9, 73.8, 69.6 and 63.2 and three
methylenes at 858.5, 45.1 and 37.9. The quaternary carbon at 8159.1 suggested the
compound still possessed a carbamate group. A iJrjH correlated 2 D N M R spectrum
allowed assignment of all non quaternaries to their attached protons. This experiment also
confirmed the presence of one set of axial equatorial protons 83.86 and 2.84.
All this spectroscopic evidence suggested that this compound had the molecular
formula C 9 H 1 5 N 0 6 , M + 2 3 3 . and w a s thus assigned as lS,6S,7R,8R,8aR-l-(2'hydroxyethyl)-l,5,6,7,8,8a-hexahydro-6,7,8-trihydroxy-3//-oxazolo[3,4-fl]pyridin-3one 207.

H9

H

7[ ™T

^ O H
02

5
O
207
This structure was also supported by a long range 2-3 bond C-H correlation
( H M B C ) experiment
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The formation of this bicyclic compound must have proceeded via a fluoride-base
promoted cyclisation, with the loss of the methoxy group (Scheme 64). Nucleophilic
displacement of the chloro group by a hydroxide ion, present in the non-rigorously dried
T B A F solution, would then account for the formation of 207.

HO*

H=
9 UH X^oH

Scheme 64

The second product from the TBAF reaction was isolated as colourless sugar-like
crystals. A n H R E I mass spectrum gave a molecular ion of m/z 235.0856, the isotope
pattern of which indicated that no chlorine atom was present
The *H N M R spectrum of this compound was similar to that of the ^H N M R
spectrum of compound 207. The major differences observed were for the proton at
82.24 (HI' of 207), which appeared as a doublet of mutiplets while the signal for the
proton H2' of 207, which appeared at 83.74 as a triplet, was shifted downfield to 84.72
and appeared as a doublet of triplets.
The

13

C N M R spectrum of this compound displayed thirteen resonances.

consisting of one quaternary carbon at 8159.0, seven methines at 877.8, 77.23, 77.27,
73.7, 69.6 and 63.1 and five methylene carbons at 883.0, 80.9, 45.1, 36.2 and 35.9. A
U C H correlated 2 D N M R spectrum, however, showed that (883.0, 80.9), (877.23,
77.27), and (836.2, 35.9) were in fact doublets. The coupling constants of 200Hz,
3 0 H z and 4 H z were in accord with for an attached ethyl chain with a terminal
fluoride1^5, ie. C H C H 2 C H 2 F . This evidence pointed to fluoride displacement of the
chloride. The molecular ion that was found at m/z 235.0856 (HREI), is consistent with
the molecular formula, C 9 H 1 4 F N 0 5 . T h e structure of this compound was then
unequivocally determined by single crystal X-ray analysis and was shown to be
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lS,6S,7R,8R,8aR-l-(2,-fluoroethyl)-l,5,6,7,8,8a-hexahydro-6,7,8-trihydroxy-3Hoxazolo[3,4-a]pyridin-3-one 208.
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T 8 Y° 2
H0^6V^3
5

O

208

The mechanism of formation of 208 would be similar to 207, but with fluoride
ion acting as the nucleophile to displace the chloride.
The third compound was isolated as colourless crystals. The H R E I mass
spectrum gave a molecular ion of m/z 215.0794, which was chlorine free.
The lH N M R spectrum of this compound confirmed the presence of nine
protons, consisting of three olefinic protons at 86.04 (IH), 5.54 (IH) and 5.44 (IH) and
six aliphatic protons at 85.03 (IH), 3.93 (IH), 3.66-3.53 (3H), 3.44 (IH) and 2.90
(IH).
The 1 3 C N M R spectrum showed the presence of nine carbon atoms, including
one quaternary carbon at 8158.6, two olefinic carbons at 8134.6 and 120.4, five
methines at 880.4, 73.5, 69.2 and 63.1 and one methylene carbon at 844.8. Based on the
above evidence and the similarity of the N M R data to that of 207 and 208, this
compound was assigned as lS,6S,7R,8R,8aR-l-(ethenyl)-1,5,6,7,8,8a-hexahydro6,7,8-trihydroxy-3//-oxazolo[3,4-a]pyridin-3-one 209.

0 2

HO^VW3
3
209

O

The percentages of 207, 208 and 209 in the mixture as determined by ^H N M R
were 6 7 % , 1 6 % and 8 % respectively.
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Although this reaction failed to give the expected product 206, the formation of
209 was useful, as an attempt to dehydrohalogenate 202 using potassium r-butoxide
failed to give any of the expected olefin 210 (Scheme 65).
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Scheme 65
The formation of the olefin 209 was also important since it opened up the
possibilty of an alternative route to the target compound 106b as outlined in Scheme 66.
HO

H

OH
=> RO

NH
HO

OH
106b

RO
RO,
RO°

-Br

H
N

-i

212

RO
—OH
RO V H ?

na^^i
111

HO
• •««.

H

jf

- n

?1H

r

\^o

OH

=>

N

HO-^ -<
209 °
Scheme 66

To increase the yield of 209, it was envisaged that the use of an equimolar
amount of T B A F would result in the preparation of the chloro analogue of 207 and 208.
This compound could then be dehydrohalogenated using a strong base like potassium tbutoxide.
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5.3.4 T h e Reaction of a Mixture of 202-205 with an Equimolar A m o u n t of
Tetrabutylammonium Fluoride ( T B A F )
A mixture of 202, 203, 204 and 205 in tetrahydrofuran was treated
with an equilmolar amount of T B A F and stirred for thirty minutes at room temperature.
This gave a single compound lS,6S,7R,8R,8aR-l-(2'-chloroethyl)-l,5,6,7,8,8ahexahydro-6,7,8-trihydroxy-3H-oxazolo[3,4-fl]pyridin-3-one, 216 in high yield.

The structure of 216 was confirmed by its EI mass spectrum and N M R spectra.
The H R E I mass spectrum of 216 gave a molecular ion of m/z 251.0586 which is
consistent with the molecular formula C Q H ^ C I N J O J , while the isotope pattern confirmed
the presence of a chlorine atom.
The 1 H N M R spectrum of 216 was almost identical to the 1 H N M R spectrum of
207. The *H N M R spectrum of 216 displayed eleven aliphatic protons at 84.79 (IH),
3.89 (IH), 3.74 (2H), 3.65-3.36 (4H), 2.86 (IH) and 2.2 (2H). The only significant
difference was a d o w n field shift of H I from 84.65 in 207 to 84.79 in 216.
The 1 3 C N M R spectrum confirmed the presence of nine carbon atoms, consisting
of one quaternary at 8158.9, five methines at 877.8, 77.6, 73.66, 69.56 and 63.0 and
three methylenes at 845.1,41.3 and 38.1. This is consistent with the above structure.

5.3.5 Dehydrochlorination of the Oxazolo[3,4-a]pyridin-3-one, 216.
A mixture of 216 and potassium f-butoxide in tetrahydrofuran/N, Ndimethylformamide was refluxed overnight to yield a mixture of two compounds. One of
these compounds was the expected olefin 209. The *H N M R of the other compound
was very similar to 209, however, the H I proton was shifted upfield approximately
0.3ppm. This compound was tentatively assigned as the amine, 217.
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This reaction was then repeated, with a shorter refluxing period which afforded
209 in 8 5 % isolated yield (Scheme 67).
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S c h e m e 67

T o verify the structure of 217, the cyclic carbamate 216 was refluxed overnight
using the same procedure as described above with potassium f-butoxide as the base; a
small amount of 1 0 % sodium hydroxide solution was then added to the reaction mixture
and this was refluxed a further hour. After acidification and workup, this gave the
cystalline hydrochloride salt of 217. A n X-ray analysis unequivocally verified the
structure of 217 as the n e w 1-deoxynojirimycin analogue, (2R,3R,4R,5S)-2-(l'hydroxy-2,-propenyl)-piperidine-2,3,4-triol (Figure 29).

CXr-OCT

Figure 29 Single crystal X-ray structure of 217.
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Since the T B D M S protection step resulted in a mixture of compounds, it was

decided to also investigate TMS-protected catanospermine in the hope of obtain

protection of all the hydroxyl groups and thus avoiding reactions with mixture

5.3.6 Synthesis of TMS Protected Castanospermine
Castanospermine was reacted with trimethylsilyl chloride (TMSC1) in N,N-

dimethylformamide with imadazole as the base, to form the required 1,6,1,8-0,0
tetra-trimethylsiloxy-castanospermine 218 in high yield (Scheme 68).
TMSO

01MS

?>l O H

TMSO. JJ?
excess TMSC1 DMF/imidazole ,

HOv

J

1

^j—\

TMSO*'*^^
218

Scheme 68

The reaction of 218 with excess methyl chloroformate using the same conditions

as noted previously (Section 6.2.2) did not proceed smoothly. The *H NMR spect

the crude reaction mixture showed more than one product. The major component o
mixture displayed a peak at 85.58 which appeared to be a doublet of doublets.
chemical shift suggested an olefinic proton, but this was not consistent with
compound 219.

™s9

H

OTMS
TMSO^A^JL^

TMSO^^NY°^CH3
219 O

Separation of this mixture was not attempted. The TMS protecting groups were

removed by the treatment of this mixture with hydrochloric acid. Separation of

resulting mixture gave 220 in high yield. The *H NMR spectrum confirmed the pr
of fouteen protons, including a methoxy group at.83.35. The 13C NMR spectrum
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showed ten carbons, including one carbonyl. There were, however, no olefinic carbons.
The H - H C O S Y spectrum of 220 showed that the peak at 85.42 was coupled to the
methylene at 82.15 and a ^ C H correlated 2 D N M R spectrum confirmed that the peak at
85.42 was connected to a aliphatic carbon at 879.04. The structure of 220 was,
however, not fully determined until the compound 220 was reacted with excess
tetrabutylammonium fluoride. It was envisage that this may result in the intramolecular
cyclisation to give a cyclic carbamate as before. The reaction of compound 220 with
excess tetrabutylammonium fluoride gave a single compound 221 in high yield. A n EI
mass spectrum of 220 gave a molecular ion m/z 247 consistent with the formula
C10H17NO6. The *H N M R spectrum confirmed fourteen aliphatic protons at 85.50 (IH),
3.90-3.65 (7H), 3.55 (IH), 3.35 (IH), 3.20 (IH), 2.92 (IH), 2.70 (IH) and 2.22
(IH). The 1 3 C N M R confirmed the presence of ten carbon atoms, consisting of one
quaternary carbon at 8160.0, five methines at 881.6, 79.3, 74.5, 72.6 and 71.2, three
methylenes at 857.9, 56.8 and 35.0, one methyl at 860.8. The quaternary carbon at
8160.0 and a methyl at 860.8 suggested a methyl carbamate was still present. A ^JQU
correlated 2 D N M R spectrum allowed assignment of all non quaternaries to their attached
protons. This experiment also confirmed the presence of three sets of axial, equatorial
protons, (82.70, 2.22 ), (2.92, 3.65) and (3.20, 3.60). Therefore, this compound must
be bicyclic.
The ! H and 1 3 C N M R spectra of 221 superficially resembled the ! H and

13

C

N M R of castanospermine, the major difference being the large downfield shift of HI
from 84.38 to 85.50. This then indicated that the methoxy carbonyl group had in fact
migrated from the nitrogen to the oxygen to give the carbonate at CI. Therefore based on
the above evidence the compound 221 must be methyl 1-castanospermine carbonate.
This migration must have taken place upon ring cleavage with methyl chlorofprmate
(Scheme 69).
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A mechanism for the methoxycarbonyl migration is as yet unresolved. Direct

carbonate formation is considered unlikely as both a carbonate as well as a carba

would be expected. Preferential acid hydrolysis of the carbamate is also unlikely
The TMS protecting group was therefore considered to be unsuitable for this

aspect of the project and it was decided to persist with the use of TBDMS-protect
castanospermine derivatives.
The next step in this synthesis required the protection of the cyclic carbamate

209. It was then proposed to oxidatively cleave the double bond to give the aldeh

223, followed by reduction with sodium borohydride to give alcohol 211 (Scheme 70
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^
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However, before investigating the oxidative cleavage, it was decided to first stu

ring oxidation adjacent to the carbamate funtionality, as this was critical in th
synthetic phase. It was envisaged that the oxidation of 224 followed by careful

hydrolysis of the activated carbamate would give 226. Protection of the alcohol a
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amide of 226 followed by dechlorination with butyl lithium should yield 227.
Deprotection of 227 would give the h o m o analogue of the target compound 228
(Scheme 71). The methodology thus developed to synthesise 228 could then be adopted
to synthesise the target compound.
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Scheme 71
However, before the oxidation of a compound of type 224 was trialled, the
oxidation of a model piperidine carbamate was checked. The next section deals with the
oxidation of this model piperidine carbamate.

5.3.7 Oxidation of a Model Piperidine Carbamate
A search of the literature revealed only one reagent that has succesfully oxidised a
range of amides to their corresponding imides in high yields, that being ruthenium
tetroxide106. The proposed ruthenium tetroxide oxidation mechanism as shown in
Scheme 72, involves hydride transfer followed by oxygen insertion, the slow step being
the transfer step. It was envisaged that the oxidation of a carbamate would also proceed
under these conditions.
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To test the feasibility of this proposed synthetic route, the oxidation of a model
carbamate was trialled. This model compound was methyl-N-piperidinecarboxylate 229
which was readily formed from the treatment of piperidine with excess methyl
chloroformate.

4
5/\ 3
6 N

L J2

O^OMe
229

The structure of 229 was readily established by its mass spectrum and N M R

spectrum. A EI mass spectrum gave a molecular ion of m/z 141, which is consistent wi
the molecular formula C7H11NO2. The lH NMR spectrum of the compound revealed

thirteen aliphatic protons at 83.66, 3.38, 1.60-1.49 in a ration of 3:4:6. The 13C NM
spectrum revealed four aliphatic carbons at 852.3, 44.8, 25.6 and 24.3 and one
quaternary carbon at 8156.0 which is consistent with the formation of a carbamate. A
!JCH correlated 2D NMR spectrum allowed assignment of all non quaternaries to their
attached protons, thus, allowing the full assignment of 229 (Table 6)
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Table 6. Assignments of 1 H and1 3 C resonances for 229
IH

1

oc

1

assignment

3.66

52.3

OMe

3.38

44.8

C2 and C6

1.56

24.4

C4

1.49

25.6

C3 and C5

|

The oxidation of 229 with ruthenium tetroxide using the method 107 developed by
Sharpless et al. which involves the catalytic generation of ruthenium tetroxide from a two
phase mixture of water, acetonitrile, carbon tetrachloride, sodium periodate and
ruthenium trichloride hydrate, gave 230 in high yield (Scheme 73).
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The structure of 230 was confirmed by its mass spectrum and NMR spectrum.
The EI mass spectrum indicated that the compound had a molecular ion of m/z 157
consistent with the molecular formula C 7 H n N 0 3 (starting material + O - 2H). The ! H
N M R spectrum of the compound revealed eleven aliphatic protons 83.84 (3H), 3.72
(2H), 2.52 (2H) and 1.82 (4H). This is consistent with the loss of the two protons at C2.
The 1 3 C N M R spectrum revealed five alliphatic carbons at 853.8, 46.5, 34.7, 22.5 and
20.3 and two quaternary cabons at 8171.2 and 154.9. The carbonyl at 8171.2 must be
adjacent to the nitrogen, as a carbonyl at C 3 or C 4 would be expected to resonate at
approximately 200ppm; this therefore confirms an a-oxo substituted piperidine ring.
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5.3.8 Acetyl Protection of 216
In order to apply this ring oxidation to the more highly functionalised precursors
in this study a careful assessment of hydroxyl protecting groups was necessary. The
protecting group needed to resist the ruthenium tetroxide oxidation conditions and be
easily removed. The acetyl group has been s h o w n 1 0 7 to withstand these reaction
conditions and it is cheap, easy to make and easy to remove. It was thus investigated
first
The reaction of 216 and excess acetic anhydride in pyridine gave in good yield
the tri-acetyl analogue 231 (Scheme 74).

HO ^Ci Ac?H r^"c|
HO^ >sj"X

Vr^b

Ac

r,
Ac

ridine

2°py

,

216 °

°v>\M,

T

T b
231 °

Scheme 74
The structure of 231 was confirmed by its mass spectrum and N M R spectrum.
A n H R E I mass spectrum indicated that the compound 231 had a molecular ion of m/z
378.0979

(C^HJQNOC)

which is consistent for the addition of three acetyl groups to the

parent compound 216. The *H N M R confirmed the presence of twenty protons at
8 5.20-4.89 (3H), 4.55 (IH), 4.16 (IH), 3.68-3.52 (2H), 3.43 (IH), 2.82 (IH) and
2.25-1.87 (11H). The 1 3 C N M R spectrum displayed fourteen resonances, including four
quaternary carbons, five methine carbons at 874.2, 72.6, 70.9, 67.6and 59.9, three
methylene carbons at 841.7, 39.4 and 37.5 and two methyl groups at 820.41 and 20.36,
the third acetyl carbon was not resolved.

5.3.9 Ruthenium Tetroxide Oxidation of the Triacetyl Compound 231.
A biphasic solution of water, acetonitrile, carbon tetrachloride, sodium periodate,
ruthenium trichloride hydrate and 231 was stirred at room temperature for seven days.
This reaction failed, however, to give the expected product 232. The only compound that
was isolated from the reaction mixture, in high yield, was starting material.
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The reason that this oxidation failed to proceed may be due to the electron
withdrawing effect of the acetyl groups. Fumeaux et al stated25 "all attempts to oxidise
the the alcohol 233. to the corresponding 6-ketone were unsuccesful, returning only
starting material alone or no discrete product" presumably due to the same electron
withdrawing effects of the acetyl groups.
Ac

? H OAc

AcO

233

It was then decided to try the oxidation on a TBDMS-protected compound.

5.3.10 TBDMS Protection of 216
The reaction of 216 with

f-butyldimethylsilyl chloride

in N,N-

dimethylformamide with imidazole as the base, gave a mixture of compounds. This
mixture was easily separated by flash column chromatography to yield two compounds
234 and 235 (Scheme 75).
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The H R E I mass spectra of both 234 and 235 were consistent with the formula
C21H42CINO5S12. The structures of 234 and 235 were then elucidated from their
D M S O - d 6 H-H C O S Y spectra. The H-H C O S Y spectrum of 234 showed that the
hydroxyl was coupled to H 7 , thus confirming a 6,8-0,0-bis-f-butyldimethylsilyl
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configuration. The H-H C O S Y spectrum of 2 3 5 showed that this hydroxyl was coupled
to H8, thus confirming a 6,7-0,Obis- r-butyldimethylsilyl configuration.
Although complete protection with /-butyldimethylsilyl chloride was
unsuccessful, the ruthenium tetroxide oxidation was still trialled on compound 234.
was expected that the free hydroxyl would be oxidised but this was not expected to
interfer with the required oxidation at C5.

5.3.11 Ruthenium Tetroxide Oxidation of 234
A biphasic solution of water, acetonitrile, carbon tetrachloride, sodium peroidate,
ruthenium trichloride hydrate and 234 was stirred at room temperature for two days.
After work up, an lH NMR spectrum of the reaction mixture revealed two components,

with one of these being starting material. The isolation and structure determination
lone product revealed it to be the expected oxidised compound 236.

TBDMSO^X^?^

T^ l o
TBDMSO°*^~" N ^((
236°
The structure of 236 was confirmed by its mass spectrum and NMR spectrum.
The HREI mass spectrum of 236 gave a molecular ion of m/z 478.2200 which is
consistent with the molecular formula G^H^NCIO^ The lH NMR confirmed the
presence of forty protons at 84.83 (IH), 4.12-4.03 (2H), 3.97 (IH), 3.9 (IH), 3.68
(2H), 3.19 (IH), 2.22 (2H), 0.8 (18H), 0.20-0.05 (12H). The 13C NMR spectrum

displayed two quaternary carbons at 8201.7 and 156.5. The quaterary carbon at 5 201.
is consistent with a ketonic carbonyl group and the peak at 8156.5 with a cyclic
carbamate.
The reaction was then repeated but for a period of eight days stirring at room
temperature. An lH NMR spectrum of the the crude reaction mixture after workup,
revealed a mixture of compounds. The separation of this mixture by flash column
chromatography was, however, unable to isolate any discrete products.
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5.3.12 Ruthenium Tetroxide Oxidation of 204 and 205

As the oxidation of the cyclic carbamate failed, the ruthenium tetroxide oxidatio
of a mixture of 204 and 205 (the mixture contained more than 50% of 205) was

studied. Using the same procedure as above, the reaction mixture was stirred at r
temperature for eight days.
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V^\LA^\
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TBDMSO *"^N'YC^CH3 TBDMSO '"^NY°SCH3
204 O

205 O

An TLC analysis of the resulting mixture revealed one major component, which
was easily purified by flash column chromatography.
An HRES mass spectrum of this compound gave a parent ion, MH+ of m/z

640.3297, consistent with the molecular formula, C28H58CINO7S13 (ie starting mater

+0 -H). This suggested that a free hydroxyl group had been oxidised and there had
an insertion of an extra hydroxyl group.
The ^H NMR spectrum of this compound, displayed peaks at 85.0, 4.78, 4.75,
4.65, 4.45-4.30, 3.9-3.5 and 2.0-1.8. The

13

C NMR spectrum suggested this

compound was in fact a 1:1 mixture of two stereoisomers or rotamers; all peaks in
spectrum were doubled up, with the same intensity. Disregarding the TBDMS

13

C

resonances, this spectrum confirmed the presence of six quaternary carbons at 8201

201.6, 156.9, 156.5, 93.5 and 93.3 (the resonances at 893.5 and 93.3 are consiste
with a tertiary hydroxyl group a to an oxygen104 or nitrogen atom, ie. as in the

calystegines), six methines at 874.2, 74.0, 67.7, 67.5, 66.1 and 65.1, four methyle
at 844.4, 43.7, 39.4 and 39.2 and two methyls at 52.9 and 52.8. As the major

component of the starting mixture was 205 it was assumed initially that oxidation
occurred at C3 and C2 to form compounds 238 and 239 (Scheme 76).
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S c h e m e 76
However, an H - H C O S Y spectrum (Figure 30) as well as a series of selective
proton decoupled experiments were not supportive of structures 238 and 239. These
experiments served to confirm the major fragment shown in Figure 31. A U C H correlated
2 D N M R spectrum allowed assignment of all non quaternary carbons to their attached
protons and this experiment also served to confirm that the very sharp singlets at 84.75
and 4.65 were in fact hydroxyl protons. These signals were also observed to exchange
quickly with D2O.
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Figure 30. H-H C O S Y spectum (CDCI3) of the compound derived from the ruthenium tetroxide
oxidation of 205.
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To determine the structure of these two compounds all that was needed was the
placement of a hydroxyl, carbonyl and a OTBDMS group. It was envisaged that a
NOESY experiment would help in the determination of the structures of these
compounds, but it only seemed to confirm a strong chemical exchange between the two
compounds (Figure 32).
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. Figure 32. H-H NOESY spectum (CDCI3) of the compound derived from the ruthenium tetro
oxidation of 205.
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T h e c o m p o u n d w a s then dissolved in DMSO-d<5 and a series of * H N M R
experiments were run at different temperatures. At 30°C the spectrum showed that the
ratio of these compounds was altered from approximately 1:1 in deuterated chloroform to
approximately 1:1.5 in D M S O - d g . The temperature was then raised to 90°C; however, at
this temperature, no change in the spectrum was observed. This therefore ruled out
rotamers due to a slow rotation of the carbamate as the peaks of the two compounds
would be expected to coalesce at a temperature lower than 90°C. The barrier for rotation
about an amide bond is typically about SOklmol"1

(EA)108.

The barrier for the rotation of

a carbamate would be expected to be similar. Also isomers due to changes in the
piperidine ring conformation could be ruled out as the broadness due to this process
typically occurs below room temperature. This finding therefore suggested a possible
equilibrium between stereoisomers.
T h e correct placement of the carbonyl group, hydroxyl group and the other
O T B D M S group was gained from a 1 3 C N M R experiment where approximately 7 0 %
deuterium w a s incorporated into the molecule. The carbons y and P to the deuterium
nucleus ( C y - C p - O a D ) will experience a recognisable upfield shift by the so called
'deuterium isotope' effect109'110. This experiment revealed a y-shift (0.04ppm) for four
carbons at 8201.9, 201.6 and at 874.2, 74.0 (Figure 33).
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Figure 33. 1 3 C N M R spectum (CDCI3) of the compound derived from the ruthenium tetroxide
oxidation of 205 with approximately 70% incorporation of deuterium.
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From these extensive N M R experiments the structure of this compound was
therefore assigned as 240a *=* 240b with the equilibrium involving geminal silyl group
migration. Vicinal silyl group migration has been noted before by Furneaux 25 with the
f-butyldimethylsilyl group migrating from the 7-hydroxyl of castanospermine to the 6hydroxyl group. The only other possible explanation of the equilibrium between two
stereoisomers would be the inversion of the stereocentre adjacent to the nitrogen.
However, insertion of deuterium would have been observed in the labeling experiments if
this was occurring.
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SL
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240a
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This structure is also verified by a 2 " 3 I C H correlated 2 D N M R experiment (pulse
field gradient H M B C experiment) the results of which are given in Figure 34 and
Table 7.

Table 7. Results of a P F G H M B C Experiment on 240a ^

Proton

Carbon

PFG HMBC

4.97

65.1

201.7, 156.7, 44.4

4.77

66.1

201.7, 156.7, 43.7
201.7, 93.4, 74.1

4.62

OH
OH

4.39

67.5

39.3

4.39

67.7

39.3

4.34, 3.56

43.7

93.4, 74.1, 66.1

4.11, 3.66

44.4

93.4, 74.1, 65.1

3.82

74.2, 74.0

201.7, 93.4

3.72

39.4, 39.2

3.63

52.9, 52.8

1.87

37.4, 37.2

4.73

201.7,93.4,74.1

240b

112

3.63.52.9
4.34, 3.56
43.7

O

R=TBDMS

Figure 34. Observed PFG HMBC corelations

To gather more evidence to support the structure of 240, it was envisag
reduction of 240a *=? 240b with sodium borohydride would possibly give the parent
compound 199 or the diastereoisomer 241 (Scheme 77).
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RO'
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Scheme 77

5.3.13 Reduction of 240a *=? 240b with Sodiun Borohydride.

The reduction of 240a, b with excess sodium borohydride in methanol res
in the formation of only one compound in high yield.
A H R E S + mass spectrum of this compound gave a parent ion (MH + ) at m/z
476.2887, free of chlorine and in accord with the molecular formula, C22H45NO<5Si2This suggested the loss of a chlorine and a f-butyldimethylsiloxy group.
A *H N M R spectrum of this compound showed relatively broad resonance
signals. It displayed peaks at 84.19, 4.13, 3.94, 3.79, 3.77, 3.66, 3.58, 3.48, 3.47,

1.80, 1.43, 0.8 (18H) and 0.05 (12H). Table 8 gives a summary of the obs
connectivity that was gained from C O S Y , H M Q C and PFG H M B C experiments.
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Table 8 Results of C O S Y , H M Q C and P F G H M B C Experiments on 243

PFG HMBC

Proton

Carbon

COSY

4.19 (IH)

64.4

3.48*, 1.80, 1.43

4.13 (IH)

70.3

3.48*

3.79 (IH)

61.1

3.68*

3.77 (2H)

74.8

3.48*

3.47

76.0

3.48

54.6

3.66

52.4

74.1

3.94

46.7

64.8, 52.5

3.58

46.7

47.1

1.80

30.1

70, 64

1.43, 3.81*, 3.89*, 61.05
4.19

1.43

30.1

1.80, 3.48, 3.79*, 64.8, 55.1
4.19

Tentative correlation.
From this data, it is tentatively determined that this compound is the new pyranopyridine derivative 243.

HO ? H | R=TBDMS

V^p\)R
RO* ^ Y

CHa
O

243
Due to time constraints no futher work was able to be carried out on the sy

approach to the 1-hydroxynortropane skeleton from castanospermine. However,

biological testing was carried out on all intermediates and the results are
following section.

5.4 Biological Testing Results.
All compounds shown below were tested as inhibitors of the commercial

a,P-amyloglucosidase, oc,p-glucosidase, oc,p-mannosidase and cc,p-galactosi

enzymes, as well as for anti-HIV and anti-tumour activity. However, all com
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were classed as inactive against each screen. The anti-HIY and anti-tumour screening was
undertaken by the National Cancer Institute, Washington, U S A and the gycosidase
inhibition assays by Professor A. Elbein, University of Arkansas, U S A .

208

209

HO°
217

216

The finding that the 1-deoxynojirimycin analogue 217 was inactive against all
commercial glycosidase enzymes was surprising as the hydrogenated analogue, 10, that
was synthesised and tested41 by Legler et al. was highly active against the processing aglucosidase enzymes from yeast (Ki = 3 p M ) andrice(Ki < 0.023pM). As the structure
of 217 has been unequivocally determined by X-ray crystal analysis, it was decided to
hydrogenate the double bond of 217 to give 10 (Scheme 79) and have this tested against
the same commercial enzymes.

H
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^
Hi, Pd/C

HO*
217

10
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Catalytic hydrogenation of the double bond in 217 (as the hydrochloride salt)
gave the hydrochloride salt of the ethyl chain extended 1-deoxynojirimycin analogue 10
in good yield. The glycosidase inhibition testing showed 10 to be inactive against
commercial cc,P-amyloglucosidase, a,p-glucosidase, a,P-mannosidase and a,P-
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galactosidase enzymes. Assuming that the compound synthesised by Legler is correct
(and the lH N M R spectrum does suggest this to be true), this finding raises questions
about the correlation between the activity against commercial enzymes and processing
enzymes. S o m e promising compounds m a y be overlooked as a result. However, the
extra manpower and amount of compound needed to screen against processing enzymes
makes it uneconomical to be used as a general test at this time.

5.5 Conclusion.
This part of the project was unsuccessful in converting castanospermine to the 1hydroxynortropane family. The major stumbling block, was the oxidation alpha to the
carbamate group. Even though the model piperidine system oxidised quite readily,
oxidation of the piperidine carbamates derived from castanospermine failed. This could
be due to electronic effects caused by the acetyl protecting groups, as well as steric
hindrance caused by the bulky T B D M S protecting groups. Time constraints did not allow
the examination of the effect of smaller, less electron withdrawing protecting groups or
the use of other amide oxidising reagents or electrochemical oxidation methods. Other
reagents that could be tried in the future include a method using isatoic anhydride111
(Scheme 80). This method, however, inserts a methoxy group alpha to the nitrogen,
which would then have to be demethylated before it could be oxidised to the carbonyl
group. However, using benzyl alcohol rather methanol m a y be an option. The removal of
the benzyl group could then be done under mild reaction conditions to afford the hydroxy
amide intermediate required.
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OMOM

MOMO

a i s a t i c anhydride
DMAP/DMF ~
H
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86%
Scheme 80
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O n e other method that is commonly used to oxidise amides is electrolysis112
usually in the presence of methanol. Hence alternative hydroxylic reactants would also
have to be investigated if this method was used.
This project was successful in developing a short high yielding route to an
unsaturated 1-deoxynojirimycin analogue 217. This compound could be used in the
synthesis of m a n y C 6 modified analogues for structure-glycosidase inhibition activity
studies.
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Chapter 6
Experimental
6.1 General Experimental Details.

Elemental analyses were performed by the Microanalitacal Service, Department of
Queensland.
Melting points were determined on a Reichert Microscopic Hot Stage and are
uncorrected. Infrared spectra were recorded on a Bio Rad Fourier Transform Infrared
Spectrometer FTS-7 and are recorded in units of cm -1 . All samples were run as either a
thin film, chloroform solution or as a potassium bromide disc.
The 300.1 and 399.9MHz lH N M R spectra, as well as 100.1 and 75.5 M H z

13

C

N M R spectra were recorded on a Varian Unity 300 or 400 spectrometer. All samples
were run on the Varian Unity 300 spectrometer at room temperature in chloroform-d
(Cambridge), referencing on residual solvent (7.26ppm), unless specified. High
temperature N M R spectra were run on the Varian Unity 400 spectrometer in D M S O - d 6
(Aldrich) referencing on residual solvent. All chemical shifts are reported relative to T M S
(80). Abbreviations used to indicate spectral multiplicities are; s (singlet), d (doublet) dd
(doublet of doublets), ddd (doublet of doublets of doublet) dddd (doublet of doublets of
doublet of doublets) b (broad) and m (multiplet).
Preparative High Pressure Liquid Chromatography ( H P L C ) was carried out using
a Waters 600E p u m p and 600 controller which was connected to a Waters 486 tunable
absorbance detector, using a reverse phase Alltech alphabond C 1 8 ( 1 0 m m x 2 5 0 m m )
preparative column (particle size lOp). Analytical thin layer chromatography (TLC) was
performed on Merk Keiselgel 6OPF254 silica on aluminium sheets. Flash chromatography
was carried out using Merk 230-400 mesh silica gel. Centrifugal chromatography was
carried out on a 7924T Chromatotron using Merk 6OF254 silica gel (with gypsum).
Electron impact (EI), electrospray (ES + ) and chemical ionisation (CI) mass
spectra were obtained using V G 12-12, V G Quattro-triple quadrupole or Mat-44
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quadrupole spectrometers via a direct insertion technique and an electron beam energy of

70 ev and a source temperature of 200°C. High resolution mass spectra (EI+), (CI) a
(ES+) were obtained using a Fisons/VG Autospec-TOF mass spectrometer or run (EI+

only) by Dr N. Davies of the Central Science Laboratory, University of Tasmania usi
Kratos Concept ISQ mass spectrometer.
Computer modelling was carried on a Silicon Gaphics Indy Workstation, using
the SPARTAN Semi-emperical and AB-INITIO PROGRAM: SGI/R4K Release 4.0.2b.
Geometry optimization Model: RHF/AM1 was used for Semi-empirical calculations and
Geometry optimization Model: UHF/STO-3G used for AB-INITIO calculations.
Organic solutions were dried over sodium sulfate prior to being evaporated under
reduced pressure. The word evaporated implies evaporated under reduced pressure.

Tetrahydrofuran (THF) was dried over sodium wire. Petroleum spirit had a boiling po

range of 40-60 °C. Dichloromethane was distilled prior to use. The deuterated solve
CDCI3, D2O, DMSO-d6, methanol^ and pyridine-ds were obtained commercially
(Aldrich or Cambridge) and were greater than 99.5 atom % d. All other commercial
solvents, chemicals and reagents were used as received unless noted otherwise.

6.2 Experimental for Chapter 2

The Reaction of Scopolamine and Magnesium-iodine-Diethyl ether.
Preparation of magnesium-iodine-diethyl ether
To a stirred mixture of magnesium turnings (lg) and diethyl ether (50ml) was

added iodine (5g) over a ten minute period. After the exothermic reaction subsided,
brown mixture was refluxed until the solution became clear (two hours).

Reaction with Scopolamine
To a solution of scopolamine (500mg, 1.65mmol), ether (25ml) and benzene

(25ml) was added the freshly prepared magnesium-iodine-diethyl ether solution (2ml).

The resulting mixture was refluxed for ninety minutes, after which it was diluted w
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dichloromethane (50ml) then washed with 1 0 % sodium thiosulfate solution (50ml) and

water (50ml). The dichloromethane extracted was dried and evaporated to yield on
starting material (400mg, 1.3mmol).
Reaction of Scopolamine with Iodotrimethylsilane

To a mixture of iodotrimethylsilane (1ml, 7.0mmol) and acetonitrile (15ml) unde

nitrogen, was added a solution of scopolamine (500mg, 1.65mmol) and acetonitril

(5ml). The resulting mixture was stirred at room temperature for three hours, af

it was quenched with 10% sodium thiosulfate solution (50ml) and water (50ml) an

extracted with diethyl ether (2 x 100ml). The diethyl ether extract was dried an

evaporated to yield a colourless crystalline residue (370mg) which was subjecte
column chromatography to yield starting material (250mg, 0.83mmol) and
aposcopolamine (70mg, 0.25mmol, 15%). The spectroscopic properties (*H and

13

C

NMR spectra) of aposcopolamine 131 were identical to an authentic sample obtain
from Phytex Australia Pty Ltd. Sydney.

(EI) m/z 285, 154, 138, 108 (100%) and 103. NMR Spectra 8H
1.63 (2H, d, J = 15.3Hz, H6e and H8e) 2.17 (2H, m, H6a and
3'

H8a), 2.52 (3H, s, NCH3), 3.15 (2H, s, HI and H5), 3.37
(2H, s, H2 and H4), 5.15 (IH, m, H7), 5.86 (IH, s, H3'),
i'

T

6.34 (IH, s, H3') and 7.35 (5H, s, Ar). §C 31.2, 42.2, 56.5,

57.9, 67.0, 126.9, 128.0, 128.2, 128.3, 136.8, 141.8 and
165.4.
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Preparation of [3(S)-(la,5a,3P)]-a-(hydroxymethyl)benzeneacetic acid 8methyl-8-azabicyclo[3.2.1]oct-6-en-3-yl ester 111.
A solution of scopolamine (12.17g, 40.2mmol) in ethanol
(150ml), was added dropwise to a refluxing suspension of

CH2OH
0

freshly prepared zinc/copper couple81 (50g) and ethanol
,nn„
(200ml). The resulting mixture was further refluxed overnight.

^

9V

ye

The zinc dust was then removed by decanting followed by

v=/
filtering. The evaporation of the solvent yielded [3(S)-(la-5a3p)]-a-(hydroxymethyl)benzeneacetic acid 8-methyl-8azabicyclo[3.2.1]oct-6-en-3-yl ester 111 as a clear oil (11.50g, 40.1mmol, 99%). Mass
spectrum (ES) m/z 288 (MH+). (EI) m/z 287 (M+ calculated for C17H21NO3, 287.1521;
found 287.1519), 164, 150, 138, 121 (100%) and 103. N M R Spectra §H 1.55 (IH, d, J
= 11.1Hz, H2e) 1.72 (IH, d, J = 11.4Hz, H4e), 2.91 (5H's, m, N C H 3 , H 2 and H4a) ,
3.34 (IH, s, HI), 3.45 (IH, s, H4), 3.72 (IH, m, H2'), 3.80 (IH, m, H3'), 4.13 (IH,
dd, J= 6.6, J= 8.4Hz, H3'), 5.02 (IH m, H3), 5.40 (IH, dd, J = 1.5Hz J = 4.5Hz,
H6), 5.83 (IH, dd, J = 1.5Hz J = 4.5Hz, H7) and 7.37-7.22 (5H's, m, Ar). 5c, 32.54
(C2 or C4), 32.73 (C2 or C4), 41.9 (NCH3), 54.29 (C2')f 63.77 (C3'), 65.39 (CI or
C5), 65.45 (CI or C5), 66.94 (C3), 127.48 (Ar), 128.13 (Ar), 128.57 (Ar), 130.99 (C6
and C7), 135.81 (Ar) and 171.65 (C=0). IR (neat) 2940, 2872, 1725, 1454, 1270,
1170 and 1037 cm -1 .

Preparation of 8-methyl-8-azabicyclo[3.2.1]oct-6-en-3a-ol 138.
A solution of 111 (30g, 105mmol), methanol (150ml) and 1 0 % sodium
g

MeN

6

.>i

2

^ " T M 3
OH
138

hydroxide solution (200ml) was refluxed for two hours. The methanol
was evaporated and the solution was then extracted with chloroform (3 x
250ml). The combined chloroform extracts were dried and evaporated to

yield an oil (10.71g, 77.1mmol, 74%). Mass spectrum (EI) m/z 139 (M+ calculated for
C 8 H i 3 N O , 139.0997; found 139.1000), 120, 122, 94 (100%), 81 and 42. N M R spectra

121

5

H 6.24 (2H, s, H 6 and H7), 3.85 (IH, m, H3), 3.43 (2H, s, HI and H2), 2.26-2.16

(5H, NCH3, H2a and H4a) and 1.81 (2H, d, J = 12.6Hz, H2e and H4e). 8C (
75.5MHz), 134.2 C6 and C7, 66.0 (CI and C5), 65.1 (C3), 41.5 (NCH3) and
and C4). IR (neat) 3468, 2934, 1652, 1277, 1232 and 1055 cm"1.

Preparation of 3a-trimethylsiloxy-8-methyl-8-azabicyclo[3.2.11oct-6-en
154.
A mixture of the alcohol 138 (2.3g, 16.5mmol), trimethylamine
(2.2ml), tetrahydrofuran (20ml) and chlorotrimethylsilane (4.7ml,
3 excess) was stirred overnight at room temperature. The solvent was
OSi(CH3)3
154
then evaporated to leave an oil which was dissolved in chloroform

(150ml) and washed with a 3% aqueous ammonia solution (3 x 100ml). The

was dried and evaporated to give the silylated compound 154 (2.4g, 11.

Mass spectrum (EI) m/z 211 (M+ calculated for CnH2iNOSi, 211.1392; fou
211.1392)210, 122, 94 (100%), 81, 73 and 43. NMR spectra 8H 5.94 (2H, s,

H7), 3.94 (IH, b, H3), 3.42 (2H, s, HI and H5), 2.32 (3H, s, NCH3), 2.23 (2H,

H2a and H4a), 1.59 (2H, d, J = 13.6Hz, H2e and H4e) and 0.02 (9H, s, Si(CH

131.6 (C6 and C7), 66.0 (CI and C5), 64.2 (C3), 41.4 (NCH3), 36.9 (C2 and C4

0.1 (Si(CH3)3). IR (neat) 3069, 2941, 2787, 1250, 1064, 1004, 876 and 840

Preparation of 3a-trimethylsiloxy-8-methyl-8-azabicyclo[3.2.1]oct-6-en
axial and equatorial /V-oxides 155 and 156.

A solution of 154 (1.3g, 6.16mmol), 35% aqueous hydrogen
peroxide (18ml) and ethanol (24ml) was stirred at room temperature
3

OSi(CH3)3 for 2 days. Evaporation of the solvent yielded a crude mixtur
156

/V-oxide isomers 155 and 156 as a semi solid (1.4g, 6.14mmol,

100%). This was used without further purification. NMR spectra 5H (mixt

and 156, ca 1:1), 6.36 (2H, s, H6 and H7) 6.28 (2H, s, H6 and H7), 4.3

122

3.42 (3H, s, N C H 3 ) , 3.40 (3H, s, N C H 3 ) , 2.70 (2H, m, H2a and H4a), 2.60 (2H, m,

H2a and H4a), 2.10 (2H, d, 2e and 4e), 1.84 (2H, d, H2e and H4e) and 0.01 (9H,
Si(CH3)3).

Thermolysis of N-oxides: General Procedure.

A solution of the appropriate //-oxide in butyronitrile and potassium carbona

refluxed for between two and three hours. The solvent was then evaporated and

resulting crude reaction mixture was redissolved in dichloromethane and filte
filtrate was then concentrated under reduced pressure and subjected to column
chromatography.

Thermolysis of N-oxides 155 and 156.

A mixture of iV-oxides 155 and 156 (0.4g, 1.8mmol) was refluxed in butyronitr

(15ml), in the presence of potassium carbonate (lg) for three hours, following
general procedure. The residue gave on flash column chromatography (100%
dichloromethane to 10% methanol/dichloromethane), two components.
H OH
7^S^2
6

T h e least polar compound was isolated as an oil and was found to be

\__^/3 3,5-cycloheptadienoF^'"-^ 157, (0.12g, l.lmmol, 62%). Mass spectrum
5

4

157 (EI), m/z 110 (M+), 95, 91, 82, 79, 67 (100%), 54 and 39. NMR spectra
5

H 5.90 (2H, m, H4 and H5), 5.67 (2H, m, H3 and H6), 4.22 (IH, b, HI) and 2.55

(4H, m, H2 and H7). 5C (CDC13; 75.5MHz) 128.1 (C3 and C6), 126.4 (C4 and C5),
68.3 (CI) and 39.4 (C2 and C7). UV (ethanol) Xmax 241nm

The second component was isolated as an oil and identified as

OH (IR*, 3S*, 5S*)-9-methyl-8-oxa-9-azabicyclo[3.2.2]non-6-en-3-ol
159. (0.09g, 0.57mmol, 32%). Mass spectrum (EI), m/z 155 (M+,
35%; calculated for C8Hi3N02, 155.0946; found 155.0942), 133

123

(34), 110 (42), 82 (100) and 44 (97). 5 H (399.9 MHz), 6.56 (IH, ddd, J6.7 = 9.2Hz 7;.

7 =6.6Hz 7j.7=1.4Hz, H7), 6.56 (IH, ddd, J6.-j =9.2Hz 75-6 = 7.0Hz J\.6 = 0.5Hz
H6), 4.48, (IH, dddd, J\JJ = 6.6Hz

J\.2Q = 5 . 7 H Z

/i_2a =2.2Hz, J\.6 = 0.5Hz, HI),

4.34 (IH dddd, 72a-3 = 6.6Hz 72e-3 = 5.6Hz 7 3 . 4a = 6.8Hz 7 3 - 4e = 5.6Hz, H3)
2.59,(3H, s, N C H 3 ) 2.46 (IH, ddd, 7 4e . 4a = 13.9Hz 74e.5 = 5.2Hz, 73-4e = 5.6Hz,
H4e), 2.38 (IH, ddd, 7i-22 = 5.7Hz 72e-3 = 5.8Hz 72a-2e = 13.9Hz, H2e), 1.90 (IH,
dddd, 7 2a . 4a = 1Hz 7 3 . 4a = 6.8Hz 7 4a . 4e = 13.9Hz 74a.5 = 3.7Hz, H4a) and 1.77
(lH,dddd, J2a-4a = 1Hz 72a-3 = 6.6Hz 7i.2a =2.2Hz J2a-2e = 13.9Hz, H2a) 5 C, 132.8
C7, 130.1 C6, 69.5 CI, 67.6 C3, 58.1C5, 46.2 N C H 3 , 41.5 C2 and 39.9 C4.

Preparation of 3-oc-*-butyldimethylsiloxy-8-methyl-8azabicyclo[3.2.1]oct-6-ene 160.
A mixture of the alcohol 138 (2.9g, 21 mmol), imadazole (3g,
excess), MA^-dimethylformamide (20ml) and f-butyldimethylsilyl
chloride (3.5g, excess) was stirred for two days at room
temperature. The /V,N-dimethylformamide was removed under
reduced pressure at 90°C. The resulting oil was dissolved in
chloroform (150ml) and washed with a 3 % aqueous ammonia solution (3x 100ml). The
chloroform was evaporated to give the silylated derivative 160 (4.7g, 18.6mmol, 88%).
Mass spectrum (EI), m/z 253 (M+ 20%; calculated for Ci4H27NOSi, 253.1862; found
253.1856), 238, 196, 167, 149 and 122 (100%). N M R spectra5 H 5.91 (2H, s, H6 and
H7), 3.93 (IH, m, H3), 3.37 (2H, s, HI and H5), 2.28 (3H, s, N C H 3 ) , 2.13 (2H,
ddd, J = 3.78 J = 5.88 J = 14.27, H2a and H4a), 1.58 (2H, d, J = 14.06, H2e and H4e)
0.83 (9H, s, C(CH 3 ) 3 ) and -0.05 (6H, s, Si(CH3)2).5 C 131.7 (C6 and C7), 66.0 (CI
and C5), 64.3 C(C3), 41.4 (NCH 3 ), 37.2 (C2 and C4), 25.7 (C(£H 3 ) 3 17.7 (£(CH 3 ) 3
and -4.9 (Si(£H3)2. IR (neat) 2930, 2856, 1463, 1253, 1068, 1005, 863 and 773cm'1.
Analysis calculated for Ci 4 H 2 7NOSi C 66.35, H 10.75 and N 5.53%; found C 66.38, H
10.69 and N 5.53%.
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Preparation of 3a-*-butyldimethylsiloxy-8-methyl-8-azabicycIo[3.2.1]oct6-ene /V-oxides 161 and 162.

A solution of the silyl ether 160 (4.0g, 15.8mmol), 35% aqueous hydrogen pero
(30ml) and ethanol (50ml) was stirred at room temperature for 2 days. Evaporation of the
solvent yielded a mixture of the /V-oxide isomers 161 and 162 as a semi solid (4.2g,
15.5mmol, 9 8 % , ca 1.5:1). Trituration of this semi-solid with diethyl ether followed by
filtration gave the /V-oxide 162 as a colourless solid (2.5g, 9.23mmol, 5 8 % ) .
Evaporation of the filtrate yielded the N-oxide 161 as a semi-solid, (1.6g, 5.90mmol,
37%).

3a-f-Butyldimethylsiloxy-8-methyl-8-azabicyclo[3.2.1]oct-6-ene axial //-oxide
Mass spectra (EI), m/z 269 (M+, calculated for Ci 4 H27N02Si,
2
4

^3

269.1811; found 269.1819), (CI) m/z 270 (MH+), 234, 223,
209, 167 (100%), 138 and 120. N M R spectra 5 H (399.9MHz),
6.18 (2H, s, H 6 and H7), 4.03 (IH, m, H3), 3.67 (2H, s, HI

and H5), 3.37 (3H, s, N C H 3 ) , 3.02 (2H, m, H2a and H4a), 1.53 (2H, d, 7 = 14.3Hz,
H2e and H4e), 0.83 (9H, s, C(CH 3 ) 3 ) and -0.02 (6H, s, Si(CH3)2). 6 C (CDC1 3 ,
75.5MHz) 132.4 (C6 and C7), 74.9 (CI and C5), 61.8 (C3). 55.8 (NCH3), 32.1 (C2
and C4), 25.7 (C(£H 3 ) 3 17.6 (C(CH 3 ) 3 and -4.9 (Si(CH3)2).

3a-f-Butyldimethylsiloxy-8-methyl-8-azabicyclo[3.2. l]oct-6-ene axial N-oxide
°\K,- / M e
^2

mp. 166-168 °C. Mass spectra (EI), m/z 269 (M+, calculated for
Ci 4 H 2 7N0 2 Si, 269.1811; found 269.1810), (CI) m/z 270 (MH+),
234, 223, 209, 167 (100%), 138 and 120. N M R spectra 8 H
(399.9MHz) 6.12 (2H, s, H 6 and H7), 4.11 (2H, s, HI and H5),

3.97 (IH, m , H3), 3.29 (3H, s, N C H 3 ) , 2.41 (2H, m, H2a and H4a), 1.91 (2H, d, 7 =
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15.6), 0.84 (C(CH 3 ) 3 and 0.02 Si(CH3)2. 8 C 130.5 (C6 and C7), 77.4 (CI and C5),

60.6 (C3), 48.7 (NCH3), 35.9 (C2 and C4), 25.5 (C(£H3)3), 17.6 (£(CH3)3) and -5.0
(Si(CH3)2).

Thermolysis of the /V-oxide 161.

A solution of the /V-oxide 161 (1.56g, 5.80mmol) in butyronitrile (30ml) a
carbonate (2g) was refluxed for two hours following the general procedure.
from the reaction mixture was separated by flash column chromatography (5%
methanol/dichloromethane) to give two compounds.

H OTBDMS
Vi^2 The least polar compound was isolated as an oil and was found to be 1' \ tf r-butyldimethylsiloxy-3,5-cycloheptadiene 163, (0.12g, 0.533mmol,
5
163

4

11%). Mass spectrum (EI), m/z 224 (M+, calculated for

Ci4H27N02Si, 224.1596; found 224.1600), 209, 167, 91 and 75 (100%). NMR spectr
8

H 5.79 (2H, m, H4 and H5), 5.67 (2H, m, H3 and 6), 4.05 (IH, m, HI), 2.47 (4H,

b, H2 and H7), 0.89 (9H, s, C(CH3)3) and 0.06 (6H, s, Si(CH3)2). 8C 128.1 (C3 a
C6), 126.0 (C4 and C5), 71.5 (CI), 40.91 (C2 and C7), 25.9 (C(£H3)3), 18.2

(C(CH3)3) and -4.8 (Si(CH3)2. IR (neat) 3024, 2955, 2929, 2897, 2857, 1472, 125
and 1082cm-1. UV (ethanol) >.max 243nm.

The second compound was isolated as an oil (0.83g, 3.09mmol,
^OTBDMS

53%

)

and deduced t0 be

(IR*, 3S*. 5S*)-3cc-f-

butyldimethylsiloxy-9-methyl-8-oxa-9-azabicyclo[3.2.2]non-6ene 164. Mass spectrum (EI) m/z 269 (M+, 0.8%; calculated for
C14H2?N02Si, 269.1811; found 269.1807), 226 (13), 144 (13), 101 (20) and 75

(100);5H (CDC13, 399.9MHz) 6.46 (IH, ddd, 7i.7 = 6.7 75.7 = 1.4 76-7 = 9.2Hz,

6.25 (IH, ddd, 7i_6 = 1.0 J5.6 = 7.7 J6-7 = 9.2Hz, H6), 4.51 (IH, dddd, J
72e-3 = 6.0 J3-4a = 9.4 73^e = 6.0Hz, H3), 4.44 (IH, dddd 7i.2a = 0.9 7i_2a
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1.0 7i.7 = 6.7Hz, HI), 3.48 (IH, dddd, 7 4a . 5 = 1.5 74e-5 = 7.1 7 5 . 6 = 7.1 7 5 . 7 = 1.4Hz,

H5), 2.62 (3H, s, NCH3), 2.38 (IH, dddd, 74e-4a = 13.1 /Me = 6.1 74e-5 = 7.1 /2e^

1.1, H4e), 2.32 (IH, dddd, 72e-2a = 13.6 73-2e = 6.0 7i_2e = 7.3 72e-4e = 1-1, H2e)

1.60 (IH, ddd, 74e.4a = 13.1 73^a = 9.4 74a.5 = 1.5Hz, H4a), 1.53 (IH, ddd, 72

13.3 73.2a = 9.4 7i-2a = 0.9Hz, H4a), 0.86 (s, C(CH3)3). 0.06 (3H, s, SiCH3) and 0.
(3H, s, SiCH3); 5C (CDC13, 75.5MHz) 132.5 (C7), 129.6 (C6), 68.8 (C3), 68.8 (CI),
57.6 (C5), 46.6 (NCH3), 41.0 (C2), 39.78 (C4), 25.72 (C(CH3)3), 17.87 (C(CH3)3)

and -4.78 (Si(CH3)2); IR (neat) 2952, 2928, 2856, 1647, 1462, 1257, 1085, 883, 83
and 775 cm-1. Analysis calculated for C14H27N02Si C 62.41, H 10.11 and N 5.20%;
found C 62.87, H 10.11 and N 5.07%.

The Thermolysis of the /V-oxide 162.

A solution of the /V-oxide 162 (220mg, O.818mmol) in butyronitrile (10ml) and
potassium carbonate (0.5g) was refluxed for three hours following the general
procedure. Separation of the products by flash chromatogaphy (5%

methanol/dichloromethane) afforded the silyl protected cycloheptadienol 163 (1
0.670mmol, 82%) and the Meisenheimer rearrangement product 164 (30mg,
0.112mmol, 14%).

Preparation of (lS*,4R*,6S*)-6-r-Butyldimethylsiloxy-4[(methyl)amino]cyclohept-2-enol 165.

Me
HN

Zinc dust (lg) was added to a cooled solution of glacial acetic acid

3 rf "\ ___„,.« (15ml) and 164 (720mg, 2.68mmol). This was then heated to

6>-"OTBDMS
j\ 7 50°C with stirring for two hours. The bulk of the acetic acid was
HO
165
then removed under reduced pressure. The resulting residue was

dissolved in water, basified (concentrated aqueous ammonia) and then extracted
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dichloromethane

to

yield

(lS*,4R*,6S*)-6-f-butyldimethylsiloxy-4-

[(methyl)amino]cyclohept-2-enol 165 as a colourless oil, (670mg, 2.47mmol, 92%).
Mass spectrum (EI) m/z 271 (M + , 7 % ; calculated for C u H 2 9 N 0 2 S i , 271.1967; found
271.1969), 253 (14), 226 (17), 183 (20), 110 (32), 96 (58) and 74 (100). N M R spectra
5

H 6.00 (m, H2), 5.75 (m, H3), 4.55 (b, H6), 4.26 (b, HI), 3.61 (b, H4), 2.43 (s,

N C H 3 ) and 1.70-1.95 (m, H 5 and H7). 5 C 139.58 (C2), 130.96 (C3), 66.57 (C6),
64.59 (CI), 53.24 (C4), 43.1 (C5 and C7)*, 38.88 (C5 and C7)*, 32.33 (NCH 3 ), 25.74
((C(£H 3 ) 3 ), 17.96 (C(CH 3 ) 3 ), -4.93 and -4.83 (Si(£H3)2). IR (neat) 3296, 2931,
2857, 1660, 1471, 1255, 1077, 837 and 775 cm'1. Analysis calculated for
C 1 4 H 2 9 0 2 S i N C 61.95, H 10.78 and N 5.16%; found C 61.76, H 10.78 and N 5.22%.

Preparation of (lS*,3S*,5R*)-3-*-butyldimethylsiloxy-5[(methyl)amino]cycIoheptanol 166.
MeHN
0

A
••..OTBDMS

HO

solution of 165 (500mg, 1.85mmol) in dry ethanol (10ml)
. J ,
was hydrogenolysed at 1 atm pressure and room temperature in
the presence of 5 % palladium on charcoal (50mg). After stirring

166

overnight the solution was filtered and the solvent evaporated to
give (lS*,4R*,6S*)-3-r-butyldimethylsiloxy-5-[(methyl)amino]cycloheptanol 166 as a
colourless oil (495mg, 1.81mmol, 98%). Mass spectrum m/z 273 (M + , 0.8%; calculated
for C 1 4 H 3 1 N 0 2 S i , 273.2124; found 273.2122), 242, 200, 185, 75(100%) and 57.
N M R spectra 5 H 4.21 (IH, m, H3), 4.00 (IH, m, HI), 2.85 (IH, b, H5), 2.38 (s,
N C H 3 ) , 2.20-1.65 (8H, m, H2, H4, H 6 and H7), 0.84 (s, C(CH 3 ) 3 ) and 0.06 (s,
Si(CH 3 ) 2 ); 8 C 67.54 (CI), 65.30 (C3), 56.77 (C5), 43.78, 37.19, 32.39, 30.76
( N C H 3 ) , 26.04, 25.68 (C(£H 3 ) 3 , 17.83 (£(CH 3 ) 3 , -5.01 SiCH 3 and -5.05 SiCH3. IR
(neat) 3280, 2929, 2857, 1472, 1253, 1070, 886 and 775 c m 4 .
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Preparation of 3a-f-butyldimethylsiloxy-8-methyl-8azabicyclo[3.2.1]octan-l-ol

167b.

Me
n KI

7

l»s

A solution of 166 (115mg, 0.421mmol) and dichloromethane

/^)^X\

(Irnl) was added to a stirred solution of pyridine chlorochromate

H O 1 2S\

' _R_M

(150mg, excess) and dichloromethane (15ml). After one hour the

167b

reaction was quenched by the addition of diethyl ether (20ml). The
solution was then filtered and the solid collected was washed with methanol (20ml). The
solvent in the filtrate was then removed and the resulting residue was dissolved in
dichloromethane (30ml) and washed with a 3 % ammonia solution (20ml). The
dichloromethane extract was dried and concentrated to yield green crystals of 3a-tbutyldimethylsiloxy-8-methyl-8-azabicyclo[3.2.1]octane-l-ol 167 (lOOmg, 0.369mmol,
88%). Repeated recrystallisation (methanol/water) yielded off white crystals, mp.l 18.5119.5 °C. Mass spectrum m/z 271 (M + , 3%; calculated for C 1 4 H 2 9 N 0 2 S i , 271.1967;
found 271.1962), 214 (20), 96 (57), 75 (100) and 57 (84). N M R spectra 5 H 4.21 (IH,
b, H3), 3.04 (IH, b, H 5 ) and 2.53-1.69 (11H, b, N C H 3 H 2 H 4 H 6 H7); 8 C 201.83,
65.79, 57.75, 47.62, 40.95, 37.95, 32.62, 27.55, 25.67 (C(CH 3 ) 3 ), 17.86 (£(CH 3 ) 3 )
and -5.12 (Si(CH 3 ) 2 ); 5 C (pyridine-d5) 8: 89.19 (CI), 68.17, 59.86, 41.42, 35.91,
33.79, 31.77 ( N C H 3 ) , 26.41 (C(£H 3 ) 3 ), 26.09, 18.54 (£(CH 3 ) 3 ) and -4.81, -4.52
(Si(CH3)2). IR (KBr) 3128, 2947, 2882, 2866, 1464, 1342, 1266, 1200, 1075, 1031,
1005, 880, 834 and 770 cm"1. IR (CHC1 3 ) 1703 cm'1.

General Procedure for Desilylation Using Hydrochloric acid.

A solution of the silylated compound and excess 3% aqueous hydrochloric acid was
stirred overnight at room temperature. The solution was filtered, basified (concentrated
aqueous ammonia) and the solvent removed under reduced pressure to give a colourless
solid consisting of ammonium chloride and the expected product. This solid was washed
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three times with an appropriate amount of acetone, filtered and evaporated under reduced
pressure to yield the desilylated compound.

Preparation of 8-Methyl-8-azabicyclo[3.2.1]octane-l,3a-diol
103a ^ 103b.

Desilylation

of

3cc-f-butyldimethylsiloxy-8-methyl-8-

,4

azabicyclo[3.2.1]octane-l-ol 167 (90mg, 0.330mmol) afforded 8-

HO'1 2 ^ 3
_u

methyl-8-azabicyclo[3.2.1]octane-l,3a-diol 103a ^ 103b. (oil,

OH
103b

40mg, 0.255mmol, 84%). Mass spectrum m/z 157 (M + , 12%; calculated
for C8H15N02,157.1103, found; 157.1105), 140 (12), 129 (10), 113 (18), 98 (17),
(29), 70 (60) and 57 (100). NMR spectra 5H (methanol-d4, 300.1MHz) 4.24QH, b,
H3), 3.82 (IH, b, H5) 2.8-1.8 (11H, b, NCH3 H2, H4, H6 H7). 5C (CD3OD) 98.28

(CI), 65.15, 64.09, 45.92, 38.08, 33.13, 30.28 and 24.17. IR (neat) 3422, 1693
1637, 1472, 1424, 1366, 1271, 1233, 1212, 1157 and 1039cm-1.

Preparation of (lR*,3S*,5S*)-9-methyI-8-oxa-9-azabicyclo[3.2.2]non-6en-3-ol 159.

Desilylation of (lR*,3S*,5S*)-3a-f-butyldimethylsiloxy-9-methyl-84

^

'OH oxa-9-azabicyclo[3.2.2]non-6-ene 164 (150mg, 0.556mmol),
7"

1 '2
159

afforded (lR*,3S*,5S*)-9-methyl-8-oxa-9-azabicyclo[3.2.2]non-6-

en-3-ol 159 as an oil (80mg, 0.516mmol, 93%). The spectroscopic
data for this oil were in all respects the same as for 159 obtained from the
N-oxides 155 and 156.
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Preparation

of

(lS*,4R*,6S*)-4-[(methyl)amino]cyclohept-2-ene-l,6-

diol.
Me
(lR*,4R*,5S*)-6-f-Butyldimethylsiloxy-4-[(methyl)amino]cyclohept"

2-enol afforded 4-[(methyl)amino]cyclohept-2-en-l,6-diol 168 as an
oil (50mg, 51%). Mass spectrum (EI) m/z 157 (M + , calculated for
C 8 H i 5 N 0 2 , 157.1103; found 157.1104). N M R spectra

8

H

(300.1MHz, methanol-d6) 6.01 (IH, m, H2), 5.68 (IH, m, H3), 4.67 (IH, m, H6),
4.23 (IH, m, HI), 4.13 (IH, m, H4), 2.66 (3H, s, N C H 3 ) and 2.03-1.7 (4H, m, H 5
and H7). 8 C (300.1MHz, methanol-d6) 143.1 (C2), 126.1 (C3), 66.0, 65.5, 54.7,
42.7, 37.7 and 31.1

Preparation of (lS*,3S*,5R*)-5-[(methyl)amino]cycloheptane-l,3-diol.

Desilylation of (lS*,3S*,5R*)-3-f-butyldimethylsiloxy-5•OH

[(methyl)amino]cycloheptanol 166 (200mg, 0.733mmol) afforded
(lS*,3S*,5R*)-5-[(methyl)amino]cycloheptane-l,3-diol 169 as an oil,
(lOOmg, 0.629mmol, 86%). Mass spectrum (EI) m/z 157 (M+,

calculated for CgHi 5 N02, 159.1259; found 159.1263). N M R spectra5 H (methanol-d4,
300.1MHz), 4.20 (IH, bm, HI), 4.02 (IH, bm, H3), 3.38, (IH, bm, H5), 2.67 (3H,
s, N C H 3 ) and 2.2-1.8 (8H, m, H2, H4, H6 and H7). 8 C (methanol-d4, 75.5MHz)
67.00, 64.49, 56.62, 45.34, 38.86, 33.17, 30.99 and 25.89.
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6.3 Experimental for Chapter 4

Preparation of 3P-Benzoic acid 8-methyl-8-azabicyclo[3.2.1]oct-6-en-3-yl
ester.
Me
ft K

\5 Diethyl azodicarboxylate (251mg, 1.44mmol) was added to a
7 ^^vA stirred solution of 138 (200mg, 1.44mmol), triphenyphosphine
183 (377mg, 1.44mmol), benzoic acid (183mg, 1.5mmol) and
tetrahydrofuran (15ml) which had been cooled to 0°C. After

stirring overnight at room temperature, the solvent was evaporated and the res

was purified by centrifugal chromatography to yield 3p-benzoic acid 8-methyl-8

azabicyclo[3.2.1]oct-6-en-3-yl ester as a semi-solid (297mg, 1.22mmol, 85%). M

spectra (EI) m/z 243 (M+), 121, 105, 94, 81 and 42. (ES) m/z 240 (MH+ calculat
Ci5Hi8N02, 244.1338; found 244.1342). NMR spectra 8H 8.00 (2H, m, Ar), 7.53

(IH, m, Ar), 7.41 (2H, m, Ar), 5.99 (2H, s, H6 and H7), 5.09 (IH, dddd, 72e
72a-3 = 9.64 74e.3 = 6.96 74a.3 = 9.64, H3), 3.59 (2H, bm, HI and H5), 2.28 (3H, s,
NCH3), 2.11 (2H, m, H2a and H4a) and 1.90 (2H, m, H2e and H4e. 8C 165.9 (C=0),

132.8 (Ar), 130.5 (Ar), 129.5 (Ar), 129.4 (C6 and C7), 128.3 (Ar), 68.5 (C3), 6
(CI and C5), 40.5 (NCH3), 31.9 (C2 and C4)

Reaction of 3a-f-butyldimethyIsiIoxy-8-methyl-8-azabicyclo[3.2.1]octanl-ol 167 with Heptafluorobutyric Anhydride.

Heptafluorobutyric anhydride (1ml) was added to a solution of 3cc-f-butyldimet

8-methyl-8-azabicyclo[3.2.1]octane-l-ol 167 (370mg, 1.36mmol) and acetonitrile

(10ml). The resulting mixture was stirred at room temperature for thirty minute

Petroleum spirit (50ml) and saturated sodium carbonate solution (100ml) was ad

the reaction solution which was then shaken. The organic layer was separated a

aqueous layer was extracted a second time with petroleum spirit (100ml). The co
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petroleum spirit extracts were dried and concentrated to yield a mixture of two
compounds which were separated by column chromatography (5%
methanol/dichloromethane).

The least polar compound was isolated as an oil and was deduced

4
6

f

\
•OTBDMS

xNOCOCF2CF2CF3

tobeheptafluorobutyi.^.((1R*)3S*)3-r-butyldimethylsiloxy-5-

oxocycloheptyl)-//-methyl carbamate 185 (300mg, 0.641 mmol,

Me
185

5 3 % ) . Mass spectrum (CI) m/z 468 ( M H + , calculated for

CigH29F7N03Si, 468.1805; found 468.1813). NMR spectra 8H mixture of rotamers ca

1:1, 4.75 (bt), 4.62 (bt), 4.31, 3.09 (s), 2.97 (s), 2.9-2.5 (m), 2.25-1.8 (m
0.85 (s) and 0.5 (s), 8C mixture of rotamers ca 1:1, 210.1 (C=0), 210.4 (C=0), 156.5

(C=0, t), 65.2, 65.0, 54.1, 54.0, 54.0, 50.5, 50.2, 42.0, 40.8, 40.2, 39.9, 29.1,

27.5, 25.6, 25.4, 17.8, 17.7, -5.2, -5.4, -5.5 and -5.5, the carbons connected to
fluorines were at baseline level between 130ppm and lOOppm, due to their lack of
protons and hyperfine splitting from a large number of coupled fluorine atoms.

The second compound isolated as an oil and was deduced
7/-/^\

to be heptafluorobutyric acid [3S-(la-5a-3P)]-3-rCF 3 CF 2 CF 2 OCO l 2
O T B D M S butyldimemylsiloxy-8-methyl-8-azabicyclo[3.2. ljoctan

181

1-yl ester 181 (250mg, 0.534mmol, 43%). Mass spectra

(CI) m/z 468 (MH+, calculated for Ci8H29F7N03Si,
468.1805; found 468.1810), (EI+) m/z 272 (MH+- COCF2CF2CF3, 100%), (EI-) m/z
427 (M - C(CH3)3, 25%), 426.6, 426, 213, 212 and 168 (100%). 8H 4.22 (IH, b, H3),
3.62 (IH, b, H5), 2.8-1.8 (11H, m, NCH3, H2, H4, H6 and H7). 8C 163.6 (t), 97.1

(CI), 65.4, 62.8, 45.2, 37.9, 32.6, 29.4, 25.6, 23.2, 17.7, -5.2 and -5.3; the c
connected to fluorines were at baseline level between 130ppm and lOOppm, due to
lack of protons and hyperfine splitting from a large number of coupled fluorine
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Preparation of [3S-(la,5oc,3p)]-heptafluorobutyric acid 3-hydroxy-8methyl-8-azabicyclo[3.2.1]octan-l-yl ester 182.
Me
8

N

Desilylation of heptafluorobutyric acid [3S-(la,5a,3[J)-3-f-

7 l^r^X\ butyldimethylsiloxy-8-methyl-8-azabicyclo[3.2.1]octan-l-yl
CF 3 CF 2 CF 2 OCO l N 3
I ester (lOOmg, 0.214mmol) 181 afforded heptafluorobutyric
182
acid (la-5oc-3P)-3-hydroxy-8-methyl-8azabicyclo[3.2.1]octan-l-yl ester 182 as an oil (50mg,
0.114mmol, 66%). Mass spectrum (CI) m/z 354 (MH+ calculated for C12H15F7NO,
354.0940; found 354.0938). NMR spectra 8H 4.34 (IH, b, H3), 3.66 (IH, b, H5),
2.75-1.80 (11H, m, NCH3, H2, H4, H6 and H7). 8C 97.1 (CI), 64.7, 62.7, 44.9,
37.1, 32.7, 29.4 and 23.3.

Attempted Preparation of the Heptafluorobutyric ester of 1Hy droxy trop acocai ne.

Diethyl azodicarboxylate (27mg, 0.155mmol) was added to a stirred solution of 18
(50mg, 0.14mmol), triphenylphosphine (40mg, 0.152mmol), benzoic acid (20mg,

0.164mmol) and tetrahydrofuran (15ml) which had been cooled to 0°C. After stirri

overnight at room temperature, the solvent was evaporated to yield an oil. A ^H n

spectrum of this oil suggested no reaction had taken place. The crude oil was the

dissolved in dichloromethane and extracted with water. Concentration of the water
yielded most of the starting material 187 (20mg, 0.0565mmol, 40%).

Attempted Preparation of 1-Hydroxytropacocaine.

Diethyl azodicarboxylate (89mg, 0.151 lmmol) was added to a stirred solution of 1
^ 103b (80mg, 0.510mmol), triphenyphosphine (133mg, 0.508mmol), benzoic acid
(62mg, 0.508mmol) and tetrahydrofuran (15ml) which had been cooled to 0°C. After

stirring overnight at room temperature, the solvent was evaporated to yield an oi
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G C M S analysis of the reaction mixture revealed that no 1-hydroxytropacocaine was
synthesised. There was only starting material detected in crude reaction mixture.

6.4 Experimental for Chapter 5

Reaction of (lS,6S,7R,8R,8aR)-l,2,3,4,5,6,7,8-Octahydro-l,6,7,8indolizinetetrol (Castanospermine 7) with f-Butyldimethylsilylchloride.

A mixture of 7 (4.24g, 22.4mmol), imidazole (5.33g, 74.0mmol), N,Ndimethylformamide (100ml) and f-butyldimethylsilyl chloride (12.2g, 81.3mmol) was
stirred for two days at room temperature. The N,Af-dimethylformamide was evaporated
and the resulting oil was then dissolved in dichloromethane (100ml) and filtered to
remove the imidazole. The dichoromethane solution was then washed with a 3 %
ammonia solution (50ml), dried and evaporated to yield an oil (8.27g). The T L C analysis
( 1 0 % ethyl acetate/petroleum spirit) of the resulting oil showed four components of Rf
0.93, 0.85, 0.55 and 0.36. This mixture was separated by flash column chromatography
into two groups. Group one, with the components of Rf 0.93 and 0.85 (4.66g, 7 6 % )
and group two, with the components of Rf 0.55 and 0.38 (l.Og, 2 0 % ) . A n E S mass
spectrum of group one gave a single peak at 533 which corresponds to castanospermine
plus three T B D M S

groups. Futher purification of this mixture afforded

(lS,6S,7R,8R,8aR)-l,6,7-fr«-f-butyldimethylsiloxy-l,2,3,4,5,6,7,8-octahydro-8indolizinol (Rf 0.85, 160mg, 0.301mmol). The balance of the material was still a
mixture. Group two was further purified by flash column chromatography to yield
(1 S,6S,7R,8R,8aR)-1,6-fcw-f-butyldimethylsiloxy-1,2,3,4,5,6,7,8-octahydro-7,8indolizinediol (R f 0.55, 0.436g, 1.05mmol) and (lS,6S,7R,8R,8aR)-6,8-fc«-/butyldimethylsiloxy-1,2,3,4,5,6,7,8-octahydro-l,7-indolizinediol (Rf 0.38, 0.314g,
0.753mmol).
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0H

OTBDMS
TBDMSOvjAsj7i
7^
\tT\2

(lS,6S,7R,8R,8aR)-l,6,7-/rij-f-Butyldimethylsiloxy-

TBDMSO%

spectrum (ES) m/z 532 (MH+, 100%, calculated for

H

5

4

3

l,2,3,4,5,6,7,8-octahydro-8-indolizinol 199; oil. Mass

199

C 2 6 H 5 8 N 0 4 S i 3 , 532.3673; found 532.3646). N M R
spectra 8 H 4.39 (IH, m, HI), 3.72 (IH, m, H6), 3.63 (IH, m, H8), 3.36 (IH, m, H7),
3.13-3.06 (2H, m, H 5 and H3), 2.20 (IH, m, H2), 2.03 (IH, m, H3), 1.90 (IH, m,
H5), 1.83 (IH, m, H8a) and 1.77 (IH, m, H2). 8 C 81.3, 72.3, 71.9, 71.7, 70.8, 57.7,
52.6, 35.1, 26.2, 26.1, 25.9, 18.4, 18.2, 18.2, -3.0, -3.5, -4.0, -4.3, -4.5 and -5.0.
H
H O

9 u

V>^!L-(

OTBDMS
1

(lS,6S,7R,8R,8aR)-l,6-^-f-Butyldimethylsiloxy-

|8a

TBDMSO* 6 ^ 4

l,2,3,4,5,6,7,8-octahydro-7,8-indolizinediol 200;

200

colourless solid, mp. 53-55 °C. Mass spectrum (EI) m/z

417 (M+ calculated for C 2 oH 4 3N0 4 Si 2 , 417.2730; found 417.2735), 460, 285, 259,
228, 200, 101 and 73 (100%). N M R spectra 8 H 4.40, 3.77-3.66 (2H, m, H6 and H8),
3.31 (IH, m, H7), 3.11-3.04 (2H, m, H5 and H3), 2.19 (IH, m, H2), 2.06 (IH, m,
H3), 1.94 (IH, m, H5), 1.86 (IH, m, H8a), 1.76 (IH, m H2), 0.88 (9H, s, C(CH 3 ) 3 ),
0.87 (9H, s, C(CH 3 ) 3 ), 0.09 (3H, s, SiCH 3 ), 0.08 (3H, s, SiCH 3 ), 0.07 (3H, s,
SiCH 3 ), 0.06 (3H, s, SiCH3),. 8 C 80.6, 71.9, 71.8, 71.5, 69.3, 57.0, 52.3, 35.0,
26.0, 25.8, 18.3, 18.0, -4.4, -4.6, -4.7 and -4.9. IR (KBr disc), 3423, 2961, 2933,
2857, 2808, 1472, 1362, 1247, 1138, 1056 and 837cm"1. Analysis calculated for
C 2 o H 4 3 N 0 4 S i 2 , C 57.51, H 10.38 and N 3.35%; found C 57.08, H 10.60 and N
3.15%.
TBDMSO

0H

"

TBDMSO* 6 ^ 4
201

'

(lS,6S,7R,8R,8aR)-6,8-foy-f-Butyldimethylsiloxy1,2,3,4,5,6,7,8-octahydro-l,7-indolizinediol 201; colourless
solid, m p 55-56 °C. Mass spectra (EI) m/z 417, 460, 285, 259,
228, 200, 101 and 73 (100%); ES+ m/z 418 (MH+ calculated

for C 2 i H 4 3 N 0 4 S i 2 , 418.2810; found 418.2804). N M R spectra 8 H 4.42, 3.78-3.67
(2H, m, H 6 and H8), 3.33 (IH, m, H7), 3.12-3.07 (2H, m, H5 and H3), 2.21 (IH, m,
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H2), 2.08 (IH, m, H3), 1.96 (IH, m, H5), 1.88 (IH, m, H8a), 1.77 (IH, m H2), 0.90
(9H, s, C(CH 3 ) 3 ), 0.89 (9H, s, C(CH 3 ) 3 ), 0.10 (3H, s, SiCH 3 ), 0.10 (3H, s, SiCH 3 ),
0.09 (3H, s, S1CH3) and 0.8 (3H, s, S1CH3). 8 C 80.5, 71.8, 71.8, 71.4, 69.1, 56.9,
52.3, 349, 259, 25.7, 18.3, 17.9, -4.4, -4.6, -4.8 and -4.9.

Preparation of Methyl (2R,3R,4R,5S)-2-(r-r-butyldimethyIsiloxy-3'chIoropropyl)-5-f-butyldimethyIsiIoxy-3,4-dihydroxypiperidine-lcarboxylate 202.

9^Li OTBDMS
'
A solution of 200 (530mg, 1.27mmol) in ethanol-free
CI
N^^o^
chloroform (18ml), potassium carbonate (1.8g) and methyl
6
II
202 °
chloroformate (5ml, excess) was refluxed overnight. The
reaction mixture was diluted with dichloromethane then
filtered. The solvent was then removed from the filtrate and the residue dissolved in
dichloromethane (50ml). The resulting solution was washed with saturated sodium
carbonate solution (20ml) then dried and concentrated under reduced pressure to yield
methyl

(2R,3R,4R,5S)-2-(l'-/-butyldimethylsiloxy-3'-chloropropyl)-5-f-

butyldimethylsiloxy-3,4-dihydroxypiperidine-l-carboxylate 202 (430mg, 0.840mmol,
74%) as colourless crystals (mp. 187-190 °C from CHCI3). Mass spectra (EI) m/z 511
(M+0.05%) 454 (M-C(CH 3 ) 3 + , 19.5%; Calculated for C lg H 37 35 ClN0 6 Si 2 ,454.1848;
found 454.1841), 322 (13.5), 304 (14.75), 172 (17), 73 (100); (ES) m/z 512 ( M H +
100%, calculated for C22H 4 7ClN0 6 Si2 512.2630 found 512.2630). N M R spectra 5 H
(399.9MHz) 4.35 (ddd, 7 = 5.3, 5.3, 11.7Hz, HI'), 4.23 (dd, 7 = 3.5, 6.35Hz, H2),
4.04 (d, 7 = 14Hz, H6), 3.82-3.62 (m, H3, H4, H5, H 3 \ O M e ) , 3.28 (dd, 7 = 1.8,
14.4Hz, H6), 2.04 (ddd, 7 = 5.5, 7.0, 12.5Hz, H2'); 8 C 157.6 ( N C 0 2 M e ) , 71.9, 71.6,
69.7, 69.5 (CI1), 60.7 (C2), 52.7 (OMe), 43.3 (C6), 40.8 (C2), 36.9 (C2'), 26.0
(C(£H 3 ) 3 ) 25.8 (C(£H 3 ) 3 ), 18.3 (C_(CH3)3) 18.0 (£(CH 3 ) 3 ) and -4.4, -4.6, -4.7, -4.9
(Si(CH3)2). IR (KBr), 3483, 3399, 2957, 2859,1667, 1471, 1258, 1077 and 841cm'1.
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Analysis calculated for C 2 2 H 4 6 C l N 0 6 S i 2 , C 51.59, H 9.05 and N 2.73%; found C
51.61, H 9.12 and N 2.57%.

Reaction of 198-201 with Methyl Chloroformate.

A solution of 198-201 (6.7g) in ethanol free chloroform (100ml), potassium carbonate
(lOg) and methyl chloroformate (15ml, excess) was refluxed overnight. The reaction

mixture was diluted with dichloromethane then filtered. The solvent was then remove
and the residue dissolved in dichloromethane (200ml). The resulting solution was

washed with saturated sodium carbonate solution (100ml) then dried and concentrate
under reduced pressure to yield a mixture of ring cleaved products including methyl

(2R,3R,4R,5S)-2-(r-/-butyldimethylsiloxy-3'-chloropropanyl)-5-f-butyldimethylsiloxy
3,4-dihydroxypiperidine-1 -carboxylate 202, methyl (2R,3R,4R,5S)-2-(l'-hydroxy-3'-

chloropropany l)-3,5-fc>/5-f-butyldimethy lsiloxy-4,1'-dihydroxy piperidine-1-carb

203, methyl (2R,3R,4R,5S)-2-(l'-f-butyldimethylsiloxy-3'-chloropropanyl)-3,5-fc/5-f
butyldimethylsiloxy-4-hydroxypiperidine-l-carboxylate 204 and methyl
(2R,3R,4R,5S)-2-(l'-f-butyldimethylsiloxy-3,-chloropropanyl)-4,5-fets-f-

butyldimethylsiloxy-3-hydroxypiperidine-l-carboxylate 205 (6g). This mixture was n
purified and was used as such in the following reaction with tetrabutylammonium
fluoride.

Reaction of a mixture of 202-205 with Excess Tetrabutylammonium
Fluoride

A solution of a mixture 202-205 (840mg, ca 1.63mmol), tetrahydrofuran (5ml) was
stirred with excess tetrabutylammonium fluoride (1.5ml of a 1M solution in
tetrahydrofuran) for 2 days. The solvent was removed and the resulting oil was
redissolved in dichloromethane (50ml) and extracted with water (50ml). The water
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extract was then chromatagraphed on a column of Dowex 1-X8 (H + ) eluted with distilled
water (100ml) and collected as one fraction. Concentration of this fraction under reduced
pressure yielded a mixture of compounds (200mg). A proportion of this mixture (50mg)
was separated by H P L C (Alltech cc-bond C18, 10mm x 2 5 m m ) to give three
compounds.
2'
H

9 H *>^OH

71 H

o 2

The first compound to be eluted was (lS,6S,7R,8R,8aR)-l-(2'hydroxyethyl)-l,5,6,7,8,8a-hexahydro-6,7,8-trihydroxy-3//-

HO^^-'Wa
5

Q

oxazolo[3,4-fl]pyridin-3-one 207 as semi solid (24mg,

207

O.lOmmol, 24%). Mass spectra (EI) m/z 215 (4), 172 (M +
- C 2 H 5 0 2 100% calculated for C ? H 1 ( ) N0 4 , 172.0610; found 172.0601), 158 (62), 143
(98), 70 (75); ES + m/z 256.1 (MNa + , 100%), 234.0 (MH + , 20%). N M R spectra 5 H
(D 2 0, 399.9MHz) 4.65 (m, HI), 3.86 (dd, 7 = 5.98, 13.06Hz, H5), 3.74 (dd, 7 =
6.72, 6.72Hz, C H 2 O H ) , 3.60-3.30 (m, H6, H7, H8, H8a), 2.84 (dd, 10.49, 12.94Hz,
H5), 1.99 (m, C H 2 C H 2 O H ) , 5 C (D 2 0) 159.1 (C9), 78.0 (C7), 77.9 (C4), 73.8 (C5),
69.6 (C3), 63.2 (C2), 58.5 (C2*), 45.1 (C6), 37.9 (CI*).
2
x

HO
HO

s~^p

The second product was isolated as colourless plate-like crystals

8 - \] rrj

Y ^ f ^ O i
5

Q

and was identified as (lS,6S,7R,8R,8aR)-l-(2'-fluoroethyl)l,5,6,7,8,8a-hexahydro-6,7,8-trihydroxy-3//-oxazolo[3,4-

208

a]pyridin-3-one 208 (9mg, 0.0038mmol, 9%). mp. 208-210 °C
from methanol. Mass spectra (EI) m/z 235 (M + , 0.31%; calculated for C 9 H 1 4 F N 0 5 ,
235.0856; found 235.0855), 163 (10), 132 (12), 102 (100). N M R spectra 5 H (D 2 0,
399.9MHz) 4.81-4.74 (m, HI, CH_2F), 4.66 (dd, 7 = 6.1, 6.1Hz, CH 2 F), 3.93 (dd, 7 =
5.9, 13.1Hz, H5), 3.62 (m, H6) 3.53 (m, H8a, H8) 3.44, (m, H7), 2.91 (dd, 7 = 10.7,
13.2Hz, H5) 2.27 (ddd, 7 = 5.4, 6.1, 6.2Hz, HI') and 2.20 (m, HI'),8 C (D 2 0) 159.0
(C3), 82.0 (d, 7 = 159.6Hz, £ H 2 F ) , 77.8 (C7) 77.3 (d, 7 = 4.4Hz, CI), 73.7 (C8),
69.6 (C6), 63.1 (C8a), 45.1 (C5), 36.1 (d, 7 = 18.9Hz, £ H 2 C H 2 F ) .
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i'^-2

HO

T h e third c o r a

Ponent

was

identified as (lS,6S,7R,8R,8aR)-l-

H

°vJ^4--\1 ethenyl-l,5,6,7,8,8a-hexahydro-6,7,8-trihydroxy-3#-oxazolo[3,47j" 8al O 2
HO^e^^1^"^
a]pyridin-3-one 209 as a semi-solid (llmg, 0.0051mmol, 13%).
5
O
209
Mass spectrum (EI) m/z 215 (M + , 6%; calculated for C 9 H 1 3 N 0 5 ,

215.0794; found 215.0794), 171 (30), 112 (20), 82 (100). NMR

spectra 5H (D20, 399.9MHz) 6.04 (ddd, 7 = 6.8, 10.5, 13.4Hz, CH=CH2), 5.54 (ddd,
7 = 1, 1, 17.1Hz, CH=CH2), 5.44 (ddd, 7 = 0.9, 0.9, 10.5Hz, CH=CH2) 5.03 (m,

HI), 3.93 (dd, 7 = 5.9, 12.9Hz, H5, ), 3.66-3.53 (m, H8a, H8 and H6), 3.44 (dd,
9.27, 9.27Hz, H7), 2.90 (dd, 7 = 10.6, 13.1Hz, H5); 5C (D20) 158.6 (C3), 134.6
(CH=CH2), 120.4 (CH=CH2), 80.4 (CI), 77.5 (C7), 73.5 (C8), 69.2 (C6), 63.1
(C8a), 44.8 (C5).

Preparation

of (lS,6S,7R,8R,8aR)-l-(2'-chloroethyl)-l,5,6,7,8,8a-

hexahydro-6,7,8-trihydroxy-3//-oxazolo[3,4-a]pyridin-3-one 216.
2'

""~^CI Castanospermine 7 (4.2g, 22.2mmol), f-butyldimethylsilyl
I
8a

T

o 2

chloride (9.4g), /V,/V-dimethylformamide (50ml) and imidazole

5 Q (5.5g) was stirred at room temperature for 2 days. The resulting
216

solution was worked up as discribed above to yield a mixture of
silylated compounds 198-201 (8.27g). This mixture of TBDMS

protected castanospermine (8.27g) was dissolved in ethanol-free chloroform (120

this was added methyl chloroformate (15ml) and potassium carbonate (5g). The r
solution was refluxed overnight. Work up as described above yielded a mixture
piperidine carbamates 202-205 (8.10g). A solution of this mixture (8.10g),

tetrahydrofuran (50ml) and TBAF (15ml of a 1M solution in tetrahydrofuran) was

at room temperature for two hours. The solvent was removed under reduced press

and the resulting oil was dissolved in dichloromethane (100ml) and extracted w
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ammonia solution (150ml). The evaporation of the solvent from the aqueous extract

yielded an oil contaminated with TBAF salts. This oil was dissolved in distilled
(50ml) and chromatographed on a column of Dowex 1-X8 (H+) eluted with distilled
water (200ml) and collected as one fraction. Evaporation of the solvent yielded

(lS,6S,7R,8R,8aR)-l-(2'-chloroethyl)-l,5,6,7,8,8a-hexahydro-6,7,8-trihydroxy-(3/

oxazolo[3,4-a]pyridin-3-one 216 as colourless crystals. (2.46g, 9.8mmol, 44% fro

castanospermine). mp. 150-152 °C from methanol. Mass spectra (EI) m/z 253, 251 (M
0.5%; calculated for C9H1435ciN05,251.0561; found 251.0586), 179 (13.5), 1158
(60), 118 (100). NMR spectra 5H (D20, 399.9MHz) 8: 4.79 (m, HI,), 3.89 (dd, 7 =
5.9, 13.1Hz, H5), 3.74 (dd, 7 = 5.5, 6.7Hz, CH2C1, ), 3.65-3.36 (m, H8a, H8, H7,
H6), 2.86 (dd, 7 = 10.6, 13.1Hz, H5), 2.2 (m, CH2CH2C1); 8C (D20) 158.9 (C3),
77.8 (CI), 77.6 (C7), 69.6 (C8), 63.0 (C8a), 45.1 (C5), 41.3 (£H2C1), 38.1
(CH2CH2C1). IR (KBr), 3468, 2932, 2892, 1726, 1450, 1253, 1094, 1066 and 954cm'
l

. Analysis calculated for C9H14C1N05, C 42.95, H 5.61 and N 5.57%; found C 43.08,

H 5.67 and N 5.51%.

Preparation of (lS,6S,7R,8R,8aR)-l-ethenyl-l,5,6,7,8,8a-hexahydro6,7,8-trihydroxy-3#-oxazolo[3,4-a]pyridin-3-one 209.
x
HO

V
H

^ A solution of lS,6S,7R,8R,8aR-l-(2'-chloroethyl)-l,5,6,7,8,8a-

«^?i

HO

8a

l
o 2 hexahydro-6,7,8-trihydroxy-3/7-oxazolo[3,4-a]pyridin-3-one 216.
HO '6 ^'4"^tC3
5
5
(l.Og, 3.98mmol), tetrahydrofuran (25ml), N, N-dimethylformamide
N>

V

209

(0.5ml) and potassium f-butoxide (lg) was refluxed for three hours.

The solvent was removed and the remaining solid was dissolved in 3% hydrochloric

solution (30ml). The resulting solution was basified with concentrated aqueous am

then evaporated to yield a solid. The solid was then dissolved in water and passe

through a column of Dowex 1-X8 (H+) eluted with distilled water (150ml). Evapora
of the first fraction (100ml), yielded (lS,6S,7R,8R,8aR)-l-ethenyl-l,5,6,7,8,8a-
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hexahydro-6,7,8-trihydroxy-3/7-oxazolo[3,4-a]pyridin-3-one 209 as a semi-solid
(680mg, 80%).

Preparation of (2R,3R,4R,5S)-2-(l'-hydroxy-2'-propenyl)-piperidine2,3,4-triol 217.
3'
1-10

U

«-^

A solution of the oxazolo-pyridinone 209 (560mg, 2.6mmol), T H F

HOv>\=^r
4|

*l
6

217

OH

(25ml), A^Af-dimethylformamide (0.5ml) and potassium f-butoxide
(lg) was refluxed overnight. To this was added 1 M sodium
&

6

hydroxide (5ml) and the mixture refluxed for a further one hour.
The mixture was acidified with 3 % HC1 then basified with dilute aqueous ammonia
solution. The solvent was evaporated and the remaining salts were sonicated with hot
ethanol. The ethanol solution was filtered and the solvent evaporated from the filtrate.
The residue obtained was purified by flash column chromatograhy (ethanol) to yield the
HC1 salt of (2R,3R,4R,5S)-2-(l'-hydroxy-2'-propenyl)-piperidine-2,3,4-triol (360mg,
1.9mmol, 7 3 % ) as colourless crystals, mp. 179-183 °C from ethanol/acetonitrile. Mass
spectrum (EI) m/z 189 (M + , 2.5%; calculated for C g H 1 5 N 0 4 , 189.1001; found
189.1008), 171 (6), 132 (100), 114 (18), 86 (34), 72 (65), 60 (90). N M R spectra 5 H
( D 2 0 , 399.9MHz) 5.92 (ddd, 7 = 4.6,10.8, 17.2Hz, C H = C H 2 ) , 5.50 (ddd, 7 = 1.2,
1.2, 17.2Hz, C H = C H 2 ) , 5.39 (ddd, 7 = 1.2, 1.2, 10.8Hz, C H = C H 2 ) , 4.71 (m, HI'),
3.74 (m, H3), 3.70 (dd, 7 = 7.1, 7.1Hz, H2), 3.50 (dd, 7 = 9.28, 9.28Hz, H4), 3.41
(dd, 5.13 and 12.57Hz, H6), 3.17 (dd, 7 = 2.1, 10.4Hz, H2) and 2.91 (dd, 7 = 11.5,
11.5Hz, H6); 5 C 137.2 ( C H = C H 2 ) , 119.0 ( C H = C H 2 ) , 77.7 (C4) 69.7 (C3), 68.6
(C5), 67.9 (CI1), 63.0 (C2), 47.6 (C6).
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Preparation of TVtfrafcw-trimethylsiloxy Castanospermine.

™S° u OTMS
TMSO^IA^J/I
TMSOx»--k^N^/^

5

A mixture of castanospermine (870mg, 4.60mmol), imadazole
(2.3g, 31.9mmol), /V,N-dimethylformamide (50ml) and

J

218

trimethylsilylchloride (5ml, 46.3mmol) w a s stirred for

overnight at room temperature, followed by stirring for two
hours at 50 °C. The /V,N-dimethylformamide was removed under reduced pressure at

90°C. The remaining oil was dissolved in dichloromethane (50ml) and filtered to re
the imidazole. The dichloromethane solution was then washed with 3% aqueous
ammonia solution (20ml), dried and concentrated to yield (lS,6S,7R,8R,8aR)-

1,2,3,4,5,6,7,8-octahydro-refra/:/5-l,6,7,8-trimethylsiloxyindolizine as an oil (2
4.57mmol, 100%). Mass spectrum (El) m/z 477 (M+, calculated for C2nH47N04Si4,
477.2582; found 477.2583), 462, 387, 361, 315, 298, 289 and 272

Reaction of (IS, 6S,7R,8R,8aR)-l, 2,3,4,5,6,7,8-octahydro-f etrakis1,6,7,8-trimethylsiloxyindoIizine with Excess Methyl Chloroformate.

A solution of (lS,6S,7R,8R,8aR)-l,2,3,4,5,6,7,8-octahydro-*errafcis-l,6,7,8trimethylsiloxyindolizine (1.5g, 3.14mmol) chloroform (30ml), methyl chloroformate

(4ml) and potassium carbonate (lg) was refuxed overnight. The solvent was evaporat

and the resulting product was redissolved in dichloromethane (100ml), filtered, dri

concentrated to yield an oil (1.4g). A solution of this resulting oil (932mg) and a

2M hydrochloric acid (20ml) was stirred at room temperature for two hours. The sol

was then basified with concentrated aqueous ammonia and reduced to yield a colourl

solid. This solid was extracted with methanol (2 x 50ml). Evaporation of the metha
yielded an oil (130mg). Flash column chromatography (5% methanol/dichloromethane-

20%methanol/dichloromethane) on this oil yielded methyl l'-(3,4,5-trihydroxylpiper
2-yl)-3'-chloro)propyl carbonate 220 as an oil (160mg, 0.643mmol, 30%).
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^
N M R spectra8 H 5.57 (IH, m, HI'), 3.86-3.46 (6H, m, H3\
H<
? H OCOMe
HO
Kj^J^L^^ni v-CI H2> H3 'H4> H 5 and H 6e) 3.36 (3H, s, O C H 3 ) , 3.05 (IH, m,
r H
HO*'S^
i
6
220

H6a)

' 2M

(1H

' m'H2,)and 2 2 0 (1H' m'H2,)-8 C

(D2

°'

75.5MHz), 156.8 (C=0), 77.5, 71.8 (CI'), 69.3, 61.8, 57.4,

50.4 (OMe), 47.8 (C6), 41.9 (C3') and 35.3 (C2')

Reaction of the Carbonate 220 with excess tetrabutylammonium fluoride.
O
HO ocOMe

A solution of meth 1

y l,-(3,4,5-trihydroxylpiperid-2-yl)-3'-

N^N="\ chloro)propyl carbonate 220 (80mg) tetrahydrofuran (5ml) and a
I

I ^**

HOx°6S^/4
221

3

/0

1M tetrabutylammonium fluoride solution (1ml) was stirred

overnight at room temperature. The solvent was then removed
and the resulting oil was separated by flash column chromatography to yield m

(lS,6S,7R,8R,8aR)-l,2,3,4,5,6,7,8-octahydro-6,7,8-indolizinetriolyl carbonate

semi solid (55mg, ). Mass Spectra, (EI) m/z 247 (M+), 171 (100%), 144, 111, 82
and 44. (ES) m/z 248 (MH+, calculated for CioHi8N06, 248.1134; found 248.1113.

NMR spectra 8H 5.50 (IH, m, HI), 3.86-3.6, 3.54 (IH, t), 3.49 (IH, dd), 3.29 (I

m), 3.06 (IH, t), 2.75 (IH, m), 2.30 (IH, m); 8C 160.0, 81.6, 79.3, 74.5, 72.6, 7
60.8, 57.9, 56.8, 35.0.

Formation of Methyl 1-Piperidinecarboxylate.
4

To a solution of piperidine (1ml, 860mg, 10. lmmol) and chloroform (20ml)

oK

6\'/2

N

cooled in an ice bath, was added drop-wise methyl chloroformate (1ml)

'OMe

O

Me ^£ t e r ^ g a(j(jition w a s complete, the reaction mixture was stirred at room
229

temperature for one hour. The solvent was then evaporated and the resulting
oil was redissolved in dichloromethane (50ml) and washed with 3% aqueous ammo
solution (20ml). The dichloromethane extract was dried and evaporated to yield

144

piperidinecarboxylate as an oil (l.lg, 7.69mmol, 77%). Mass spectrum (EI) m/z 143

(M+, calculated for C7H13NO2, 143.0946; found 143.0940), 142, 88, 70, 59
8

H (CDC13, 300.1MHz), 3.66 (3H, s, OMe), 3.38 (4H, bm, H2 and H6) and 1.6

(6H, bm, H3, H4 and H5). 8C (CDCI3, 75.5MHz), 156.0 (C=0), 52.3 (OMe), 44.8
(C2 and C6), 25.6 (C3 and C5) and 24.3 (C4).

Oxidation of Methyl 1-Piperidinecarboxylate with Ruthenium Tetroxide.

5

1 |3 A two phase mixture of carbon tetrachloride (2ml), acetonitrile (2m

j

2 u

(3ml), ruthenium trichloride hydrate (13mg), methyl 1-piperidinecarb

rr* OMe
u

230 (140mg, 0.979mmol) and sodium periodate (887mg) was stirred at

230

room temperature for two hours. To this was added dichloromethane (30ml

and the organic phase was separated. The aqueous phase was then further

dichloromethane (2 x 30ml). The combined organic extracts were dried an

The resulting residue was diluted with diethyl ether (30ml) and filtere

sovent under reduced pressure yielded methyl 2-oxo-l-piperidinecarboxyl

0.70mmol, 71%). Mass spectrum (EI) m/z 157 (M+, calculated for C7H11NO3

157.0739; found 157.0737), 101, 88, 55 and 42 (100%). NMR spectra 5H 3.82,

2.46 and 1.81. 5C 171.24 (C2), 154.91 (C=0), 53.82 (OMe) 46.48 (C6), 34.
22.55 (C5), 20.29 (C4).

Preparation of (lS,6S,7R,8R,8aR)-6,7,8-fm-0-acetyl-l-(2*chloroethyI)-l,5,6,7,8,8a-hexahydro-3/7-oxazolo[3,4-a]pyridin-3-one
231.

A solution of (lS,6S,7R,8R,8aR)-6,7,8-/m-0-acetyl-l-(2'-

chloroethyl)-l,5,6,7,8,8a-hexahydro-3//-oxazolo[3,4-a

3-one 216 (1.3g, 5.18mmol), pyridine (10ml) and aceti
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anhydride (5ml) was stirred overnight at room temperature. Water was added (10ml) and
the solvent evaporated under reduced pressure. The resulting oil was redissolved in
dichloromethane (50ml) and washed with 3 % aqueous ammonia solution (10ml). The
dichloromethane extract was reduced to dryness and the resulting solid was recrystallised
from ethyl acetate/petroleum spirit to yield (lS,6S,7R,8R,8aR)-6,7,8-fn-0-acetyl-l-(2'chloroethyl)-1,5,6,7,8,8a-hexahydro-3#-oxazolo[3,4-a]pyridin-3-one 231 as a
colourless solid (1.8g, 9 1 % ) . m p 189-190 °C. Mass spectra, (EI) 257, 215, 137 and 40
(100%); (ES) 378 ( M H + , calculated for C i 5 H 2 i 3 5 C l N 0 8 , 378.0956; found 378.0979).
N M R spectra 8 H 5.16-4.87 (3H, m , H6, H 7 and H8), 4.55 (IH, m, H4), 4.16 (IH, dd,
7 = 6.6, 7 = 13.1Hz, H9e), 3.68-3.53 (2H, m, H2'), 3.44 (IH, dd, 7 = 4.64, 7 = 9.4,
H5), 2.82 (IH, dd, 7 = 10.38, 7 = 13.2Hz, H9a) and 2.25-1.88 (11H, O M e , O M e ,
O M e , HI'); 8 c 154.90 (C=0), 74.2 (C4), 72.6, 70.9, 67.6, 59.9 (C5), 41.7 (C9), 39.4
(C21), 37.5 (CT), 20.4 ( O M e ) and 20.4 ( O M e and O M e ) . IR (KBr disc) 2967, 1746,
1738, 1446, 1382, 1229, 1034 and 753cm"1. Analysis calculated for C i 5 H 2 o C l N 0 8 C
47.69, H 5.34 and N 3.71%; found C 47.66, H 5.35 and N 3.67%.

Oxidation of (lS,6S,7R,8R,8aR)-6,7,8-*ri-0-acetyl-l-(2'-chloroethyl)l,5,6,7,8,8a-hexahydro-3#-oxazolo[3,4-a]pyridin-3-one 231 with
Ruthenium Tetroxide.

A solution of carbon tetrachloride (12ml), acetonitrile (12ml), water (16ml) ruth
trichloride hydrate (20mg), 231 (800mg, 2.12mmol) and sodium periodate (5g) was
stirred at room temperature for eight days. Dichloromethane (50ml) was then added to the
reaction mixture and the organic phase was separated. The aqueous phase was then
further extracted with dichloromethane (2 x 50ml). The combined organic extracts were
dried and evaporated. The resulting residue was diluted with diethyl ether (50ml) and
filtered. Evaporation of the solvent yielded the starting material 231 (720mg,

1.91mmol).
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Reaction

of (lS,6S,7R,8R,8aR)-l-(2'-ChloroethyI)-l,5,6,7,8,8a-

hexahydro-6,7,8-trihydroxy-3H-oxazolo[3,4-a]pyridin-3-one 216 with
f-Butyldimethylsilyl Chloride.

A solution of 216 (lg, 3.98mmol), /V,iV-dimethylformamide (20ml) and imidazole

(1.2g, 16.6mmol) was stirred at room temperature for two days. The solvent was
removed under reduced pressure (90°C) and the remaining oil was dissolved in

dichloromethane (100ml), filtered and washed with 3% ammonia solution (50ml). T

dichloromethane solution was dried and evaporated to yield an oil (2g). Column

chromatography using 15% ethyl acetate/petroleum spirit as eluent gave two co
234 (825mg, 1.72mmol, 43%) and 235 (650mg, 1.36mmol, 34%).

H

H V^CI
TBDMSO^i^^i

?

The first compound isolated was (lS,6S,7R,8R,8aR)-7,8-

7| Ho 2
TBDMSO»«g\/N^^
5

Z?w-/-butyldimethylsiloxy-l,5,6,7,8,8a-hexahydro-l-(2'-

O

23

4 ~
chloroethyl)-6-hydroxy-3r7-oxazolo[3,4-a]pyridin-3-one
234 as colourless crystals, recrystallised from ethyl acetate/petroleum spirit
118 °C. Mass spectra (EI) m/z 422 (M+ -C(CH3)3), 290, 216, 147, 73 (100%), 57 and
41; (ES) m/z 480 (MH+, calculated for C2iH4335ClN05Si2, 480.2368 found;
480.2368). 8H (CDC13, 399.9MHz), 4.38 (IH, m, HI), 3.94 (IH, dd, J = 5.4 and J =

13.2Hz, H5), 3.70-3.66 (2H, m, H2'), 3.52 (IH, m), 3.38 (IH, m), 3.33 (IH, m),

3.19 (IH, dd, J = 4.39 and J = 903Hz) 2.70 (IH, dd, J = 9.89 and J = 13.3Hz), 2.3

(IH, d, J = 3.05, OH), 2.26-2.07 (2H, m, HI'), 0.92 (9H, s C(CH3)3), 0.91 (9H,
C(CH3)3), 0.15 (3H, s, SiCH3), 0.13 (6H, s, SiCH3, SiCH3) and 0.10 (3H, s,
SiCH3). 8C 155.9 (C3), 78.9, 75.0 (CI), 74.3, 70.4, 61.6, 45.7, 39.9, 37.8, 26.1
(C(CH3)3), 26.0 (C(CH3)3), 18.1 (C(CH3)3 and C(CH3)3), -3.3 (SiCH3), -3.5
(SiCH3), -4.3 (SiCH3) and -4.6 (SiCH3). IR (KBr disc), 3445, 2954, 2930, 2858,
1745, 1441, 1256, 1148 and 837cm"1. Analysis calculated for C2iH42ClN05Si2, C
52.53, H 8.82 and N 2.92%; found C 52.75, H 9.08 and N 2.72%.
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TBDMSO

*>^ci

H0

vJ^-\1 Second compound isolated was (lS,6S,7R,8R,8aR)-l-(2'7T

8a|

TBDMSO^fN-"' 4 **x(3

chloroethyl)-6,8-Wj-r-butyldimethylsiloxy-1,5,6,7,8,8a-

hexahydro-7-hydroxy-(3//)-oxazolo[3,4-a]pyridin-3-one
235 as colourless crystals, recrystallised from ethyl acetate/petroleum

122 oc. Mass spectra (EI) m/z 422 (M+ -C(CH3)3), 392, 330, 290, 254 and 2

(100%); (ES) m/z 480 (MH+, calculated for C2iH4335ciN05Si2, 480.2368; found

480.2372). 4.56 (IH, m, HI), 3.89 (IH, dd, J = 5.4 and J = 13.2Hz, H5), 3

(2H, m, H21), 3.42 (IH, m), 3.42 (IH, m, H2'), 3.30 (IH, m), 3.13 (IH, d

and J = 9.03Hz) 2.69 (IH, dd, J = 9.89 and J = 13.3Hz, H5), 2.32 (IH, d

OH), 2.22-2.07 (2H, m, HI'), 0.92 (9H, s C(CH3)3), 0.91 (9H, s C(CH3)3), 0.1

(3H, s, SiCH3), 0.13 (6H, s, SiCH3, SiCH3) and 0.10 (3H, s, SiCH3). 5C 155.9

78.9, 75.0 (CI), 74.3, 70.4, 61.6, 45.7, 39.9, 37.8, 26.1 (C(CH3)3), 26.0 (C(
18.1 (C(CH3)3 and C(CH3)3), -3.3 (SiCH3), -3.5 (SiCH3), -4.3 (SiCH3) and -4.6
(SiCH3). IR (KBr disc), 3462, 2959, 2932, 2859, 1736, 1472, 1253, 1151, and

836cm"1. Analysis calculated for C2iH42ClN05Si2, C 52.53, H 8.82 and N 2.
found C 52.62, H 9.03 and N 2.77%.

Oxidation of (lS,6S,7R,8R,8aR)-7,8-£w- M)utyldimethylsiloxy-l-(2'
chloroethyl)-l,5,6,7,8,8a-hexahydro-6-hydroxy-3//-oxazolo[3,4a]pyridin-3-one 234, with Ruthenium Tetroxide.

°H ^
TBDMSO v jJt v |?^i
7| 8a|

C l
A solution of carbon tetrachloride (4ml), acetonitrile (4ml),

0 2

TRDMSO°6v^'4"^tC3 water (6ml) ruthenium trichloride hydrate (28mg), 234
5
O
236
(140mg, 0.293mmol) and sodium periodate (lg) was

stirred at room temperature for two days. To this was added dichloromet
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the organic phase was separated. The aqueous phase was then further extracted with
dichloromethane (2 x 50ml). The combined organic extracts were dried and evaporated.
The resulting residue was diluted with diethyl ether (50ml) and filtered. Evaporation of
the sovent followed by flash column chromatography (dichloromethane), yielded starting
material 2 3 4

(20mg) and

(lS,6S,7R,8R,8aR)-l-(2'-chloroethyl)-7,%-bis- f-

butyldimethylsiloxy-l,5,6,7,8,8a-hexahydro-6-hydroxy-3//-oxazolo[3,4-a]pyridin-3one 236 (90mg, O.188mmol, 6 4 % ) as colourless crystals, m p 85.5-87 °C. Mass
spectra, (EI), m/z 420, 376, 244, 147, 129, 73 (100%), 57 and 41; (ES) m/z 478 (MH+,
calculated for C 2 i H 4 i 3 5 c i N O S i 2 , 478.2212; found 478.2200). N M R spectra, 8 H
(CDC1 3 , 300.1MHz), 4.82 (IH, m , HI), 4.12-4.25 (2H, m , H 5 and H6),3.98 (IH, d, J
= H 7 ) , 3.90 (IH, d, J = H8a), 3.69 (2H, m , H2'), 3.19 (IH, m , H5), 2.34-2.10 (2H,
m , HI') 8 C (CDCI3, 75.5MHz), 201.7 (C8), 156.5 (C3), 76.7 (C7), 72.5 (C6), 70.5
(CI), 63.6(C8a), 45.4 (C5), 39.6 (C2'), 38.1 (CT), 25.7, 25.6, 18.1, 17.8, -4.7, -4.9
and -5.0.
This reaction was then repeated using the same quantities as above, but the
mixture was stirred for eight days at room temperature. Workup of the reaction mixture
followed by flash column chromatography failed to yield any identifiable products.

Oxidation of a Mixture of the Carbamates 204 and 205 with Ruthenium
Tetroxide.

A solution of carbon tetrachloride (10ml), acetonitrile (10ml), water (12ml) ruth
trichloride hydrate (50mg), a mixture of the carbamates 204 and 205 (240mg) and
sodium periodate (lg) was stirred at room temperature for eight days. To this was added
dichloromethane (50ml) and the organic phase was separated. The aqueous phase was
then further extracted with dichloromethane (2 x 50ml). The combined organic extracts
were dried and evaporated. The resulting residue was diluted with diethyl ether (50ml)
and filtered. Removal of the sovent under reduced pressure followed by column
chromatography ( 1 0 0 % dichloromethane), yielded methyl (l'S,2R,5S)-2-(l'-f-
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butyldimethylsiloxy-3'-chloropropyl)-5,6-i'w-f-butyldimethylsiloxy-4hydroxypiperidine-1-carboxylate 240 (interconverting diastereoisomers 240a ^
as an oil, 40mg, ca 33%.
O rvruriiX*e

HO
Mass spectra, (EI), m/z 582 (M+ -C(CH 3 ) 3 ), 490, 422,
TBDMSO
358,
244 and
207;
(ES)
640 (MH+, 100%, calculated for
TBDMSO
5
!
CH3
'* 6 Y ^
O C28H59ClN07Si2 640.3288 found 640.3297). 8H
240a ^ 240b
(CDC1 3 , 399.9MHz), 5.00 (IH, d, H2) 4.78 (IH, d,
H2), 4.75 (IH, s, OH), 4.65 (IH s, OH), 4.45-4.30 (3H, m, HI', HI' and H6a)

(IH, d, H6a), 3.9-3.5 (14H, m, H6e, H6e, H3\ H3', H5, H5, OMe and OMe) and

2.0-1.8 (2H, m, H2'). 8C (CDCI3, 100.1MHz) 201.9 (C3), 201.6 (C3), 156.9 (C=0),
156.5 (C=0), 93.5 (C4), 93.3 (C4) 74.2 (C5), 74.0 (C5), 67.7 (CT), 67.5 (CI'), 66.1
(C2), 65.1 (C2), 52.9 (OMe), 52.8 (OMe), 44.4 (C3'), 43.7 (C3'), 39.4 (C2'), 39.2

(C21), 26.0, 25.8, 25.6, 25.6, 25.4, 22.7, 18.0, 17.9, 14.1, -2.7, -2.7, -2.8, -4.6, -4.

and -4.7. IR (neat) 3472, 2954, 2930, 2858, 1735, 1715, 1462, 1361 and 1253cm"

Sodium Borohydride Reduction of the Carbamates 240a, b.
!

2

O'"^ 3
A mixture of the diastereoisomeric carbamates 240a, b
H O 8aj> H U
g Y ^ ^ p ^ O T B D M S (150mg, 0.234), methanol (10ml) and sodium
%,.L

N

o^

TBDMSO* 7 ^ ^ 5 ^ Y ' "CH 3
borohydride (50mg, 1.35mmol) was stirred at room
O
243
temperature for two hours. The mixture was diluted with
acetic acid (20ml) and extracted with dichloromethane (2 x 50ml). Evaporation
dried extract yielded an oil. Purification of this oil by flash column chroma
ethyl acetate/petroleum spirit) afforded the methyl (4aS,7S)-4,7-fe/j-r-

butyldimethylsiloxy-2,3,4,4a,6,7,8-octahydro-8-hydroxy-5//-pyrano[3,2-fc]pyri

carboxylate as an oil (lOOmg, 0.210, 90%). Mass spectrum (ES) m/z 476 (MH+, 10
calculated for C22H46NOS12, 476.2891; found 476.2887). NMR spectra, 8H
(399.9MHz) 4.19 (IH, m H3), 4.13 (lH,m), 3.94 (IH, m, HlOa/e), 3.79 (2H, m, H5),
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3.77 (lH,m), 3.66 (3H, s, O M e ) , 3.58 (IH, m, HlOa/e), 3.47 (2H, bs), 1.80 (IH, m,
H4a/e), 1.43 (IH, m, H4a/e), 0.88 (C(CH 3 ) 3 ), 0.82 (C(CH 3 ) 3 ), 0.13 (SiCH3), 0.65
(SiCH 3 ) and 0.45 (Si(CH3)2); 8 C (100.1MHz), 76.3, 74.9, 70.7, 64.8, 61.5, 55.1,
52.5, 47.1, 30.1, 25.7, 25.6, 17.9, 17.9, -4.8, -4.8, -5.0 and -5.1

Preparation of (2R,3R,4R,5S)-2-(l'-hydroxypropyl)-piperidine-3,4,5triol 10.
3'
- ^

HO

V H f

A solution of the hydrochloride salt of 217 (16mg, 0.0847mmol)

HOV3AX^T:r
4

1

H

°

V5

MH
6*

OH

and e m a n

°l (10ml) was hydrogenated at room temperature and 1 atm

pressure of hydrogen in the presence of 5 % palladium on charcoal
(lOmg) as a catalyst. After stirring overnight, the mixture was
filtered and the solvent evaporated from the filtrate to give the HC1 salt of
(2R,3R,4R,5S)-2-(l'-hydroxypropyl)-piperidine-3,4,5-triol 10 as an oil41 (15mg,
0.0785mmol, 93%). Mass spectrum (EI) m/z 191 (M+ calculated for C g H i 7 N 0 4
191.1158 found 191.1179), 174, 160, 132 (100%) and 72. N M R spectra8 H 4.05 (IH,
ddd, 7 = 1.8, 7 = 5.62 and 7 = 8.62Hz, HI'), 3.81 (IH, m, H5), 3.66 (IH, dd, 7 =
9.28 and 7 = 10.38, H3), 3.53 (IH, m, H4), 3.50 (IH, m, H6a/e), 3.15 (IH, dd, 7 =
1.9 and 7 = 10.5, H2), 3.00 (IH, m, H6a/e), 1.62 (2H, m, H2') and 0.99 (3H, m,
H3'); 5 C 77.3 (C5), 69.4 (C3), 68.7 (CI1), 67.8 (C5), 62.8 (C2), 47.1 (C6), 27.6
(C2') and 10.9 (C31).
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